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Abstract 
Recent developments of Metabolic Control Analysis include the derivation of a 
general method (the Universal Method') which aims to define the conditions under 
which a pre-determined change in the flux to a specific end-point metabolite may be 
achieved without changing other fluxes or metabolite concentrations. This thesis 
describes the application of this method in the yeast, Saccharomyces cerevisiae, by 
overexpressing genes of the shikimate and tryptophan pathways and, by analysing the 
outcomes, attempts an evaluation of the method's validity. 
A single-copy plasmid, pPH28, bearing the 4 genes encoding the enzymes of the 
shikimate pathway was constructed and introduced into a strain along with a multi-
copy plasmid, pME554, bearing the 5 genes of the tryptophan pathway. In this way 
the activity of the shikimate enzymes and tryptophan enzymes were overexpressed by 
factors of about 2-5 and 20-60, respectively. The stability of the plasmids, both 
separately and together, under selective and non-selective conditions in different 
media was studied, along with enzyme activities. Results showed higher losses of 
plasmids for growth without selection, greater loss of the 2-micron plasmid than for 
the centromeric plasmid, and, in general, corresponding rates of loss of enzyme 
activities. 
The effects of the plasmids upon the production of tryptophan, phenylalanine and 
tyrosine were studied. pME554 and, subsequently, pPH28 had no observable effect 
upon the total flux to tryptophan, phenylalanine and tyrosine. pME554 did not 
significantly change the intracellular concentrations of these amino acids. However, 
when pPH28 was also introduced, intracellular tryptophan, phenylalanine and tyrosine 
concentrations increased by factors of 2-3. There were also corresponding changes in 
the amounts excreted into the medium. The failure to achieve increases in flux arises 
because flux to protein contributes most of the total flux, namely 97 - 99%. The 
dynamics of the production, excretion and re-uptake of aromatic amino acids are 
considered by estimating intracellular, extracellular and total culture concentration 
during culture. The role of anthranilate synthase in regulating intracellular 
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concentrations of tryptophan, and its effects upon tyrosine and phenylalanine 
concentrations are also investigated by feeding cells on anthranilic acid. 
The results show that, for tryptophan biosynthesis at least, the Universal Method is 
not an appropriate method of making large specific changes in flux. The method's 
failure is likely to arise from the lack of increased excretion of tryptophan at wild-type 
intracellular concentrations. The study suggests that the flux control coefficients of 
all the shikimate and tryptophan enzymes may be very low, and that the intracellular 




The application of microbiological fermentation by humans has a long history. Both 
yeast and bacteria, for instance, have long been used in the production of bread, milk 
products and alcoholic drink. Recently, there has been a trend toward a systematic 
study of micro-organisms and, more recently, plants to address the possibilities of 
other applications such as the production of food and nutrients, fuel, polymers, 
chemicals, drugs and antibiotics. This is now taking place in a context where a 
number of important dynamics are at play. The economics of industrial production 
are increasingly constrained by the costs and sustainability of raw materials, disposal 
of waste products and measures designed to improve health and safety. There is an 
awareness that the range and complexity of useful products such as enzymes and 
therapeutic agents produced by organisms outstrips conventional technologies. For 
instance, our growing understanding of enzymology may allow the design and 
production of new or modified catalysts. Finally, our exploitation of this potential by 
generating useful strains of bacteria, fungi, plants and animals with classical genetics is 
giving way to a more directed approach which uses our ability to identify, characterise 
and manipulate relevant genes. There is therefore considerable interest in the 
possibility of large and specific increases in the production of metabolites, using 
recombinant DNA technology to overexpress particular gene products, which may 
allow biotechnological exploitation. 
Initial attempts to generate increased production of metabolites by increasing the 
copy number of 'key' genes have generally been disappointing (Westerhoff, 1995). 
There is a growing appreciation that successful outcomes may be limited by the 
structure and organisation of metabolism which may regulate the operation of specific 
pathways and/or constrain the functioning of metabolism as a whole. These factors 
may limit the effects of rather simplistic strategies which seek to 'knock out' genes or 
to generate large increases in expression of key genes. However, it may be possible 
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to increase yields by large amounts if changes are made within a context which seeks 
to minimise the effects on other pathways. 
The project described here attempts to address experimentally the question 'how may 
we increase the production of a metabolite in a general, predictable and specific way? 
Generality requires that a strategy should be applicable to many different situations 
and problems. Predictability demands that we should be able to define the magnitude 
of the increase to be achieved. Specificity means that only the production of the 
defined metabolite should change. Such a strategy is in contrast to the traditional 
genetic methods by which strain manipulation, or mutation followed by selection, may 
produce a required phenotype, but which may give unexpected yields and produce 
other ill-defined changes. It is also in contrast with the simple application of 
recombinant DNA technology which may manipulate the activities of one or more 
'key enzymes. Such methods do not usually give predicted increases in production, 
nor are wild-type characteristics such as the growth rate or other pathway fluxes 
necessarily maintained. 
The context of the project is shaped by two fields. The first is the study of how 
metabolic systems respond in vivo to changes in enzyme activities. Metabolic Control 
Analysis (MCA) is one such approach. Although MCA deals with the effects of small 
changes in enzyme activity or metabolite concentrations, more recent developments 
have attempted the analysis of large changes. Furthermore, attempts have been made 
to predict how specific and predictable increases in metabolic flux or metabolite 
concentrations may be made. The model employed in this work, the Universal 
Method', attempts to define how increases in flux to any end-point metabolite may be 
achieved without concomitant change in other pathways. Secondly, the system 
chosen for the evaluation of this method is tryptophan biosynthesis in Saccharomyces 
cerevisiae. Studies of the enzymes, genes and regulation of this pathway have 
produced a large body of knowledge. It includes some progress in the understanding 
of the ways in which the pathway is regulated, attempts to overproduce tryptophan 
and more recently, analysis of the data, using the concepts, definitions and theorems 
of MCA. 
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The present work described in this thesis therefore attempts to apply a theory, called 
the Universal Method', whose roots lie in MCA, to tryptophan biosynthesis as an 
experimental model, building upon the successes of previous work. 
The project has the following goals 
• 	to apply the Universal Method' to tryptophan biosynthesis in yeast 
• 	to test the validity of the Universal Method' 
• 	to achieve increases in tryptophan production 
• 	to minimise changes in other closely-related pathways 
• 	to understand what factors may limit the effectiveness and 
applicability of the method 
The remainder of this introduction is organised as follows. The theoretical basis of 
Metabolic Control Analysis, its experimental confirmation and its application to the 
treatment of large changes are presented in section 1.1. This concludes with a 
description of the 'Universal Method'. Section 1.2 describes our present 
understanding of the structure of aromatic amino acid biosynthesis, including a brief 
introduction to transport and catabolism. Descriptions of the possible regulatory 
mechanisms are given. Section 1.3 attempts to analyse the control and regulation of 
flux and metabolite pools in the tryptophan pathway using the work of Niederberger 
and others who considered various mutations and their effects upon flux and 
metabolite pools within the pathway and the effects of overexpressing the enzymes. 
Finally, the objectives of the project are developed and experimental strategies 
outlined in section 1.4. Section 1.5 explains the structure of the thesis and the 
contents of each chapter. 
1.1 	Theoretical AsDects of Metabolic Control 
Traditionally, many biochemical texts and courses treated the question of regulation 
and control as 'add-on' features to the central concerns which were the identification 
of metabolic pathways and gene-enzyme relationships which culminated in the 
'metabolic map'. It is sometimes difficult to perceive much difference today, even 
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with the present concern for the control of gene expression, cell signalling and 
structure-function studies of biomolecules. Once the modulation of enzyme activity 
by effectors was understood, along with the phenomena of allostery, co-operativity, 
cascades, co-valent modification of protein and some principles of the regulation of 
gene expression, it proved all too easy to convince ourselves that we understood how 
metabolic pathways are controlled and regulated. According to this view, all that 
remained was to identify the feedback and regulatory circuits. 
This problem was (and to some extent still is) compounded by a number of factors. 
The dominant paradigm for the control of metabolic flux was the 'rate-limiting' step. 
For example, Lehninger (1975) wrote 
"There is now good evidence that the phosphofructokinase reaction is the major rate 
limiting reaction in glycolysis." 
Thus, if control mechanisms could alter the activity of an enzyme catalysing a 'rate-
limiting' step in a pathway, then this would change the flux in that pathway. 
Disturbing questions may be asked, such as; 'how is a rate-limiting step defined?' and 
'how much increase in flux is observed when an enzyme activity is increased by a 
given amount?'. It is probable that the discomfort wrought by these questions has 
contributed to the 'toning-down' of the terminology. Thus, Stryer (1988) wrote 
"Phosphofructokinase is the most important control element in glycolysis". 
Confusion is often increased when concepts such as first committed step, irreversible 
reactions and regulatory properties of an enzyme are introduced and applied 
uncritically. For instance, there often appeared to be an implicit (if not explicit) 
assumption that the regulatory properties of an enzyme was assurance that these 
enzymes control flux. For instance, Stryer (1988) explained that 
"the activity [of phosphofructokinase] increases when the ATP/AMP ratio is lowered. 
In other words, glycolysis is stimulated when the energy charge of the cell is low." 
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Without a rigorous definition of the question or terminology along with an attempt to 
quantify the variables involved, the discussion of how metabolism is controlled or 
regulated becomes fruitless. For instance, a relevant question might be 'what effect 
does the manipulation of a specific enzymatic step have upon metabolism'? This 
question is important to those wishing to understand metabolism and its regulation. It 
should also concern biotechnologists who wish to achieve specific goals such as 
increased metabolite concentrations or flux to end product. 
A number of systematic approaches have been developed. These provide a theoretical 
framework for the asking of questions, design of experiments and analysis and 
interpretation of results. The one most commonly used by both theoretical and 
experimental biochemists is Metabolic Control Analysis (MCA) (Kacser and Bums, 
1973; Heinrich and Rapoport, 1974) which is a form of sensitivity analysis. However 
other approaches such as Biochemical Systems Theory (Savageau, 1976) or the 'flux 
oriented' approach of Crabtree and Newsholme (1987) are available. MCA combines 
ease of use, mathematical simplicity and comprehensive theoretical and experimental 
development, and can be 'mapped' quite easily onto an intuitive concept of 
metabolism. For these reasons the other approaches are not discussed further. 
1.1.1 	Metabolic Control Analysis 
MCA provides a comprehensive framework for the understanding and quantitation of 
metabolic control. It tackles the basic question 'what is the effect on pathway flux or 
metabolite concentration if the activity of a specific enzyme is changed'? 
In addition to the original formulation of MCA (Kacser and Bums, 1973; also Kacser 
et al., 1995), there are a number of excellent reviews which discuss the central tenets 
of MCA, its development and its implications (Fell, 1992, 1997; Kacser, 1995; 
Westerhoffet al., 1984) 
MCA depends upon (Fell, 1992) 
a set of explicit assumptions regarding the metabolic system 
IVA 
. 	a set of definitions which quantify the response of the system and its 
elements and hence, 
a set of derived theorems 
Assumptions 
Metabolism consists of a set of enzymatic reactions which are interconnected by 
metabolites, the concentrations of which influence the rates of individual reactions. 
MCA studies the system at steady state, the characteristics of which include constant 
concentrations of metabolites, fixed source (substrates or nutrients) and sink 
(products or excretants) pools and constant fluxes within the pathway of the system. 
The system may be perturbed by changing a parameter (such as enzyme activity) by a 
small (strictly, limiting) amount, after which the system attains a new steady state, 
with new fluxes and metabolite concentrations. MCA deals with the comparison 
between these two states although subsequent developments have characterised the 
dynamic behaviour as the system relaxes (Melendez-Hevia etal., 1990; Easterby, 
1990). Parameters may be altered by the experimentalist; variables are dependent and 
will vary from one steady state to another when parameter values are changed. 
Enzyme activities are treated as parameters. They can be altered by site-directed 
mutagenesis, manipulation of copy number, inducible promoters, antisense RNA and 
specific inhibitors etc. Metabolites must be homogenous within compartments and 
enzyme activities should be proportional to concentration. Enzyme-enzyme 
interactions therefore need special treatment. Further developments in MCA have 
allowed some of these assumptions to be relaxed and have widened the scope of the 
analysis (Hofineyr et al., 1986; Fell and Sauro, 1990; Kacser et al., 1990; Sauro and 
Kacser, 1990). 
Definitions of MCA 
A central task of MCA is to quantitate how a system variable such as metabolic flux 
or metabolite concentration responds to the variation in a parameter (usually the 
enzyme activity). If a simple linear pathway consisting of enzymes with Michaelis-
Menten type kinetics is modelled then, for any of the enzymes in the pathway, there 
exists a hyperbolic relationship between flux through the pathway and enzyme 
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activity, as illustrated in Figure 1-lA. A number of important points may be 
understood by considering this relationship. The sensitivity of flux to small changes in 
the activity of an enzyme is related to the gradient of this graph at a particular point. 
When the flux and the enzyme activity are high, a change in the activity of an enzyme 
gives a small change in the flux. When the flux and enzyme activity are smaller, then 
the changes in flux brought about by small changes in enzyme activity are somewhat 
greater. The actual values will, of course, depend upon the precise kinetic parameters 
of the enzymes within the pathway, the activities of all the other enzymes in the 
pathway and the concentrations of the initial substrate and final product. 
The changes which occur when the system is perturbed by altering the value of one 
enzyme's activity may be considered by defining a 'flux control coefficient', C. as 
C.= urn a/jo 
bE-*0 bEIE O (1) 
where Ej is the activity of a defined enzyme, E is its initial value, 8E is a small change 





Thus the flux control coefficient is equal to the gradient of the function of pathway 
flux with respect to enzyme activity (Figure 1-lA), multiplied by a scaling factor (EIJ) 
so that the values obtained are independent of absolute fluxes, enzyme activities and 
the units used. The values of the control coefficients for the hypothetical pathway are 
given in Figure 1-lB. As the enzyme activity increases, the control coefficient 
decreases from unity when the flux is zero towards a value of zero at high enzyme 
activities and maximum flux. Three out of the four examples show coefficients of less 
than 0.1 at an enzyme activity of 1 (wild-type activity). This is reflected in the rather 
small changes in flux which result when enzyme activity is increased or decreased 
from wild-type activity. 
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Figure 1-1 	The relationships between pathway flux, flux control 
coefficient and enzyme activity 
These graphs show the relationship between flux (A) or flux control coefficient (B) 
and the activity of a single enzyme within a hypothetical pathway consisting of a 
linear sequence of enzymes whose kinetics behave according to Michaelis - Menten 
equations. An enzyme activity of 1 represents wild-type activity. 
The flux through the pathway is calculated according to the hyperbolic 
function J = aE/(b+E) where J = the pathway flux, E = enzyme activity, a = the 
maximum flux through the pathway and b = the enzyme activity giving half of the 
maximum flux. Thus the graphs are normalised so that a wild-type enzyme activity 
gives an arbitrary flux of 1. 
The control coefficients are calculated by multiplying the gradients of the 
graphs in A by a scaling factor = RE 
—a1.001,b=0.00I. 
—a=1,010 b0.010 
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There will be a coefficient for every flux-enzyme pair. Thus for example, Cis a 
measure of the sensitivity of the flux (W) through the tryptophan pathway to an 
infinitesimally small change in the activity of anthranilate synthase (as). Flux control 
coefficients will often be between zero and one. However, in some branched 
pathways a positive change in one enzyme activity may produce a reduction in flux in 
the other branch. This would be represented by a negative coefficient. Similarly, it is 
conceivable that a coefficient will be greater than one. This would occur lithe 
fractional flux change in a pathway were greater than the fractional change in an 
enzyme activity. 
In general, there will be a control coefficient C for every variable/parameter pair, 
where V may be a flux or metabolite concentration and P may be any parameter but, 
typically, is an enzyme activity. Thus there is also a metabolite concentration control 
coefficient, defined as follows. 
S 	dSE 
C = (3) E  
This defines the extent to which the concentration of a specific metabolite (S °) 
depends upon the activity of a given enzyme. This metabolite may or may not be a 
substrate, product or effector. Since an increase in enzyme activity will tend to 
decrease metabolite concentrations upstream of a particular step (e.g. the substrates) 
and increase metabolite concentrations downstream (e.g. products), these values may 
be positive or negative. 
It is vital to understand that control coefficients (flux or metabolite concentration) are 
system properties in that they may depend upon the species or strain, developmental 
stage, metabolic state, growth condition, media composition and genetic background 
etc. There is no simple way of predicting the control coefficients even if all the 
parameters of the system are identified and known. 
However, the system properties do emerge from the behaviour of enzymes in 
response to changes in the concentrations of effectors, as substrates, products, 
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activators and inhibitors. These effects may be considered using 'elasticity 
coefficients', which describe the effect of a change, 8S, in a metabolite Si,  upon the 
rate of a reaction v 1 , catalysed by the enzyme E 1 , at constant and prevailing 
concentrations of other effectors, and are defined as 
dvSr 
vi =j•;;- 	 (4) 
An elasticity coefficient therefore defines the responsiveness of the enzyme activity to 
changes in the concentration of an effector. Values will be positive for substrates 
(except when substrate inhibition occurs) and activators and negative for products and 
inhibitors. Although the elasticity coefficient is a 'local' property in that it does not 
depend upon the behaviour or properties of other elements in the system (such as 
other enzymes), it is essential to understand that it is dependent upon the enzyme's 
cellular milieu. Therefore, it is not possible to assume that the elasticity coefficient 
may be derived from kinetic parameters obtained from enzyme assays in vitro. Firstly, 
the enzyme's elasticity with respect to a given effector may be a complex function of 
the concentrations of any number of the cytosolic components. Secondly, the task of 
measuring these cellular concentrations is far from straightforward. Thirdly, even if 
these were definable, the effect of cellular location, supra-molecular organisation, and, 
even cytosolic structure may modify an enzyme's kinetic parameters. The conclusion 
is that, in most cases, elasticity coefficients must be measured not derived. 
In conclusion, two control coefficients have been defined. They measure how much 
the flux or concentration of a metabolite changes when an enzyme activity is modified 
by a small amount. Elasticity coefficients describe the response of an enzyme activity 
to small changes in the concentration of any effector within the system. 
Theorems of MCA 
The theorems of MCA were originally derived for simple linear pathways, and were 
gradually extended to more complex systems. They include the summation theorems 
which relate the flux (or metabolite concentration) control coefficient of all the 





formalises the statement that the sum of every enzyme's control coefficient, with 
respect to one specified flux, is equal to 1. Also, the metabolite control coefficient 
summation theorem, 
l c i = 0 	 (6) 
summarises the finding that the sum of every enzyme's metabolite control coefficient, 
with respect to a single specified metabolite concentration, is equal to zero. These 
theorems constrain the allowable values of control coefficients for a particular flux or 
metabolite concentration. For instance, if an enzyme is truly rate-limiting (control 
coefficient = 1) for a particular flux, then all other control coefficients must be equal 
to zero, unless another enzyme has a negative control coefficient. They also allow the 
possibility that many or all enzymes contribute to the control of flux or metabolite 
concentration. 
Other theorems have been derived, including the important connectivity theorems. 
These relate elasticities and control coefficients. They suggest how values of control 
coefficients depend in a complex manner upon the elasticities (and hence the kinetic 
properties) of the enzymes and place limits upon the values of control coefficients and 
emphasise how they are systemic properties, not properties of isolated enzymes. They 
also allow the determination of control coefficients provided that the elasticities of the 
enzymes are known. In some cases, it may be easier to determine these, rather than to 
make direct and accurate estimates of the control coefficients. Essentially they can 
form a set of simultaneous equations which may be represented and solved in matrix 
form (Fell and Sauro, 1985, Sauro et al., 1987). 
Implications of the theorems of MCA 
The flux summation theorem (Equation 5) formalises the following observations. 
All enzymatic steps have the potential for some control 
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. 	There are constraints on the values which the control coefficients may 
have 
. 	Most enzymes will have very low flux control coefficients 
. 	The number of enzymes with significantly high flux control coefficients 
will be limited 
. 	If there is a change in one control coefficient, there will be complementary 
changes in one or more of the others 
These implications have now been supported by experimental determination of control 
coefficients in defined pathways. 
Experimental applications of MCA 
The theoretical results of MCA guide the development of relevant experiments 
designed to probe how control is distributed in biological systems. Conversely, 
experimental work has confirmed the central theorems of MCA and suggested new 
directions for development. A full review of the experimental justification of MCA is 
outside the scope of this review. Therefore, only some data are presented to illustrate 
the implications of the theorems of MCA, in contrast to Fell (1992) whose excellent 
and comprehensive review is organised on the basis of the various methodologies 
employed. 
The summation theorems suggest that control may be shared amongst all the enzymes 
of the system. This has been confirmed for the control of oxidative phosphorylation 
in intact mitochondria, studied by Groen et al. (1982), using specific inhibitors for the 
adenine nucleotide translocator, dicarboxylate carrier, cytochrome c oxidase and the 
bcj complex. In respiratory state 3, values of the control coefficients were 0.29, 0.33 
and 0.17 respectively. The control coefficients for the bcj complex, proton leakage 
and hexokinase were 0.03, 0.04 and 0.0, respectively. These values sum to 0.86. 
Values for succinate dehydrogenase and ATP synthase were left undetermined. Thus 
there is no 'rate-limiting' step, in the sense that one particular step, and no other, has 
control of flux. Alternatively, most of the steps are 'rate-limiting' in the sense that 
they show some control of flux. 
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Another implication of MCA is that many control coefficients will have low values. 
Since most experiments deal with limited pathways and measure only enzymes closely 
associated with the relevant flux, the flux control coefficients for only small numbers 
of enzymes are available. Nevertheless, the occasions when these have values greater 
than 0.5 are rare. Flint etal. (198 1) used heterokaryons in Neurospora crassa, 
containing various doses of genes encoding four enzymes of arginine synthesis. The 
control coefficients of all of these enzymes were less than 0.1. This, of course, also 
suggests that significant control is contributed by enzymes more distal to the arginine 
pathway. 
Of particular relevance to this study is the work of Miozzari et al. (1978a) who 
considered the effect of gene dosage in the tryptophan pathway in S. cerevisiae by 
constructing a tetraploid gene dosage series and measuring growth rate. The data fit 
rectangular hyperbolae (as in Figure 14A) and allow the determination of control 
coefficients with respect to growth rate. Of the five enzymes of the pathway, four 
have coefficients less than 0.04, while the other, phosphoribosyltransferase, has a 
coefficient of only 0.174. The sum of the five coefficients is 0.258, indicating that 
most of the control lies outwith those steps specific to tryptophan biosynthesis 
(Niederberger et al. 1992). 
In view of the status of phophofructokinase as the classic example of a 'rate-limiting' 
enzyme, the result that a five-fold increase in the enzyme leads to no change in 
glucose consumption or ethanol production in yeast in anaerobic culture and only a 
30% increase under aerobic conditions, is important (Davies and Brindle, 1992). It 
suggests that its control coefficient is probably no more than 0.2 even under aerobic 
conditions. 
The distribution of control coefficients may change as the environmental conditions, 
genetic composition or metabolic state of the system changes. For example, Stiff et 
al. (199 1) considered the control coefficient of ribulose bisphosphate carboxylase 
(rubisco) upon carbon assimilation under different conditions of light intensity, partial 
pressure of carbon dioxide and relative humidity. At wild-type rubisco levels, control 
coefficients changed from 0.7 to 0.1 on reduction of light intensity, 0.8 to 0.1 when 
the partial pressure of carbon dioxide was reduced and 0.75 to 0.5 when humidity was 
reduced. The contributions of other steps were not considered. 
Finally, MCA suggests, as a corollary, that large changes in activities may have rather 
small effects on flux. Thus in glycolysis, separate large increases in the expression of 
most of the enzymes of glycolysis, including hexokinase, phosphoglucose isomerase, 
phosphofructokinase, pyruvate kinase etc., gave small changes in flux (Schaaff et al., 
1989). Similar results have been obtained when the enzymes of tryptophan 
biosynthesis are overexpressed (Niederberger et al., 1992). This effect can, of course, 
work in the opposite direction. An example which cautions against the uncritical use 
of enzyme inhibitors for therapeutic applications shows that even a small reduction in 
purine biosynthesis (10% reduction in flux) requires a very large reduction (86%) in 
the activity of the enzyme phosphoribosylglycinamide transformylase by the use of a 
specific inhibitor (Smith et al., 1990). However, the two situations are not 
symmetrical. In overexpression of enzyme activity, a control coefficient may well 
decrease as the enzyme activity rises, leading to a situation of 'diminishing returns'. 
However, when an enzyme activity is decreased, the flux control coefficient tends to 
increase. Thus the effect on flux becomes greater as increased inhibition is obtained. 
These effects may be simply visualised with reference to Figure 1-1. 
Results such as those described above illustrate why most deleterious mutants in 
genes for enzymes are recessive in diploid organisms. For many enzymes and fluxes, 
a halving of activity will result in an insignificant change in flux or metabolite 
concentration. The phenotype is thus not apparent. Indeed, the explanation for the 
dominance of wild-type genes in terms of the central concepts and theorems of MCA 
has been comprehensively developed (Kacser and Bums, 1981). The phenomenon 
can be viewed as a simple consequence of the summation theorem which formally 
acknowledges that control may be spread over many enzymes, often in pathways 
remote to the local pathway in question; hence, most enzymes have low flux control 
coefficients. 
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Taken as a whole, the data from experimental work described here show why the 
analysis of control in pathways according to the concept of rate-limiting enzymes is 
often misleading, ambiguous or simplistic. 
1.1.2 	Large chances 
Classical MCA deals with small (strictly speaking, infinitesimal) changes in 
parameters. However, the changes occurring in organismal development and cell 
differentiation or demanded by industrial concerns may be very large. Is there any 
way of extending MCA into a treatment of such changes? 







where AJ and AE represent the difference between final values of flux, Jr, and enzyme 
activity, Er,  and initial values (JO  and E0).  Note that this is analogous to the definition 
of a flux control coefficient. Large defined differences have replaced small changes 
and the scaling factor (YIE) refers to the flux and enzyme activity at the values after 
the large change, while the control coefficient uses a scaling factor which refers to 
these parameters before the small change. Given important simplifying assumptions 
about the kinetics of enzymes in the pathway (with respect to linearity etc.), they 
show that the deviation coefficient is equal to the control coefficient. 
DJ =C 	 (8) 
The theorems of control analysis are then derived for the deviation indices. These 
results were tested and supported by consideration of data from tryptophan 
catabolism and glucose metabolism in rat liver and the growth rate responses to - 
galactosidase activity in Escherichia coli. This gives some support to the idea that 
large changes may be considered in control analysis, in certain limited situations where 
the quali1ring assumptions may be justified. 
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Subsequently, Kacser and colleagues have applied these concepts to the possibility of 
generating large changes in flux (Kacser and Acerenza, 1993) or metabolite 
concentration (Small and Kacser, 1984) by using DNA technology in a 
biotechnological context. 
1.1.3 	'The 'Universal Method" 
The Universal Method' (Kacser and Acerenza, 1993) defines the changes in enzyme 
activities required to achieve a predetermined and large increase in a specific output 
whilst maintaining all metabolite pools and (thereby) all other fluxes at unchanged 
levels. It is illustrated in Figure 1-2 and its features are described below. 
Sections of pathways between branch point metabolites are the units of 
manipulation. Increases in enzyme activities (enzyme multipliers, r) are 
applied to all enzymes in a given section. 
• 	Sections upstream of the output flux may be considered in turn. In order 
to maintain constant fluxes in side-branches, the absolute increase in flux 
(namely iJ) will be the same in all sections of the main pathway. 
• 	Since fluxes of upstream sections are larger (by the magnitude of flux in 
branch pathway), i.e. J3 = J2 + J, the ratio of the absolute flux increase to 
the original flux (AJ/J) decreases as upstream sections are considered in 
turn. 
The enzyme multipliers to be applied within each section are a function of 
this ratio, namely 
AJ 
(9) jo 
r2 =1 	 (10) 
AJ r3 	1+ 	 (11) 
J 
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Figure 1-2 The universal method 
A model branched pathway is represented schematically. Substrates (S) are converted 
to the branchpoint metabolite (B) in a series of enzymatic reactions (section 3). The 
branchpoint metabolite forms product (P) through section 1. A side-branch (section 
2) produces other metabolites (M). The original fluxes in the three sections are 
shown (in green) as J° (with subscripts 1,2 or 3). The original enzyme activities are 
represented (in yellow) as E ° (with subscripts). At steady state 
TO TO TO 
'3 	'2 	J1 
Changes are made to all enzyme activities within sections of the pathways in order to 
generate new fluxes. These are represented as I (with subscripts 1,2 or 3). The 
absolute change in flux in section 1 is AJ, such that 
jr =AJ+J 
The new enzyme activities within the sections of the pathway are E 1 (with subscripts 
1, 2 or 3). Original and final enzyme activities are related to the 'enzyme multipliers' 




Note however, that the flux in the side-branch remains unchanged and therefore 
Tr - 
' 2 	"2 
Also the concentrations of the metabolites, S, B, M and P remain unchanged as well 
as those of all intermediate metabolites in all three sections. 
By over-expressing 
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. 	As sections further upstream are considered, J becomes progressively 
larger and, therefore, r, becomes smaller (as AJ becomes smaller in 
relation to J''). Smaller increases in enzyme activities are therefore 
required. 
A given increase in output flux may be achieved by overproducing 
enzymes of the final section by a specified amount, rj where 
AJ 
r1 = 1+ 	 (12) 
TO 
J1 
. 	rj is therefore equal to the 'flux multiplier',fj, given by 
jo 
	 (13) 
Enzymes in side branches are left unchanged since AJ = 0. Metabolite 
pools concentrations within sections of pathways and at branch points will 
remain unchanged. Therefore, fluxes in branch pathways will also remain 
unchanged. 
To summarise, the overall output flux in the pathway may be pre-set. The fluxes in 
side-branches and all metabolite concentrations are required to remain unchanged. 
Most importantly therefore, a knowledge of the regulatory network is unnecessary. 
The maintenance of metabolite pools ensures that factors such as enzyme inhibition or 
activation, modulation of enzyme expression by induction, de-repression and 
transcriptional activation etc. should remain unchanged. The only data required are 
the relative fluxes of the various branches with respect to the fluxes in sections of the 
main pathway. The methodologies required to implement the defined increases in 
enzyme activity are not defined but may include changing the copy number of the 
corresponding genes and the use of heterologous, variable and inducible promoters. 
The organisation and regulation of aromatic amino acid biosynthesis is discussed in 
the following sections so that the experimental application of the 'Universal Method' 
to this system may be introduced in section 1.4. 
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1.2 	Aromatic Amino Acid Biosynthesis 
The considerable interest shown in aromatic amino acid biosynthesis probably derives 
from a number of factors. It has a central importance in the biosynthesis of aromatic 
(and related) compounds which are essential to the production of a range of 
'secondary metabolites' among which are included many candidate compounds with 
antibiotic or therapeutic properties. It also has industrial relevance for the production 
of economically important chemicals such as indigo, tryptophan, p-aminobenzoic acid, 
adipic acid etc. Thus, aromatic biosynthesis serves as a paradigm for how biocatalysts 
can be manipulated to achieve the yield, rate and purity criteria central to chemical 
manufacture (Frost and Draths, 1995). Also, because the biosynthesis of tryptophan, 
phenylalanine and tyrosine is limited to archaebacteria, eubacteria, plants and fungi 
(Braus, 1991), chemical species which specifically inhibit the enzymes of these 
pathways may be promising candidates for herbicides, and anti-bacterial or -fungal 
agents. Finally, the low concentrations of tryptophan within the cell, the low 
percentage of all three aromatic amino acids in protein, the high energetic costs of 
making tryptophan, phenylalanine and tyrosine, and the branched-nature of the 
pathway make it an excellent system for the study of biosynthetic regulation. 
An outline of the tryptophan biosynthetic pathway is illustrated in Figure 1-3. The 
genes, enzymes and effectors of enzyme activities inS. cerevisiae are shown in Figure 
1-4. The synthesis involves a common pathway, called the shikimate pathway which 
was first identified and characterised by Davis and co-workers during the early 1950's 
(Davis etal., 1955). The shikimate pathway uses intermediates of glycolysis 
(phosphoenolpyruvate (PEP)) and the pentose phosphate pathway (erythrose-4-
phosphate (E4P)) to produce a branch-point metabolite, chorismic acid. From here, 
tryptophan is synthesised via the tryptophan pathway and tyrosine and phenylalanine 
are synthesised via the prephenate pathway. Several important metabolites, such asp-
aminobenzoate and ubiquinone, are also synthesised from chorismic acid. A number 
of reviews focus on specific parts of the pathway. For example Bentley (1990) gives 
a detailed review of the shikimate pathway including details of the multiple branches, 
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Figure 1-3 The tryptophan biosynthetic pathways 
Above, from the precursors, phosphoenolpyruvate (PEP) and erythrose-4-phosphate 
(E4P), the shikimate pathway produces the branch-point metabolite chorismic acid 
(CHA). Intermediates shown are 3-deoxy-D-arabino-heptulosonate7-phosphate 
(DA}{P), 3-dehydroquinate (DHQ), 3-dehydroshikimate (DHS), shikimate (SHK), 
shikimate 3-phosphate (S3P) and 5-enolpyruvyl shikimate 3-phosphate (EPSP). 
Below, tryptophan is synthesised from chorismic acid through the tryptophan 
pathway. Intermediates shown are 2-amino-2-deoxy-isochorismic acid (A), 
anthranilate (B), phosphoribosylanthranilate (C), 1-(2-carboxyphenylamino)-1-
deoxyribulose 5-phosphate (D) and indoleglycerol phosphate (E). 
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Figure 1-4 Enzymes and genes of aromatic amino acid 
biosynthesis 
The genes of the shikimate pathway (ARO) and the tryptophan pathway (TRP) are 
shown in blue, while the activities encoded are shown in green. For the prephenate 
pathway, only the gene (AR07) encoding the first enzyme, chorismate mutase, is 
shown. 
Red dashed lines indicate feedback inhibition of enzyme activity. Green dotted line 
indicates tryptophan relieving inhibition of chorismate mutase by tyrosine. The black 





AR03, AROI 	DAHP synthases (phe, tyr inhibitable) 	 inhibition 
ARC)] 	AR(M complex 
(inc. DHQ synthase, DHQ-ase, shikimate dehydrogenase, 
shikirnate kinase and EPSP synthase) 	 : 
ii 
ARO2 	Chorismatesynthase 
__________________ 	- - - Chorismic 	 Phenylalanine  
ARO7 Chorismate mutase and Tyrosine - - - 
acid 
	
TRP213C 	Anthranilate synthase - - - - - - - 
TRP 4 Pho sphoribo syl- anthranilate transferase 
TRP 1 	Pho sph oribosyl-anthranilate is om erase 
JRP3B Indole-glyceroiphosphate synthase 	feedback 
TRP5 	Trvptophan synthase 	 inhibition 
Tryptophan .- ............................................................. 
while Hutter et al. (1986) reviews the tryptophan pathway. Specific aspects of the 
genomic organisation of the genes, association of enzymes and activities and the 
regulatory mechanisms (at the level of transcription, translation and the kinetic 
behaviour of enzymes) differ considerably in different species (Henner and Yanoky, 
1993). For instance, genes of the tryptophan pathway in Escherichia coli are located 
in the trp operon which allows co-ordinate regulation of gene expression, while S. 
cerevisiae has tryptophan genes distributed over the genome but whose expression 
may be co-ordinated by the action of a common transcriptional activator, GCN4 
(Hinnebusch, 1988). Interestingly, S. cerevisiae and other fungi, such as Aspergillus 
nidulans and Neurospora crassa also have a multi-functional enzyme complex (the 
AROM complex) in the shikimate pathway, which has also been considered as a 
means of co-ordinate regulation (Duncan et al., 1988). Therefore, other reviews limit 
themselves to a discussion of the organisation and regulation of the pathways in one 
species or within a group of closely related organisms. For example, Pittard (1987) 
and Henner and Yanofsky (1993) discuss biosynthesis of aromatic amino acids in 
enteric bacteria and gram-positive bacteria, respectively. The most relevant review in 
the context of this study is that of Braus (1991) who reviews aromatic amino acid 
biosynthesis in S. cerevisiae and focuses upon gene-enzyme relationships, the 
regulation of the pathway at the level of transcription, mRNA stability and translation 
and the modulation of enzyme activity by metabolite inhibition and activation. The 
following sections review knowledge of the genes and enzymes of the shildmate and 
tryptophan pathways relevant to this study. A brief review of tryptophan catabolism 
and the transport of aromatic amino acids into the cell is also included. Finally, the 
possible mechanisms of regulation and control are summarised. 
1.2.1 	The shikimate nathwa 
Seven activities are encoded by four genes. The first activity, 3-deoxy-D-arabino-
heptulosonate-7-phosphate (DA}{P) synthase is executed by two isoenzymes, 
encoded by the genes AR03 and AR04, which have feedback sensitivity to 
phenylalanine and tyrosine, respectively. The next five activities, 3-dehydroquinate 
(DHQ) synthase, 3-dehydroquinate dehydratase (3-dehydroquinase), shikimate 
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dehydrogenase (SDH), shikimate kinase and 5-enolpyruvyishikimate phosphate 
(EPSP) synthase constitute the pentafunctional AROM complex, encoded by the gene 
ARO1. Lastly, chorismate synthase is encoded by AR02. Details of the genes and 
enzymes are shown in Table 1-1. 
DAHP synthase (AR03 and ARO'() 
The condensation of erythrose-4-phosphate and phospho-enol-pyruvate in an aldol-
type condensation is carried out by two differentially regulated isoenzymes encoded 
by the genes AR03 and AR04. They share 61% amino acid identity. The cognate 
genes have both been cloned and sequenced (Paravicini et al., 1988; Kunzler etal., 
1992). 
The AROM complex (AROJ) 
This multi-functional protein, encoded by AR01 located on chromosome IV, catalyses 
5 activities; DHQ synthase (which achieves ring closure), 3-dehydroquinase (which 
introduces the first ring double bond), SDH, shikimate kinase and EPSP synthase. 
The gene has been cloned (Larimer etal., 1983) and sequenced (Duncan etal., 1987). 
The five genes corresponding to these activities are termed ARO1C, AROJE, 
AROJD, AROJB, ARO1A, as judged by sequence similarity with the homologous 
genes in E. coil. These are not co-linear in the AR01 gene. Instead the order of 
genes is ARO1C, ARO1A, AROJB, ARO1D, ARO1E (Duncan etal., 1987). 
The AROM complex has attracted speculation that it may show channelling 
characteristics (Welch and Gaertner, 1975). Channelling crudely means that an 
intermediate metabolite does not fully equilibriate with the bulk cytosol. it is a 
complex phenomenon. For example, definitions of channelling make a distinction 
between static and dynamic channelling. Also, the criteria used to determine and 
distinguish channelling phenomena experimentally are not obvious. It should, 
therefore, come as no surprise that some controversy has occurred over the question 
of whether channelling occurs in the AROM complex (for review, see Lamb et a!, 
1997). 
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Gene Gene Activity E.C. Amino homologous Reference 
product (inc. regulation) number acids E. coli gene 
AR03 DAHP inhibited by phenylalanine 4.1.2.15 370 aroF Paravicini etal. (1988) 
AR04 synthase inhibited by tyrosine 370 aroG Kunzler et a! (1992) 
AROJ AROM 1,588 Duncan etal. (1987, 
complex 1988) 
AROJC DHQ synthase 4.6.1.3 1-392 aroB 
ARO1E 3-dehydroquinase 4.2.1.10 1059-1293 aroD 
AROJD Shikimate dehydrogenase 1.1.1.25 1306-1588 aroE 
ARO1B Shikiniate kinase 2.7.1.71 886-1059 aroL 
ARO1A EPSP synthase 2.5.1.19 404-886 aroA 
AR02 Chorismate 4.6.1.4 376 aroC Jones etal. (199 1) 
synthase 
Table 1-1 	Enzymes and genes of the shikimate pathway 
The chromosomal locus of the genes are given in the text. The amino acids coding for activities on the multi-functional AROM complex are 
derived by similarity with the homologous E. coil genes. 
Chorismate synthase (4R02) 
Chorismate is formed from EPSP by the loss of phosphate and the introduction of 
another double bond in the ring structure. Chorismate synthase is encoded by AR02 
located on chromosome VII. It has been cloned and sequenced (Jones etal., 1991). 
Although the enzymes from all of the species studied so far have a requirement for a 
reduced flavin cofactor, they may be classified into two groups. One, including the 
enzyme from bacteria, algae and plants, does not have an intrinsic NADPH-dependent 
flavin reductase (diaphorase) activity (Horsburgh et al., 1996) while those from the 
fungi Neurospora crassa (Henstrand et al., 1995) and S. cerevisiae (Jones et al., 
1991) both have this activity. 
1.2.2 	The tryptophan pathwa 
Five enzymatic steps convert chorismic acid into tryptophan. The five enzymes are 
anthranilate synthase, phosphoribosyl - anthranilate transferase, phosphoribosyl - 
anthranilate isomerase, indole glycerophosphate synthase and tryptophan synthase. 
Table 1-2 summarises data relating to the pathway's genes and enzymes. A review 
specific to the tryptophan pathway is given by Crawford (1989). 
Anthranilate synthase (TRP213C) 
Anthranilate synthase activity resides in a bifunctional complex consisting of two 
subunits encoded by TRP2 and TRP3. This complex also catalyses the fourth reaction 
of the pathway (indole glycerophosphate synthase, see below). The genetically 
defined TRP3C contributes a glutamine amidotransferase activity to the complex. 
Both genes have been cloned and sequenced (Aebi etal., 1984; Zalkin etal., 1984). 
Phosphoribosyl - anthranilate transferase (TRP4) 
This enzyme catalyses the transfer of a 5-phosphoribosyl moiety from 5-
phosphoribosylpyrophosphate to the amino group of anthranilic acid to give 
phosphoribosylanthranilate. The TRP4 gene has been cloned and sequenced (Furter 
etal., 1986). 
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Amino Homologous Reference 
Gene 	Enzyme name 
	Activity 	E.C. 	acids 	to E. coli 
	
number (no.) gene 
4.2.1.10 	224 	trp(C-)F Tschumper and 
Carbon (1980) 
4.1.1.48 	(218-484) 	trpC(-F) Zalkin etal. (1984) 
4.2.1.20 	707 	1-239trpB Zalkin and Yanofsky 
319-707trpA (1982) 
TRP2 






TRP3B Indole-3-glycerol phosphate 
synthase 
TRP5 	Tryptophan synthase 
anthranilate synthase 	 528 	trpE 	Aebi et al. (1984) 
4.1.3.27 
	
Zalkin etal. (1984) 
glutamine-amido transferase 
	
1-206 	trpG(-D) 	Pranti etal. (198 5) 
2.4.2. 18 
	
380 	trp(G-)D 	Furter et al. (1986) 
Table 1-2 	Enzymes and genes of the tryptophan pathway 
The relationship between anthranilate synthase and indole glycerol phosphate synthase activities and the genes TRP2 and TRP3 are explained 
in the text. 
Phosphoribosyt - anthranilate isomerase (TRPJ) 
This enzyme catalyses an essentially irreversible rearrangement, involving an internal 
redox reaction which yields carboxyphenylamino- 1 -deoxyribulose-5-phosphate. The 
gene was cloned by complementation of an E. coil ip mutant and was used in some 
first generation yeast vectors. The sequence of TRP1 has been determined 
(Tschumper and Carbon, 1980). 
Indole-3-glycerol phosphate synthase (TRP3B) 
This enzyme catalyses the decarboxylation of carboxyphenylamino- 1 -deoxyribulose-5-
phosphate and closure of the second ring to give indole-3-glycerol phosphate. It is 
encoded by the 3' half of the TRP3 gene. 
Tryptophan synthase (TRPS) 
In the final reaction of the tryptophan pathway, indole-3-glycerol phosphate is cleaved 
and indole condensed with serine to yield tryptophan. In most organisms, these two 
reactions are catalysed by two separate proteins but in S. cerevisiae and Neurospora 
crassa, the two activities are present on one polypeptide. In all cases, however, there 
are two distinct active sites on opposite sides of the protein or complex. Indeed there 
is now overwhelming evidence that, in enteric bacteria the intermediate, indole, 
diffuses directly from one active site to the other (Yanofsky, 1989) through a 'tunnel' 
which passes through both subunits (Hyde et ai., 1988) of a complex. The function of 
this arrangement may be the avoidance of unwanted side reactions by the intermediate 
indole or the generation of favourable thermodynamic conditions (Pan et al., 1997; 
West, 1997). The gene from S. cerevisiae has been cloned and sequenced (Zalkin and 
Yanofsky, 1982). 
1.2.3 	The prephenate pathwa 
Chorismic acid is converted into phenylalanine and tyrosine by five reactions. Firstly, 
chorismate mutase, encoded by the gene AR07 catalyses the intramolecular 
rearrangement of chorismate to form prephenate. This product is converted to 
phenylpyruvate and 4-hydroxyphenylpyruvate by prephenate dehydratase (encoded by 
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PHA2) and prephenate dehydrogenase (TYRJ), respectively. Two aminotransferases 
then yield phenylalanine and tyrosine. There may be an important role for chorismate 
mutase in the regulation of the pathway. The regulatory properties of this enzyme are 
discussed below in section 1.2.6. 
	
1.2.4 	Tryptophan transport 
A number of genes involved in the transport of amino acids across the cell wall and 
membrane have been identified by biochemical and genetic methods while others have 
been suggested on the basis of sequence data now available (Andre, 1995). Both 
non-specific and specific transport systems co-exist. There is a general amino acid 
permease, encoded by GAP1 (Jauniaux and Grenson,, 1990) which is repressed 
completely in the presence of ammonia (Grenson etal., 1970). Among the specific 
permeases identified are TAT] and TAT2 (also called TAP2 or SGMl) which show 
specificity to the aromatic amino acids (Heitman etal., 1993; Chen etal., 1994; 
Schmidt etal., 1994). TA T2 shows particular specificity for tryptophan, while TAT] 
has specificity for tyrosine (Schmidt et al., 1994). 
It is generally assumed that these transporters (proton antiporters) function uni-
directionally in fuvour of uptake and that excretion must therefore occur through non-
specific diffusion mechanisms. However this question appears not to be fully 
resolved. 
1.2.5 	Catabolism of aromatic amino acids 
Kradolfer et al. (1982) identified the products of degradation of tryptophan and 
partially characterised the enzymes involved. Tryptophol is the main product, the first 
step being catalysis by a trans- or de-aminase to indole-pyruvate, presumably followed 
by decarboxylation and reduction. Two aminotransferases are involved, encoded by 
the genes, AA TI and AA T2. The former is a low affinity enzyme with a Km = 6 m 
with respect to tryptophan with 2-oxoglutarate as amino acceptor. AA T2 has a higher 
affinity with a Km = 0.2 - 0.4 mM and phenylpyruvate as amino acceptor. They both 
show a greater affinity for phenylalanine and tyrosine. In contrast with the affinities to 
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tryptophan, AA TI shows a much greater affinity for phenylalanine and tyrosine than 
AA T2. AA T2 is induced by media containing tryptophan or phenylalanine as nitrogen 
source. AAT1 is therefore proposed to catalyse the final reactions in the biosynthesis 
of phenylalanine and tyrosine while AAT2 is predominantly responsible for catabolic 
degradation. Kradolfer et al. (1982) also isolated an aat2 mutant strain, R11805. This 
showed an increase in the excretion of tryptophan, due to increases in the intracellular 
concentration of tryptophan. 
1.2.6 	Re2ulatory mechanisms in the pathway 
The biosynthesis of aromatic amino acids incur high energetic costs. It would 
therefore be surprising if the intracellular concentrations of these amino acids were 
not highly regulated. Indeed the intracellular concentrations of tryptophan, 
phenylalanine and tyrosine, reported to be 20, 500 and 600 j.tM, respectively (Fantes 
etal., 1976; Messenguy etal., 1980), are amongst the lowest of the amino acids. 
The possible regulatory mechanisms functioning in aromatic amino acid biosynthesis 
are now reviewed. 
Regulation of enzyme activity 
The network of effectors acting upon enzymes of the shikimate, prephenate and 
tryptophan pathway are shown as broken lines in Figure 1-4. In vitro analysis of 
purified or partly purified enzymes show that the first enzymes of the shikimate 
pathway, DAHP synthase, encoded by the genes AR03 and AR04 are inhibited by 
phenylalanine and tyrosine, respectively (Takahashi and Chan, 1971; Paravicini et al., 
1989b). Tryptophan has no detectable effect upon them. Anthranilate synthase 
activity is inhibited by tryptophan. This is competitive with respect to chorismate (K 
= 56 .tM) (Prantl et al., 1985). Mutants with feedback resistant anthranilate synthase 
activity have been isolated (Fantes, et al., 1976). There is a TRP2 allele which 
encodes a feedback-insensitive enzyme with a single amino acid substitution (Graf et 
al., 1993). Chorismate mutase, which catalyses the first step of the prephenate 
pathway to phenylalanine and tyrosine, shows co-operative kinetics with respect to 
chorismic acid. The enzyme is inhibited by tyrosine. Tryptophan relieves this 
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inhibition and activates the enzyme by negating the positive co-operativity 
(Scbmidheini etal., 1990). 
This network therefore conforms to some of the classical patterns of enzyme 
regulation in metabolism, whereby initial (first committed) steps are inhibited by end 
products and where cross regulation exists between two branches of a common 
pathway. 
Regulation of gene expression and 'general control' 
Most of the genes of the tryptophan pathway and the shikimate pathway are subject to 
de-repression of gene expression. This phenomenon is an example of 'general control 
of amino acid biosynthesis' (Schurch etal., 1974; Delforge etal., 1975; Hinnebusch, 
1988) whereby a general derepression of enzymes in amino acid biosynthetic 
pathways such as histidine, arginine, lysine, tryptophan, isoleucine, valine and leucine 
occurs in response to starvation by one, or more, amino acids. Such limitations of an 
amino acid can occur in bradytrophic (slow growing in absence of exogenously 
supplied nutrient) mutants (Niederberger et al., 1981), with the use of analogues such 
as 5-methyl tryptophan (Schurch, et al., 1974) or in media lacking amino acids. A 
study of the genetics of this system has yielded two classes of mutants, gcd (general 
control derepressed) and gcn (general control non-derepressible, formerly aas, or 
amino acid analogue sensitive). The gene product GCN4 is a transcriptional 
activator, required for general control. It has similarities with the human c-jun 
oncoprotein (StruM, 1987). It has a 'leucine zipper' structure characteristic of DNA 
binding proteins which require dimerisation (Agre et al., 1989). It activates 
transcription in the general control aromatic amino acid biosynthesis (Hinnebusch and 
Fink, 1983) which leads to an increase in the activity of enzymes of the tryptophan 
and shikimate pathway (Miozzari etal., 1978a), amongst others. The GCN4 binding 
site, the GCN responsive element (GCRE) is well characterised, having a consensus 
sequence ATGA(C/G)TCAT, usually varying from this at one or two positions (Arndt 
and Fink, 1986; Oliphant et al., 1989) and has been found upstream of every 
structural gene known to be subject to general control (Hinnebusch, 1988). These 
include all the genes of the tryptophan and shikimate pathways, except for TRP1. The 
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locations of GCN4 binding sites upstream of the ARO genes are given in Chapter 3, 
Table 3-1. 
In contrast to the regulation of amino acid biosynthesis in bacteria, S. cerevisiae 
exhibits a significant (basal) level of expression of the biosynthetic enzymes even 
when amino acids are present in excess concentrations. In AR03, this basal level of 
transcription is also, unusually, GCN4 dependent (Paravicini et al., 1989a). 
Transcription from TRP1 is not regulated by GCN4. Instead, a transcriptional 
terminator element located in the 5' untranslated region is required for TRP1 
expression. Deletion of this element results in large, poorly translated transcripts 
(Braus etal., 1988) 
The biological significance of general control has been interpreted in terms of the co-
ordinate regulation of most enzymes in a pathway. Thus, a functional relationship 
may exist between organisation of such genes into operons in bacteria (e.g. the trp 
operon in E. coli) and general control in fungi. The extension of MCA to the 
treatment of large changes in enzyme activity (section 1.1.2), and specifically, the 
relationship between group control coefficient, enzyme multipliers and flux 
amplification constitutes a theoretical treatment of the functional implications of 
general control and operons as forms of co-ordinate regulation (Kacser and Acerenza, 
1993). 
1.3 	Control and regulation of tryptophan pools and 
flux to tryptophan 
This section attempts to draw together a disparate collection of data and 
interpretations concerning the control and regulation within the tryptophan pathway. 
In section 1.3.1 some data on tryptophan concentrations and flux estimations are 
given, along with the changes which occur in various mutant strains. In section 1.3.2 
results of experiments where enzymes of the pathway are overexpressed are given. 
Finally, section 1.3.3 attempts to evaluate the interpretations of the data which have 
been offered and gives a perspective through which the present work as well as past 
work may be interpreted. 
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1.3.1 	Intracellular concentrations and flux 
Intracellular concentration of tryptophan 
The concentration of tryptophan in wild-type cells grown on minimal media (MV) is 
about 20 j.tM (Fantes etal., 1976). However, this can be modulated by a number of 
factors. The presence of anthranilic acid, indole or tryptophan in the medium 
increases this by a factor of 30, 50 and 10, respectively. Mutants with a feedback 
resistant anthranilate synthase (lbr) gave 50 - 60-fold increases in tryptophan, whilst 
mutants with feedback supersensitive enzyme give tryptophan pools half that of the 
wild-type (Fantes et al., 1976). These results suggest that feedback inhibition of 
anthranilate synthase regulates the tryptophan pool. Mutants with defects in general 
control (ndr mutants, now known as gcn mutants, were selected by increased 
sensitivity to 5-methyl tryptophan, 5-MT) showed no significant changes in the 
tryptophan pool, on MV alone, but showed no de-repression of enzymes subject to 
general control, and reduced pool size, compared to wild-type strains, under de-
repressed conditions (5-MT). Finally constitutively de-repressed mutants (cdr, now 
known as gcd) gave 20 - 30-fold increases in tryptophan pools (Fantes etal., 1976). 
Miozzari etal. (1978a) obtained similar results for mutants with a feedback resistant 
anthranilate synthase (trp2fbr) but only 2-fold increases in tryptophan pools with gcd 
mutants. Other mutations which have given increased intracellular pools include aro7 
(chorismate mutase) and aat2 (Kradolfer et al., 1982). Unfortunately, the effect on 
the tryptophan pool of a single point mutation which abolishes the regulatory 
behaviour of chorismate mutase (Schmidheini etal., 1989) has not been investigated. 
Flux to tryptophan 
Flux to tryptophan consists of a number of components. Theoretically, the total flux 
to tryptophan is the sum of the flux to protein, internal pool, excretion, degradation 
and fluxes into other pathways, such as nicotinamide synthesis. In practice, the fluxes 
into other pathways are assumed to be small and, therefore, ignored. The 
contribution of tryptophan degradation may be highly significant, but in many 
investigations, including the present one, the use of aat2 mutants is assumed to 
minimise this factor. Therefore, flux is operationally defined as the flux to tryptophan 
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in protein plus flux to intracellular and extracellular pools. The sum of the free 
tryptophan pools can be used to calculate the 'accumulation rate'. Therefore the total 
flux can be considered to equal the flux to protein plus the accumulation rate. Unless 
excreted tryptophan forms a significant fraction of total tryptophan, the accumulation 
rate is largely composed of flux to intracellular pool. 
In general, the contribution of the accumulation rate to total flux to tryptophan is 
small (< 1%) (Miozzari et al., 1978a). Flux to protein in strains which grow at wild-
type rates is about 0.3 nmol • mini' • mg protein' while the accumulation rate is about 
0.001 nmol' mm 4  • mg proteiif'. This means that large changes in the tryptophan 
pool may have quite small effects upon flux. Even a trp2jz,r mutant gave only a 50% 
increase in flux despite a 40-fold increase in intracellular pool. A gcd mutant with a 
trp2,z,r allele showed a 2-fold increase in flux with no further increase in intracellular 
pool (Miozzari etal., 1978a). 
1.3.2 	Overexpression of enzymes of the tryptophan Dathwa 
The results of the 'down-modulation' experiment obtained by constructing a tetraploid 
gene dosage series for enzymes of the tryptophan pathway (Miozzari etal., 1978a; 
Niederberger et al., 1992) were discussed in the context of an experimental 
justification of MCA in section 1.1.1. The control coefficients for all of the enzymes 
were low. This result is not exceptional and is equivalent to the finding that 
functional alleles are usually genetically dominant (Kacser and Bums, 198 1) with 
respect to null alleles. 
Niederberger and colleagues also conducted a series of experiments with strains 
overexpressing enzymes of the tryptophan pathway from multi-copy plasmids. A 
summary of these experiments is given in Table 1-3 (Niederberger etal., 1992). 
Strains were grown in minimal media with added anthranilic acid. Therefore, in all 
cases, the feedback of anthranilic acid was by-passed. Overexpression of genes raised 
enzyme activities by factors of 10-60 by using high copy number plasmids. 
Overexpression of each gene alone does not increase tryptophan flux significantly 
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1.0 1.0 1.0 1.0 1.0 0.10 0.33 0.43 1.0 
1.2 19.9 1.2 1.6 1.2 0.27 0.30 0.57 1.3 
1.5 1.2 10.6 1.6 0.7 0.20 0.30 0.50 1.3 
1.5 0.8 1.8 51.5 1.1 0.13 0.31 0.44 1.0 
1.3 0.8 1.7 1.6 37.1 0.23 0.29 0.52 1.2 
1.5 0.6 58.6 56.0 0.5 0.58 0.29 0.87 2.0 
25.0 34.0 1.7 47.0 1.0 0.72 0.31 1.03 2.4 
29.4 1.0 30.6 40.9 1.0 0.22 0.31 0.53 1.2 
26.5 26.4 30.3 37.4 0.8 0.59 0.32 0.91 2.1 
20.0 15.2 1.6 20.7 18.1 3.25 0.29 3.54 8.2 
24.0 19.6 22.1 26.9 23.9 3.51 0.28 3.79 8.8 
Table 1-3 	Changes in flux upon over-expression of genes of the tryptophan pathway (from Niederberger et 
al., 1992) 
PRAT is phosphoribosyl- anthranilate transferase, PRAI is phosphoribosyl-anthranilate isomerase, IndGP synthase is indole glycerol phosphate synthase. TRP2Jbr 
refers to a mutant gene which encodes an anthranilate synthase with resistance to feedback inhibition by tryptophan. TRPJd refers to cloned TRPJ gene without a 
fully functional promoter. It gives greatly reduced expression as shown. The experimental details, strains and plasmids are given in Niederberger et al. (1992) and 
in references contained therein. 
a significant but not a dramatic increase in tryptophan flux (up to 2.4-fold). Large 
increases in flux (8-fold) were only achieved by overexpression of four (not TRP 1) or 
all five genes of the pathway. In all cases, the growth rate remained unchanged and, 
therefore, increases in tryptophan concentration accounted for the flux increases. 
These results show how control is still distributed amongst four of the enzymes of the 
pathway, and how, despite the limited extent of the defined pathway (anthranilic acid - 
tryptophan), significant control lies elsewhere (i.e. the flux multipliers obtained, about 
8, fall far short of the probable enzyme multipliers, about 25-50). The data do not tell 
us how control will be distributed when strains are growing on normal media. In this 
situation, other enzymes of metabolism are likely to share some control and the effect 
of inhibition of anthranilate synthase will come into play. Nevertheless, some general 
comments may be made for the purpose of defining the context of the present project. 
They are 
• 	control is distributed over the pathway 
• 	up-modulation of most, if not all, enzymes is required for significant flux 
amplification 
although control of flux, with respect to enzymes outwith the limited 
pathway defined by the experimental situation, may be limited before the 
manipulation, it clearly becomes significant over the range of increases 
achieved here. 
Prasad et a! (1987) report an experiment where a strain RH1095 (aro7, trp5, 1eu2, 
aat2) was transformed with a multi-copy plasmid, pME554, containing a copy of all 
five TRP genes, both in the presence and absence of anthranilic acid. At least during 
exponential phase, flux to free tryptophan was less than 0.05 nmol ' min' • mg 
protein'). In the presence of anthranilic acid, flux to free tryptophan increased to 
between 0.5 and 3.5 nmol • min' 'mg protein'. When the multi-copy plasmid, 
pME559, bearing a TRP2Jbr allele was used (in a different strain), the fluxes to free 
tryptophan were similar and were not greatly increased by the presence of anthranilic 
acid in the medium. 
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1.3.3 	InterDretin2 the reu1atorv mechanisms 
The elements which may contribute to the regulation of tryptophan biosynthesis were 
identified in section 1.2.6. These include feedback inhibition two DAHP synthase 
isozymes are inhibited by phenylalanine and tyrosine, anthranilate synthase is inhibited 
by tryptophan and chorismate mutase by tyrosine. Secondly, all of the enzymes of the 
shikimate and tryptophan pathway, except for phosphoribosyl anthranilate isomerase 
(encoded by TRP1), are subject to the general control of amino acid biosynthesis. 
They are de-repressed under conditions of amino acid starvation. Finally, there are 
the roles of tryptophan transport and catabolism to be considered. 
How do these factors contribute to the control and regulation of both intracellular 
concentration of tryptophan and pathway flux? 
Interpretations of the regulatory behaviour of the pathway in terms of this network of 
feedback interactions have been advanced. For instance Jones and Fink (1982) give a 
qualitative account of the regulation of amino acid biosynthesis, a summary of which 
follows. If the intracellular concentration of tryptophan falls, then anthranilate 
synthase is released from feedback inhibition which redirects flux into the tryptophan 
pathway. At the same time, chorismate mutase will become relatively inhibited (by 
tyrosine in the absence of tryptophan). As tryptophan concentration increases, flux 
becomes redirected back to the prephenate pathway by inhibition of anthranilate and 
activation of chorismate mutase. Furthermore, they describe other mechanisms of 
regulation within the prephenate pathway. Firstly, prephenate dehydratase (leading to 
phenylalanine) has a higher affinity for prephenate than prephenate dehydrogenase. 
Secondly, prephenate dehydrogenase is modulated by tyrosine and phenylalanine in an 
analogous way to the regulation of chorismate mutase by tyrosine and tryptophan, 
respectively, and prephenate dehydratase is inhibited by phenylalanine alone. 
Therefore, they suggest that if phenylalanine concentrations drop, then this pool will 
be regulated by inhibition of prephenate dehydrogenase (by tyrosine) until 
phenylalanine concentrations increase sufficiently to release this inhibition. 
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The work of Fantes, Miozzari, Niederberger and Hutter, discussed above, leads to the 
following conclusions (Miozzari etal., 1978a). 
Flux through the tryptophan pathway is adjusted to the rate of protein synthesis by 
means of feedback inhibition of the first enzyme [anthranilate synthase] by 
[tryptophan]. 
Increasing or lowering the concentration of individual enzymes had no noticeable 
influence on the overall flux to tryptophan. 
Our results [ ..... ] suggest that de-repression does not serve as an instrument for the 
specific regulation of the flux through the tryptophan pathway. 
In summary, the following perspectives are offered. One is that feedback inhibition of 
anthranilate synthase (and perhaps chorismate mutase and other enzymes) is an 
important regulatory mechanism whereby tryptophan concentrations (and those of 
phenylalanine and tyrosine) are maintained at the levels normally found within the cell. 
Another, borne out by the over- (and under-) expression of enzymes of the tryptophan 
pathway is that no single enzyme contributes significant control of tryptophan flux. 
Thirdly, de-repression mediated by GCN4 does not result in increases in flux, except 
under very low flux conditions obtained in bradytrophic mutants or by the action of 
tryptophan analogues. In other words, precise regulation of flux and metabolite 
concentrations occurs, despite low control coefficients for all enzymes of the 
pathway. 
1.4 	Aims of the project 
The central task of this project is to apply the Universal Method' to the shikimate and 
tryptophan pathway and to evaluate its success. 
Briefly, the plasmids pM1E554 or pME559 (Niederberger et al., 1984; Prasad et al., 
1987) may be used to overexpress all of the enzymes of the tryptophan pathway. 
Given values for the fluxes in the shikimate, tryptophan and prephenate sections of the 
pathway, it is possible to use the Universal Method' to calculate a factor by which the 
activities of enzymes of the shikimate pathway should be increased to achieve the 
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conditions set by the constraints of the model. These constraints are, a predicted 
large increase in flux to tryptophan, minimised changes in flux to phenylalanine and 
tyrosine and maintenance of metabolite concentrations within and outwith the 
pathway. 
The plasmids (pME554, pME559) may be used to apply an enzyme multiplier of 
between 20 and 50 to the tryptophan pathway (Niederberger et al., 1984; Prasad et 
al., 1987). This factor sets the flux multiplier for flux to tryptophan and, given the 
wild-type flux to tryptophan, the absolute increase in flux, AJ. This value, AJ, and 
estimations of the flux in the prephenate pathway allows the determination of an 
enzyme multiplier for the shikimate pathway using Equation 9. 
As will be described in Chapter 2, fluxes to tryptophan, phenylalanine and tyrosine 
during exponential phase may be calculated from an estimation of the intracellular 
concentrations within the cell, the concentration of the amino acid within protein, the 
growth rate and the relationship between cell volume and protein concentration, given 
certain simplifying assumptions. These predicted fluxes are shown in Table 1-4. 
These predicted data allow the calculation of an enzyme multiplier for the shikimate 
pathway in order to give a flux multiplier of 25 in the tryptophan pathway, given the 
overexpression of tryptophan pathway enzymes by a similar factor. This enzyme 
multiplier is predicted to be 3.5. 
The central strategy of the project is, therefore, to construct a single copy plasmid 
containing one copy of all four shikimate pathway genes, which can be introduced 
along with the multicopy plasmids pME554 or pME559. This has the theoretical 
consequence of introducing an enzyme multiplier of 2, close enough to the estimated 
required enzyme multiplier to allow a reasonable evaluation of the method. Attempts 
to overexpress the shikimate pathways enzymes by a factor of 3.5 precisely would 
have involved the introduction of slightly stronger constitutive or inducible promoters 
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 0.0097 1.50 1.51 0.64% 
Table 1-4 Proposed fluxes in the shikimate pathway 
The data in this table are calculated from the intracellular pools previously reported (Fantes et al. 1976; Jones and Fink, 1982), an estimate 
for the intracellular volume at a given 0D 546  (de Koning and van Dam; 1992), an estimate of protein concentration at a given 0D 546 (Fantes 
etal., 1976) and a growth rate (i.t)  in minimal media of 0.31 hr- ', according to the methods set out in Chapter 2. It assumes no excretion of 
amino acids into the medium, no degradation of these amino acids, zero fluxes to other metabolites and maintenance of steady state with 
respect to intracellular concentrations of these amino acids and of protein composition. 
The transformation of the appropriate strains with the multi-copy plasmid carrying the 
TRPJ-5 genes and/or single-copy plasmids carrying the AROJ-4 genes will be 
followed by culture and measurement of enzyme activities and concentrations of 
tyrosine, phenylalanine and tryptophan. These experiments will be carried out without 
the use of anthranilic acid as an external source for phosphoribosyl-anthranilate 
transferase. It was planned to evaluate the effects of these changes in 'batch' culture 
initially. 
Finally, the strict application of the 'Universal Method' demands that intracellular 
concentrations of tryptophan remain at wild-type levels. In these circumstances, an 
increase in flux to tryptophan can be achieved by excretion of tryptophan. That work 
was planned independently of this project. 
1.5 	Plan of the thesis 
The remainder of the thesis is organised as follows. Chapter 2 describes the materials 
and experimental methods used in the project. Chapter 3 describes the design and 
construction of a yeast plasmid used to overexpress enzymes of the shikimate 
pathway. Chapter 4 describes the construction and validation of yeast strains used in 
the project, the validation of a plasmid used to overexpress enzymes of the tryptophan 
pathway and the measurement of enzyme activities in all transformed strains. Chapter 
5 analyses the stability of both TRP and ARO plasmids in different media. Chapter 6 
discusses the data relating to flux and metabolite pools obtained in transformed and 
untransformed strains during exponential phase of batch culture. Chapter 7 considers 
the dynamic changes in these variables during other phases of batch culture. Chapter 
8 offers an overall evaluation of the 'Universal Method' in the context of this study 
and considers other approaches to the problem of over-producing aromatic amino 
acids in micro-organisms. 
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Chapter 2 
Materials and methods 
	
2.1 	Bacterial strains 
Various strains of E. coli were acquired and employed in the construction of plasmids. 
They are listed in Table 2-1. 
Strains were grown in Luria-Bertani (LB) medium (1% tryptone, 1% NaCl, 0.5% 
yeast extract and, for solid media, 1.5% agar). Media were sterilised by autoclaving. 
Ampidilhin (stock 150 mg ml-) or kanamycin (50 mg nit 1 ) were filter sterilised and 
added after partial cooling, as required, to give LB-amp or LB-kan with final 
antibiotic concentrations of 150 p.g nit' or 50 p.g mF', respectively. 
Glycerol stocks (triplicate) of host strains and transformants were made by adding 
750 p.1 of an overnight culture to 250 p.1 of sterile 80% glycerol. After mixing, cells 
were frozen on dry ice and stored at -70 °C. When required, cells were retrieved with 
a sterile toothpick and streaked onto solid selective media. 
2.2 	Yeast strains and standard media 
Yeast strains used as hosts for flux analysis and for testing the functionality of cloned 
genes are shown in Table 2-2. 
Untransformed yeast strains were grown in YEPD media (1% yeast extract, 2% 
bacteriological peptone, 2% glucose plus 2% agar for solid media) or in minimal 
medium plus supplements required for growth. Minimal medium (MV) is Yeast 
Nitrogen Base (without ammonium sulphate) (1.45 g t1 ), ammonium sulphate (5.25 g 
t'), glucose (20 g r'), succinic acid (10 g t 1 ), pH to 4.0 (liquid) or 5.5 (solid media) 
with potassium hydroxide. Nutrients required for growth were filter sterilised and 
added, as required. These included adenine (20 p.g nit'), uracil (20 p.g nit 1 ), 
tryptophan (20 p.g mF), tyrosine (30 jig nit'), phenylalanine (50 p.g nit'), histidine 
(20 p.g nit'), arginine (20 p.g nit'), methionine (20 p.g nit), leucine (30 p.g nit'), 
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endAl, relAl, recAl, supE44, hsdRl 7 (r 
mk), thi, gyrA96,zi(lac-proAB), [F', 
traD36, 1acPZAM15, proA B] 
endAl, relAl, recAl,supE44, hsdR17 (rk 
mk), thi, gyrA96, lac, [F', traD36, 




Table 2-1 	Bacterial strains used in this study 
Strain 
	
Genotype 	 Source or 
Reference 
RH805 aat2 (mating type not defined) Kradolfer et al. 
(1982) 
RH1207 tip], trp2, t,p3, 17p4, 17p5, leu2, aat2 Prasad et al. (1987) 
(mating type not defined) 
HK1 trpl, trp2, trp3, tp4, tp5, leu2, aat2, This study 
ura3 (mating type not defined) 
R.H1220 a, aro3, aro4, leu2-2 G. Braus 
RH1380 a,aro4, ura3-52, gcn4-101 G. Braus 
RH1 129 a, aroiC, trp5, leul, hom2, ade6, lysi, G. Braus 
ura3, arg4-1, thri, his6, met], gal2 
RH1 181 a, arol, trpl, ura3 and/or ura4, his4-15, G. Braus 
cani, ade2, karl-i 
RH1 182 a, arol, trpi, ura3 and/or ura4, leu2, G. Braus 
lysi", can], ade2, karl-i 
RH1610 a, aro2 G. Braus 
Table 2-2 	Yeast strains used in this study 
a Nutrient requirement for growth as determined in this work showed that this strain 
was not auxotrophic for lysine, but was auxotrophic for methionine (see Chapter 3). 
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lysine (30 jg m17 1 ), valine (150 j.tg m1) and threonine (200 jig mF). Investigations 
of plasmid stability and flux analysis sometimes used media which contained different 
concentrations of leucine, valine, tyrosine and phenylalanine (all 100 jtg mf) and 
tryptophan and uradil (40 jig 
In this thesis, media are abbreviated as follows. For minimal media plus additives, the 
abbreviation is MV + XZ(concentration in p.g ml). Thus, for example, MV + 
LV(100) is MV medium plus leucine and valine at 100 jig ml - ' 
Growth of strains was monitored by measuring the optical density at 546 nm (0D546) 
using a Pye Unicam spectrophotometer (SP8-100). Where cultures had reached an 
0D546  greater than 0.8, optical densities were determined on appropriately diluted 
culture, with medium as diluent. 
Glycerol stocks of yeast strains and transformants were prepared and maintained as 
for bacterial stocks. 
	
2.3 	Plasmids 
A list of the plasmids employed within this study are shown in Table 2-3. Relevant 
data are also included on the reference card held in the end flap pocket, for 
convemence. 
2.4 	Chemicals and media 
Table 2-4 gives details of the sources or suppliers of chemicals, reagents and 
materials. 
2.5 	DNA techniques 
The DNA techniques used during this study were drawn from standard protocols 
(Sambrook et al., 1989). The descriptions given here, therefore, only outline 
the(Sambrook et al., 1989). The descriptions given here, therefore, only outline the 
particular method employed and emphasise important points or variations from 
Plasmid 
	
ARO/TRP I Reference 
pK19 	general cloning vector Pridmore (1987) 
pRS416 centromeric yeast/bacterial 1 Sikorski and Hieter shuttle vector (1989) pZH2 	source plasmid for AR02 AR02 Jones et al. (199 1) 
pME631 source plasmid for AR03 AR03 Teshiba et al. (1986) 
pMEl 199 	source plasmid for AR04 AR04 Kunzler et al. (1992) 
pME173 source plasmid for AROJ AROJ Duncan etal. (1987) 
The following plasmids are derived from the 
ARS/CEN single copy plasmid, pRS416 I pPH16 derived frompRS4l6 This study pPH17 derived from pPH16 This study 
pPH18 derived from pKl9 and pZH2 AR02 This study 
pPH19 derived from pPH18 AR02 This study 
pPH20 derived from pPH29 AR02 This study 
pPH22 derived from pPH20 and AR02,3 This study 
pME631 
pPH23 derived from pPH22 and AR02,3,4 This study 
pMEll99 
pPH24 derived from pKl9 and pME 173 ARO1 This study 
pPH27 derived from pPH24 AROJ This study 
pPH28 ARO plasmid derived from AROJ,2,3,4 This study 
pPH23 and pPH27 
pPH29 derived from pPH17 and pPH19 AR02 This study 
pPH30 ARO plasmid AR01,2,3,4 This study 
derived from pPH23 and pPH27 
pPH3 1 derived from pRS416 and ARO1 This study 
pPH27 
The following plasmids are derived from the 
2j.t multi-copy plasmid 
pME554 TRY plasmid 
2 gm multicopy 
pME559 TRY plasmid 
2 J.Lm multicopy 
TRP2, 4, id, 3, INieder 
5 	(1984) 




Table 2-3 	Details of plasmids used and constructed 
Because pPH28 was used to investigate the effects of over-expression upon the 
production of tryptophan, phenylalanine and tyrosine in investigations described in 
Chapter 6 and 7, it is shown in bold. For easy reference, these data are also given on 
a card in the inside back cover of volume 2, along with data on the yeast strains used. 
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Chemical or reagent Use Grade Supplier 
Chemicals including amino acids General BDH, Fluka, Fisons, 
(except for quantitative analysis) laboratory Sigma, Biometra 
Molecular NBI, New England 
Restriction enzymes biology Biolabs, Boehringer 
Mannheim 
Klenow, Alkaline Phosphatase, Molecular NBI 
DNA ligase, T4 polymerase biology 
Tryptone, yeast extract, Bacterial Oxoid 
bacteriological peptone, agar media 
Yeast nitrogen base Difco 
Agarose Amresco, Biometra 
Glucose, ammonium sulphate, Yeast media Biometra 
succinic acid 
o-phthaldialdehyde reagent for 99% Sigma 
amino acid purity 
analysis 
boric acid, sodium hydroxide and amino acid highest BDH, Fisons 
citric acid analysis quality 
Standard amino acids (inc. amino acid highest Sigma 
chlorotyro sine) analysis quality 
NADPH, chorismic acid, shikimic enzyme highest Sigma 
acid, erythrose-4-phosphate, analysis quality 
phosphoenolpyruvate 
EPSP chorismate gift of John Coggins 
synthase 
assay 
DAIiP DAHP gift of John Coggins 
synthase 
assay 
Table 2-4 	Chemicals and reagents 
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2.5.1 	DNA DreDaration 
In order to propagate enough DNA of suitable quality for molecular cloning (midi-
preps), bacterial strains containing the required plasmid were grown from a single 
colony overnight in 100 ml cultures of LB-amp or LB-kan. Plasmids were purified 
from these cultures using 'Qiagen-tips 100' (Qiagen). The manufacturer's protocols 
were followed. Typically, over 100 p.g of DNA were recovered and dissolved at a 
concentration of 1 p.g ml in TE buffer (10 mM Tris-Cl, 1 mM EDTA, pH 8.0). 
Samples were analysed on agarose gels after digestion with restriction enzymes used 
to distinguish between relevant plasmids. 
In all cases, these preparations proved to be satisfactory for all subsequent 
manipulations such as restriction digestion and modification with DNA polymerase 
(Klenow fragment), T4 polymerase, alkaline phosphatase, ligation and transformation. 
For the selection of transformants containing the required recombinant plasmid, mini-
preparations (minipreps) of DNA were made from transformants for restriction 
analysis. DNA was prepared from 10 ml overnight cultures by the alkaline lysis 
procedure (Jsh-Horowicz and Burke, 1981). After removing the supernatant after 
potassium acetate treatment, DNA was precipitated with 0.7 volumes of propan-2-ol, 
and washed with 70% (v/v) ethanol. The pellets were dissolved in 100 p.1 sterile 
distilled water (SDW) and RNA was digested with 1 p.1 of RNAse A (10 mg/ml) at 37 
°C for 30 minutes. DNA was recovered by phenol treatment, as follows. DNA 
solutions were made to 250 p.1 with SDW and 250 p.1 of phenol/chioroforni/isoamyl 
alcohol (25:24:1 v/v) added. After shaking, the aqueous phase was recovered after 
centrifugation and traces of phenol removed with 500 p.1 of chioroform/isoamyl 
alcohol (24:1). 225 p.1 of aqueous phase was made to 0.3 M sodium acetate and 
DNA was precipitated with 2 volumes of ethanol. The pellet was disturbed and 
washed with 500 p.1 of 70% (v/v) ethanol. After centrifugation, the last traces of 70% 
(v/v) ethanol were carefully removed and pellets were air dried for 5 minutes. DNA 
was dissolved in 20 p.1 sterile TE buffer prior to restriction analysis, usually of 1 p.1 
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aliquots. In all cases, DNA prepared in this way was a suitable substrate for 
restriction enzymes. 
2.5.2 	Restriction analysis and aarose ael electronhoresis 
In most cases, DNA (usually 0.5 - 1.5 j.ig) was digested in 20 j.d reactions containing 
appropriate buffer, and approximately 2-10 units of enzyme for 1 hour at the 
appropriate temperature (usually 37 °C). The buffer system was chosen from those 
supplied along with the enzyme, the 'universal buffer' supplied by Strategene, 
Promega, or 'KGB' buffer (McClelland et al., 1988). These buffers were supplied or 
made as 1 Ox concentrates and were appropriately diluted to 0.5x - 2; depending on 
the enzyme used. Where two or more enzymes were included in a reaction, the most 
appropriate compromise buffer was used, or occasionally, after digestion with one 
enzyme, DNA was retrieved by ethanol precipitation and resuspended in different 
buffer before digestion with the other enzyme. Also, a non-standard incubation 
temperature was occasionally required (for example, Smal), in which case, two 
separate incubations were necessary. 
After digestion, reactions were quenched by the addition of 5 ptl of gel loading buffer 
(25% Ficoll, 50 mM EDTA (pH8.0), and 0.05% bromophenol blue and/or xylene 
cyanol). The reactions were heated to 75 °C for 5 minutes and quenched on ice prior 
to loading on agarose gels. 
Agarose gels were prepared from solutions of agarose in TBE buffer (0.089 M Tris-
base, 0.089 M boric acid, 2 mM EDTA (pH 8.0)). The concentration of agarose 
depended upon the size of the distinguishing fragments. 0.7% agarose was most 
commonly used. Particular care was taken to avoid small particles of undissolved 
agarose and to ensure a homogenous gel. Ethidium bromide was added to a 
concentration of 0.5 .i.g m1. Mini-gels containing 4 - 14 samples were run at 80 - 
120 V for a period of about 20 -60 minutes, alongside DNA size markers such as 
lambda phage DNA digested with HindIH, or '1 kb ladder'. Gels were removed and 
bands viewed under UV light. Photographs were taken for analysis and record-
keeping. 
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2.5.3 	DNA modifications and clonin 
For the construction of recombinant plasmids, at least 2 j.tg of plasmid DNA was 
restricted with appropriate enzymes. As well as the enzymes generating the required 
fragment, those cutting within unwanted fragments but not within the required 
fragment were sometimes included in order to reduce the number of unwanted 
ligation products and/or to avoid the purification of fragments from gels. Where 
necessary, and particularly where a background of non-recombinant plasmids was 
expected, samples were analysed by gel electrophoresis prior to subsequent steps. 
The filling-in of cohesive ends was required in a number of steps. 5' - protruding ends 
were 'blunt-ended' with Kienow fragment in the presence of dATP, dCTP, dGTP and 
dTTP (dNTPs). Restriction enzymes were heat inactivated or the DNA was extracted 
with phenol/chloroform and precipitated prior to resuspension in reaction buffer (50 
mM Tris-CI (pH 7.5), 10 mM MgC12, 1 mM DTT, 50 ig mF 1 BSA). 10 units of 
enzyme and 33 tM dNTPs were added per ig DNA and incubated for 15 minutes at 
room temperature. 3' - protruding ends were 'blunt-ended' with T4 polymerase (2 
units per jig DNA in 10 j.il KGB buffer plus 100 LLM of each dNTPs, 5 minutes at 
37 C) In both cases, DNA was recovered by phenol extraction and ethanol 
precipitation. 
When a single enzyme site was used to generate a cloning site for a donor fragment, a 
background of non-recombinant transformants could be avoided by de-
phosphorylation of 5' ends of the host plasmid after restriction digestion, using calf 
intestinal alkaline phosphatase (CIP). This was performed in CIP buffer (10 mM Tris-
Cl (pH8.3), 1 mM ZnC12, 1 mM MgC12) with 1 unit of enzyme/l00 picomoles of 5'-
protruding ends, or 1 unit/2 picomoles of 3'-protruding ends or blunt ends. The 
amount of phosphatase used in the reactions was sometimes increased in order to 
reduce background intramolecular ligation to an acceptable level. Control mock 
dephosphorylation reactions were always included. Reactions were incubated for 30 
min at 37 °C. The reactions were stopped by the addition of 0.1 volume of 50 mM 
M. 
EDTA (pH8.0). DNA was recovered prior to ligation by phenol extraction and 
ethanol precipitation. 
DNA ligations were performed according to standard protocols. The concentration 
and amounts of plasmid and fragment DNAs were adjusted according to the size of 
the fragments, the numbers of molecular species competing for cohesive ends and the 
possibility of intramolecular ligation etc. As a general guide, 250 ng of DNA were 
used in a 10 j.tl volume with vector and insert in molar ratios of 1:3. Ligation 
reactions were usually set up by co-precipitating DNA components by ethanol 
precipitation followed by resuspension in ligase buffer (supplied with DNA ligase). 
Where high concentrations of reacting ends were thought to be desirable, 
polyethyleneglycol (PEG) was added to a final concentration of 5%. Control ligation 
reactions always included vector alone without ligase to monitor undigested DNA, 
vector alone with ligase to monitor intramolecular ligations, and the required reaction 
containing vector, insert and ligase. When the insert was derived from another 
plasmid which could produce transformants too, a control including the insert alone 
plus ligase was used. Where dephosphorylation reactions were performed, another 
control was employed, where mock dephosphorylated vector was ligated. This 
reaction could be compared with dephosphorylated vector, allowing an evaluation of 
the dephosphorylation efficiency. 
2.5.4 	Bacterial transformation 
The propagation of recombinant DNA requires its introduction into an appropriate 
bacterial host which has been made competent. Competent cells were prepared by the 
calcium chloride method of Cohen et al. (1972). Approximately 1 ml of a 10 ml 
overnight culture was transferred to 500 ml of medium and grown to an 0D 550 of 0.3 
- 0.5. Cultures were cooled on ice and cells pelleted (Beckmann JA-14, 2,500 rpm, 5 
mm, pre-cooled 0 °C). They were resuspended in 400 ml of 100 mM calcium chloride 
(ice-cold) and left on ice for 15 minutes. Cells were pelleted and resuspended in 9 ml 
calcium chloride. This was mixed with 1 ml sterile glycerol on ice and stored at -70 °C 
in 100 il aliquots for use in transformation reactions. 
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Small aliquots (typically, 2 j.tl) of ligation reactions (including controls) were 
incubated with an aliquot of competent cells for 45 min on ice. After 90 seconds of 
heat-shock at 42 °C and a further 10 minutes on ice, 1 ml LB (37 °C) was added (no 
antibiotic) and samples were incubated at 37 °C for 1 hour. Samples were spun 
briefly and supernatant replaced with 100 j.tl fresh pre-warmed LB. The suspension 
was plated onto selective plates. Three control plates were processed. A mock 
transformation with no DNA was plated on both selective and non-selective plates. 
Furthermore an aliquot of a standard plasmid dilution (with the appropriate antibiotic 
resistance) was used to monitor the competence of the cells and the effectiveness of 
the transformation procedure. 
On occasions, selection of recombinant plasmids was possible using 'blue/white' 
selection on media containing IPTG and X-gal. In such cases LB-amp or LB-kan 
plates were spread with 40 d of IPTG (24 mg mt) and 40 p.1 of X-Gal (20 mg ml) 
Transformants derived from the selective plate were taken and grown in 10 ml 
cultures of selective media, for analysis of minipreps and identification of the required 
recombinant plasmid. Single colonies were isolated on selective solid media for 
establishing glycerol stocks and propagation of midi-prep DNA for future cloning 
steps. 
2.5.5 	Yeast transformation 
Some plasmids contained suitable genes for transformation of auxotrophic yeast 
strains to prototrophy and selection on media lacking specific nutrients. A lithium 
acetate procedure was used throughout. Host strains were grown with aeration in 
100 ml YEPD to an OD546 of 1-2. For generating transformants containing two 
plasmids ('double' transformant), it was necessary to grow the host strain, containing 
one plasmid ('single' transformant), on selective media in order to maintain the original 
plasmid. Cells were harvested and resuspended in 40 ml lithium acetate (100 mlvi in 
TE buffer) and incubated for 90 minutes at 30 °C to establish competence. After 
harvesting, cells were resuspended in 2 ml of 100 mM lithium acetate in TE. 100 p.1 
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aliquots were transformed with 5 j.tg of plasmid DNA and incubated at 30 °C for 10 
minutes. 0.5 ml of 50% PEG (MW 4000) was added and incubated for a further 30 
mins at 30 °C. The cells were subjected to heat shock (42 °C) for 5 minutes and were 
pelleted gently and resuspended in 200 il of 0.8M sorbitol prior to the plating onto 
selective media, which was often, but not always, synthetic complete (SC) medium 
(Sherman, 1991). Transformants appeared within 3-5 days. These were picked onto 
plates for evaluation of their growth requirements and individual colonies were 
isolated from appropriate transformants and glycerol stocks established. Selected 
transformants were grown in 50 ml cultures for assay of enzyme activities. In some 
cases DNA was isolated for transformation of bacteria in order to rescue plasmid for 
analysis. 
2.5.6 	Plasmid rescue 
When appropriate strains were transformed with plasmids containing all of the TRP 
genes and/or those containing the ARO genes, it was appropriate to analyse the 
structure of the plasmid after yeast transformation in order to validate the strain 
obtained. Cultures were grown in selective media and plasmid DNA extracted by the 
method of Strathern and Higgins (1991). Yeast cells were resuspended in TENS 
buffer (10 mM Iris-Cl (pH 8.0, 100mM NaCl, 1 mM EDTA, 0.1% SDS) and 
disrupted by vortexing with glass beads and again in the presence of phenol. After 
extraction with more phenol and then chloroform, total DNA was purified by 
extraction using 'glassmilk' (Geneclean), according to the manufacturer's instructions. 
DNA was precipitated with ethanol, dissolved in TE and small amounts transformed 
into a bacterial host for propagation, in parallel with a preparation obtained from the 
untransformed strain, as an appropriate control. Miniprep DNA from bacterial 
transformants was analysed by restriction digests to confirm the identity of plasmid(s) 
contained within the yeast strains. In the case of transformants containing both the 
multi-copy TRP plasmid and the single-copy ARO plasmid, an aliquot of DNA was 
additionally digested in BamHL prior to the transformation of E. coil, in order to 
reduce the background of the multi-copy TRP plasmid and, thereby, to allow the 
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detection of the less abundant single-copy ARO plasmid, in which there is no BamHl 
site. 
2.6 	Plasmid stabifi 
To assess the loss of plasmid during long-term culture, two experiments were 
performed. In the first, the basic growth medium was MV + LV(l00). In the second, 
the base medium was MV + LVFY(100). In both experiments, there were eight 
strain/media combinations, as follows. HK1/pME554 was grown in both selective 
and non-selective media (-1+ W(40)), HK1/pPH28 was similarly grown in selective 
and non-selective media (-1+ U(40)) and the double transformant, 
I{K1/pME554/pPH28, was grown under four conditions, namely, non-selective 
conditions (+ U(40), + W(40)), selection for both plasmids ( - U(40), - W(40)), and 
selection for one plasmid only ( - U(40), + W(40)), and ( + U(40), - W(40)). 
Before inoculation of flasks containing the above media, yeast strains containing one 
or two plasmids were grown from a fresh colony in 10 ml MV medium with leucine, 
valine, phenylalanine and tyrosine (all at 100 jig ml') (LVFY(lOO)). Uracil and/or 
tryptophan (both at 40 jtg ml) were added if required for growth of the strain. 
These were subcultured at least once (when 0D 546  < 1.5) into similar media. Prior to 
inoculation of 50 ml flasks containing selective and non-selective media, samples were 
taken for estimation of enzyme activities (see section 2.10) and dilutions were made in 
LVFY( 100) for spreading onto selective and non-selective plates. For inoculation of 
main cultures, cells were pelleted, washed and resuspended in MV + LV(100) or 
LVFY( 100). Pre-warmed and aerated flasks, containing 50 ml of medium were 
inoculated with a suitable numbers of cells. Amounts of inoculum were calculated to 
keep growth in exponential phase (0D 546  < 1. 5).  After 24 hours, appropriate 
dilutions were made for plating and counting of cells, samples were processed to 
measure enzyme activities and a suitable inoculum was prepared and delivered to 
another aerated and pre-warmed flask containing similar medium. This process was 
repeated daily for a total of 5 days culture. 
To determine the loss of plasmid and the appearance of auxotrophy, cells were plated 
daily on selective and non-selective media. Dilutions were calculated to produce 
between 200 and 500 colonies on the non-selective plates. Plates used were 
LVFY(100), LVFY(100) + U (40), LVFY(100) + W (40) and LVFY(100) + U,W 
(40). Plates were spread in triplicate using 100 p1 of dilutions and incubated for 3 
days at 30°C. After counting the numbers of colonies, the means of triplicate plates 
were expressed as a percentage of the means of the counts obtained from the LVFY + 
U,W plates. 
The mitotic instability (q, fractional loss of prototrophy per generation) may be 
calculated as follows. 
mp/ 
- iO t2 
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- 	 100 
% prototrophy is plotted logarithmically (base 10) against time. The gradient of this 
line (m) may be divided by the doubling time (1n2/p). 
2.7 	Enzyme activity and Drotein determination 
Enzyme assays and protein determinations were carried out on permeabilised cell 
preparations as described by Miozzari etal. (1978b). These were prepared from 
cultures as follows. Appropriate volumes of culture (<50 ml) were cooled on ice for 
20 minutes and cells pelleted in a bench top centrifuge (2,500 rpm, 4 mm). The 
supernatant was discarded (or sampled for amino acid analysis) and cells washed in 15 
- 50 ml ice-cold SDW. After centrifugation, the cells were washed again in 15 ml ice-
cold SDW and pelleted once more. These pellets were drained thoroughly. The 
following steps were carried out on ice using ice-cold reagents. Thorough mixing and 
agitation were carried out in order to ensure a homogenous cell suspension at all 
times. Appropriate volumes of cell suspension buffer (100 mM potassium phosphate, 
pH 7.6, 2.1 mM f3-mercaptoethanol and 1.2 mM phenylmethylsulphonyl fluoride) 
were added. The cells were resuspended and the volume measured. Further volumes 
of cell suspension buffer were mixed with the appropriate volumes of 1% Triton X- 
100 (in cell suspension buffer) in order to standardise the concentration of protein and 
to maintain Triton X-100 at a concentration of 0.05%. The formulae used to 
calculate the final volumes of suspension and 1% Triton to be added were 
Vol of cell suspension buffer 	= Vol of culture taken x 0D 546 x 0.019 
Vol of 1% Triton X-100 added = Vol of culture taken x 0D 546 x 0.001 
This procedure was adopted to ensure that an accurate and reliable concentration of 
Triton X- 100 was achieved. The cell suspension and extra buffer were then 
thoroughly mixed, dispensed into aliquots of appropriate volumes for protein analysis 
and enzyme assays, placed on dry ice and stored at -70 °C until required. Before 
analysis, the samples were thawed on ice for at least 2 hours prior to assay, in order to 
ensure proper permeabilisation which occurs during the thawing process. 
2.7.1 	DAHIP synthase assay 
DA}IP synthase catalyses the reaction between erythrose-4-phosphate (E4P) and 
phosphoenolpyruvate (PEP) to yield DAHP, which is measured according to the 
method of Gollub et al. (1970). The assay mixture (total volume 200 j.d) contained 20 
d of 25 mM E4P, 40 jl of 10 mM PEP, 100 tl 100 mM bis-tris propane (pH7.4) and 
the reaction initiated by the addition of 10 t1 of permeabilised cell suspension. The 
reaction was allowed to proceed for 5 minutes at 37 °C. 40 jil of 20% (w/v) 
trichloroacetic acid (TCA) was added to stop the reaction. The stopped assay was 
incubated on ice for 5 mins and spun in a microfuge for 2 mins. 75 j.tl of supernatant 
was removed and 75 j.tl of sodium periodate (200 mM in 9 M phosphoric acid) was 
added. This was incubated at 37 °C for 10 minutes. 150 il of 800 mM sodium 
arsenite (in 0.5 M Na2SO4, 50 mM H2 SO4) were added, mixed and incubated for 5 
minutes at room temperature. 600 .tl of 80 mM thiobarbituric acid (in 500 mM 
Na2 SO4) were added, mixed and incubated in a boiling water bath for 10 mins. The 
mixture was cooled to 55 °C and 1 ml of cyclohexanol was added, mixed and allowed 
to stand for 2 minutes at 55 °C. The optical density of the organic layer was 
measured in a spectrophotometer at 549 nm within a cuvette holder at 55 °C. A 
calibration curve using known concentrations of DAHP (gift from John Coggins and 
Chris Abel, University of Glasgow) was obtained which allowed the determinations of 
DAHP concentrations in samples. Control incubations included the stopping of 
reactions at t=O and the use of null mutants of AR03 and/or AR04. 
The specific estimation of phenylalanine inhibitable DAHP synthase and of tyrosine 
inhibitable DAHP synthase was achieved by adding tyrosine or phenylalanine to the 
reaction mixtures at concentrations of 1mM or 5 mM, respectively (Teshiba et al., 
1986). Concentrations of phenylalanine and tyrosine which gave complete but 
specific inhibition of one activity were sought unsuccessfully. Generally these two 
activities did not summate to the total (uninhibited) enzyme activity and the conditions 
given above represent a reasonable compromise. 








V 	10 Prot 
where 'grad' represents the gradient of the standard curve for 0D549 against amount of 
DAHP (nmoles) in the assay mixture, 'V is the volume (tl) of cell suspension used in 
the assay and 'prot' represents the protein concentration in the undiluted cell 
suspension in mg m1'. The average of triplicate determinations was used. 
Experimental reproducibility was poor, with variability between similar samples of up 
to 30%. 
2.7.2 	Shikimate dehvdroenase activi 
Dehydroshikimate is reduced to shikimate by the action of SDH. The activity is 
assayed in the reverse direction to that occurring in the cell, using NADP as the 
electron acceptor. SDH activity was simply determined in a 1 ml reaction volume in a 
cuvette containing 200 j.tl of 500 mM sodium carbonate (pH 10.6), 100 .tl of 40 mM 
shikimic acid, 100 j.tl of 20 mM NADP and SDW to the final volume. The reaction 
was initiated with the addition of permeabilised cell suspension (usually 10 or 20 t1). 
Because temperature control proved to be important, the buffer and SDW were 
prewarmed to 32 °C and the reaction cuvette was placed in a temperature controlled 
holder round which water was supplied at 32 °C, within the spectrophotometer. The 
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appearance of NADPH was followed by measuring the increase in absorbance at 340 
nm using a chart recorder. A straight line was drawn tangentially through at the 
starting point to represent the initial velocity and the specific activity was calculated 
according to the following formula. 
Specific activitysdh 
 = a
2 —a 1 auf 	106 	1 
X x x -i 
where a1 and a2 represent the absorbance units indicated on the straight line at an 
interval of t minutes, aufs indicates the absorbance units at full scale deflection, v 
defined the volume (jtl) of enzyme suspension added to the reaction and prot indicates 
the protein concentration of the suspension in mg mf'. The formula was derived 
using the value given for the molar extinction coefficient for NADPH. Triplicate 
samples gave enzyme activities which varied by up to 10% 
2.7.3 	Chorismate svnthase activi 
Chorismate synthase stop assays were performed based upon the methods of Jones et 
al. (199 1) where the appearance of chorismate is measured spectrophotometrically. 
A reaction mixture (final volume 200 j.tl) containing 100 mM potassium phosphate 
(pH7.6), 500 j.iM NADPH, 10 M FMN, 100 tM EPSP (added to initiate the 
reaction) and between 10 and 50 j.tl of permeabilised cell suspension (depending on 
the specific activity). The reaction was carried out at 30 0C, stopped by the addition of 
40 .ti of 1 M HC1. The mixture was centrifuged for 2 minutes and the supernatant 
removed from the cell debris, made up to 1 ml with water and the amount of 
chorismate was monitored spectrophotometrically at 275 nm (extinction coefficient of 
263 M 1 cm) after subtraction of negative control assay using the aro2 mutant, 
RH1 610. 
A io 106 	1 
Specific activity 	x 	— x = 
xprot 
The specific activity is expressed in units of nmol . min d mg protein' where A 
represents the absorbance measured, 'v' is the volume (s.d) of cells used in the assay 
and 'prot' is the concentration of protein in the cells (mg mt) 
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2.7.4 	Anthranilate synthase activity 
Anthranilate synthase activity was assayed according to the method of Egan and 
Gibson (1970). Chorismic acid is converted by anthranilate synthase to anthranilic 
acid in the presence of glutamine and magnesium ions. Anthranilic acid may be 
sensitively quantitated by fluorescence spectroscopy. A 3 ml reaction volume in a 
fluorescence cuvette contains 1.5 ml PK buffer (200 mM potassium phosphate, 
pH7.6), 0.58 ml PG buffer (200 mM potassium phosphate, pH7.6, 15% glycerol), 
0.24 ml 250 mM glutamine, 0.06 ml 250 mM magnesium sulphate and 0.6 ml 50 mM 
chorismic acid. The PK and PG buffers, glutamine and magnesium sulphate were pre-
warmed to 33 °C while the chorismic acid was maintained on ice. The reaction was 
initiated by the addition of 20 tl of permeabilised cell suspension and the cuvette was 
placed in a heated holder. The fluorescent emission at 408 nm (excitation 340 nm) 
was monitored by chart recorder. A straight line tangential to the initial increase in 
fluorescence was used to estimate rate of fluorescence change. The fluorescence of 
standard concentrations of anthranilic acid under assay conditions was used to obtain 
a calibration curve relating anthranilic acid concentration to fluorescence change. 
The specific activity within the enzyme sample is calculated from the following 
expression 
specific activity = f2-f1 x Vfs x  1000 x  3 
grad 	t 	v 	Prot 
where fl , fj represent the units of fluorescence from the chart recorder, Vfs is the 
fluorimeter output voltage giving full scale deflection, 'v' the volume of permeabilised 
cells used in the assay, 'Prot' the protein concentration of the permeabilised cells in mg 
ml and 'grad' the gradient of the calibration curve (output volts nm 1). Triplicate 
determinations rarely gave a variation greater than 10%. 
2.7.5 	Tryptophan synthase activity 
The tryptophan synthase activity was estimated using a stop assay (Yanofsky, 1955). 
The full reaction catalysed by the enzyme is the conversion of indolyl 
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glycerophosphate into tryptophan with indole produced as an intermediate. Here, 
only the second reaction was assayed and the disappearance of indole over a fixed 
time period was measured. The volume of cells used in the assay was calculated in 
order to produce a fairly small change in indole concentration. In this way, any 
inaccuracies incurred as a result of a non-linear decrease in indole over time, were 
minimised. 
The reaction mixtures were composed of 250 gI of 4 mM indole (all reagents 
dissolved in PK buffer (200 mM potassium phosphate, pH7.6), 1.25 ml of 120 MM 
serine, 250 j.t1 of 15 mM pyridoxal-5-phosphate, 250 jtl of 100 mM EDTA. The 
reaction was initiated by the addition of 500 .tl of appropriately diluted cells. At two 
time points (0 and 20 minutes), 500 p.il of reaction mixture was aliquoted into 100 d 
of 5% sodium hydroxide and indole was extracted by the addition of 2 ml of toluene. 
After vortexing for 30 seconds, 500 j.il of upper (toluene) layer was removed and 
placed on ice. Indole concentrations were measured by the addition of 1 ml ethanol 
and 2 ml of Ehrlich's reagent (prepared by dissolving 36 g ofp-dimethylamino-
benzaldehyde in 500 ml of ethanol, followed by the addition of 180 ml of concentrated 
HC1 and adjustment to 1 litre with ethanol). Colour development occurred over 60 
minutes and was estimated spectrophotometrically at 570 nm. A series of standard 
indole solutions were used to obtain a calibration curve under assay conditions. 
Triplicated assays gave a variation of less than 20%. 
2.7.6 	Protein determination 
Protein determinations were carried out according to the method of Herbert et al. 
(1971). 100 j.il of a permeabilised cell preparation were diluted to 500 j.il with 100 
mM potassium phosphate, 0.05% Triton X-100, pH 7.6. 250 jl of 3M NaOH was 
added, mixed and placed in boiling water bath for 5 minutes. The tubes were 
removed and cooled for 5 minutes. 250 p.1 of 2.5% copper (H) sulphate was added, 
mixed and incubated at room temperature for 5 minutes. The tubes were centrifuged 
for 2 minutes and the 0D 555 of the supernatant determined against a sample 
containing no protein as 'blank. A calibration graph was generated using a set of 
70 
samples containing known concentrations of bovine serum albumin as standard. The 
gradient of the linear portion of this graph was determined and was used to determine 
protein concentrations from the 0D 555 . Samples were performed in duplicate and 
averages taken. Duplicates were usually within 5%. 
2.8 	Analysis of flux to tryptophan, phenylalan ne and 
tyrosine 
2.8.1 	Culture methods and sample collection 
Cultures were generated from a freshly grown single colony in a 10 ml starter culture. 
The medium used was similar to that used in the final large-scale culture, except for 
those strains harbouring the multi-copy plasmid, pME554, where phenylalanine and 
tyrosine were added at 100 p.g m1'. These starter cultures were sub-cultured at least 
once prior to the inoculation of pre-warmed and pre-aerated 100 - 200 ml pre-
cultures containing identical medium to that of the final cultures. These were grown 
(usually overnight) until the 0D 546 reached about 1. Cells from these cultures were 
then pelleted by centrifugation and used to inoculate pre-warmed and pre-aerated 
main (200-400 ml) cultures to an 0D 546 of between 0.1 and 0.5. In this way two 
conditions were satisfied. Firstly, the cells were adapted to their final medium. 
Secondly, the starter cultures used medium (MV+LVFY (100)) which was thought 
most likely to reduce the loss of plasmid (Prasad et al., 1987). 
Cultures were monitored for 0D 546 throughout the growth phase and samples taken at 
appropriate times for generation of permeabilised cells for enzyme assays, for protein 
determination and for analysis of phenylalanine, tyrosine and tryptophan 
concentrations, as follows. 
For the analysis of the amounts of intracellular amino acids, a measured volume of 
culture (10 - 50 ml) was vacuum filtered through 4 cm Millipore HA (4 gm pore size) 
filters and cells washed in 2 x 15 ml aliquots of ice-cold water. The filters were 
rapidly removed and placed into 1.35 ml of ice-cold TCA (6.67%) for rapid disruption 
of cells and cessation of metabolism. After thorough agitation and a 30 mm 
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incubation, the liquid was removed to a labelled sample tube and stored at -20 °C. For 
analysis of the amount of amino acids in the culture (supernatant + intracellular), 900 
j.ti of culture was dispensed into pre-cooled tubes containing 300 .tl of TCA (20%) 
and mixed. They were also incubated on ice for 30 mins before storage at -20 °C. 
Supernatant samples (extracellular pools) were treated in a similar way to those of the 
whole culture, except that supernatants were removed from centrifuged culture and 
further centrifuged (2 mm, xl 6,000g) prior to TCA treatment. 
Before estimation of amino acid concentrations, samples were centrifuged at 4 °C for 5 
minutes and supernatants removed into new tubes. This was repeated twice. 
2.8.2 	Analysis of amino acid content 
Samples were analysed by chromatography (involving ion-exchange and reverse phase 
components) using a suiphonated polystyrene solid phase (8 pm bead size; The 
Locarte company, London, UK) and citrate buffer in the mobile phase. The flow rate 
was 1.4 ml min'. Amino acids were derivatised by post-column reaction with o-
phthaldialdehyde (OPA) reagent in borate buffer and detected by on-line fluorescence 
at 440 nm. 
For analysis of all samples, the running buffer was citric acid (20 g f'), sodium 
hydroxide (9.4 g 1.1)  and sodium chloride (2.92 g 1'), pH 5.67. Buffer was filtered 
(0.4 pm) under partial vacuum. The reagent buffer was 0.4 M sodium borate, pH 
10.5. After thorough saturation with nitrogen, OPA (12.5 mg m1' in absolute 
ethanol) was added to a final concentration of 125 mg r1. The solution was sparged 
with more nitrogen before the addition of 250 p1 r' of (-mercaptoethanol. 
For all determinations, the sample was prepared in a final volume of 300 p1, including 
a suitably diluted sample in the running buffer plus a standard addition of chioro-
tyrosine which acted as an internal standard. The actual sample volume passed onto 
the column (loop volume) was 150 p.1. After elution of amino acids, the column was 
washed with 0.4 M sodium hydroxide (22 min) and equilibrated with buffer (29 min) 
prior to the loading of another sample. Occasionally during analysis, and particularly 
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for calibration purposes, known concentrations of tryptophan, phenylalanine or 
tyrosine were included. 
The elution times for tyrosine, phenylalanine, chioro-tyrosine and tryptophan were 23, 
27, 37 and 67 mins, respectively. 
Amino acid concentrations were estimated from peaks obtained as follows. A 
baseline was drawn across the bottom of the peak and the peak height measured in 
mm. The width of the peak at half peak height was estimated. In most cases, 
repeated measurements of the same small peak was +1- 0.3 mm. The height and width 
were multiplied to give an area indicator (loosely called 'area'). The area was divided 
by the area of the chloro-tyrosine peak to give a relative area. In order to generate a 
concentration for each amino acid within the sample, the relative area was divided by 
factors specific for each amino acid, derived empirically, by calibration. The 
concentration within the culture could then be calculated from the volume of culture 
used to generate the sample and the dilution used to form the injected sample. This 
means that internal pools are expressed as if they were diluted throughout the culture 
volume. They may be subtracted from the 'total' culture concentrations to give an 
estimate of the concentration within the supernatant. These values generally gave 
reasonable agreement with the empirical determination of supernatant concentrations. 
The estimation of the actual intracellular concentration is based upon the relationship 
between cellular volume and protein mass (3.75 tl. mg proteiif 1) (de Koning and van 
Dam, 1992) and the relationship between protein concentration and 0D 546 (160 mg r l 
at 0D546 =1) obtained in this study, thus - 
Intracellular cone. = Culture cone. x 1667 
OD 
These values are also used in this thesis, where defined, in order to monitor 
intracellular concentrations during culture of different strains. 
Terminology of metabolite pools 
In discussion of the various metabolite pools, the following terminology is used 
throughout the rest of the thesis. Intracellular concentrations with respect to culture 
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volume is referred to as an 'internal pooi' and is expressed in IM (imoles of amino 
acid/litre of culture) while the corresponding value with respect to cell volume is 
termed 'intracellular concentration' (jiM, or pmoles of amino acid4tlitre of cell 
volume). Extracellular and total concentrations are also termed extracellular and total 
pools (extracellular pool + internal pool), respectively. They are expressed with 
reference to culture volume. The flux to total pool is termed 'flux to free metabolite' 
or, 'accumulation rate'. 
2.8.3 	Flux calculations 
Flux to tryptophan, phenylalanine and tyrosine was calculated by adding the 
accumulation rate and the flux to protein. This assumes that no degradation of 
tryptophan occurs, and ignores all other fluxes from tryptophan. 
Flux to protein may be calculated from the composition of yeast protein and the 
growth rate, assuming steady state. The values used for the tryptophan, phenylalanine 
and tyrosine content of yeast protein were 1.22, 4.74 and 3.96% by weight (Cortassa 
eta!, 1995). These yield values of 59.75, 288.7 and 218.5 nmol • mg protein', 
respectively. These may be converted into flux by multiplying by the growth rate (p.) 
and dividing by 60 to give the flux per minute. 
Accumulation rates are calculated from the metabolite pools (c) at a given 0D 546 as 
follows. 
Accumulation rate = cx p x 1000  60 	prot 
where c represents the concentration of metabolite pool (intracellular + extracellular) 
in p.M (with respect to culture), p. represents the growth rate (hr - ') and 'prot' 
represents the protein concentration in mg F'. The protein concentration was 




Plasmid and strain construction 
The requirements of the 'universal method' predict that in order to generate a given 
change in flux to tryptophan, the enzymes of the shikimate pathway should be 
overexpressed by a factor which depends upon the relative fluxes to tryptophan and 
prephenate (tyrosine + phenylalanine) as well as the factor by which enzymes of the 
tryptophan pathway should be overexpressed. Estimates made in Chapter 1 (section 
1.4) suggest that with enzymes of the tryptophan pathway overexpressed from a 
multi-copy plasmid by a factor of 25, shikimate pathway enzymes might have to be 
overexpressed by a factor of about 3 - 4. 
Given these requirements, this chapter describes the cloning strategy used to construct 
a plasmid bearing a copy of each of the genes (AROJ-4) encoding enzymes of the 
shikimate pathway, and reports upon its implementation. It describes the strains of 
yeast acquired for functional testing of cloned genes, the verification of their genotype 
and the results of their transformation with the plasmids constructed. 
3.1 	Plasmid construction 
The options available for the introduction of ARO genes into the parent strain include 
integration into the host genome, the use of single or multi-copy plasmids or 
employing yeast artificial chromosomes (YACs). Because the 'universal method' 
demands that enzymes of the shikimate pathway should be overexpressed by a small 
factor (relative to the enzyme multiplier of the tryptophan pathway), centromeric 
plasmids or yeast artificial chromosomes (YACs) were judged to be most appropriate. 
YACs require special techniques and need very large inserts (> 100kb) for stability 
while stable centromeric plasmids may be smaller, are easily transferable from E. coli 
to yeast and back and allow simple manipulation and analysis. For these reasons, the 
pRS413-6 series of centromeric plasmids (Sikorski and Hieter, 1989) was chosen as 
suitable vectors. They contain autonomous replicating sequences (ARS) and 
centromenc (CEN) sequences, which confer the properties of autonomous replication 
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and stable segregation at mitosis in yeast, and feature a comprehensive multiple 
cloning site (MCS) for ease of cloning fragments, blue/white colour selection for 
identification of recombinant transformants and a high copy number in E. co/i. Four 
different vectors are available with different selectable markers in yeast; HIS3, TRPJ, 
LEU2 and URA3 (pRS413-6, respectively). Finally, because they each have a 
corresponding vector which lacks the ARS/CEN sequences, integration of cloned 
sequences into the chromosome is possible, if desired. 
Some of the general features of the four genes, AROJ-4 were discussed in Chapter 1. 
The sequences of the genes were mapped and analysed using the University of 
Wisconsin CiCG package (UWGCG). This information was used both to design 
possible cloning strategies and to identify restriction digests which could be used to 
validate the source plasmids containing fragments of choice. 
3.1.1 	Plannin2 the strate2V 
The final cloning strategy adopted was developed to fulfil the following criteria. 
Fragments containing genes were chosen from the source plasmids 
so that all likely upstream promoter sequences (i.e. GCRE and 
TATA sequences) were included. 
. 	Similarly, downstream sequences thought to play a role in 
transcriptional termination and mRNA 3'-end formation (Zaret and 
Sherman, 1982; Henikoff and Cohen, 1984; Guo and Sherman, 
1996) were included. 
. 	The final plasmid should contain a 'cassette' containing all 4 genes 
which could, in principle, be transferred to other vectors with ease, 
using restriction enzymes which only cut at one site. 
It was anticipated that control of flux by each of the shikimate 
pathway enzymes could be investigated if it were possible to 
'disrupt' each of the additional plasmid-borne genes easily and 
selectively. This is possible if the coding regions may be cut at a 
unique site in the final plasmid, followed by 'blunt-ending' and 
,r,i 
ligation. This may require the destruction of some restriction sites 
in plasmid or cloned genes during construction. 
• 	The order in which genes were introduced into the plasmid added an 
additional constraint. Monitoring the functionality of genes by 
transforming specific mutants requires that AR03 should be cloned 
before AR04. The former relies upon GCN4 for basal transcription. 
It should therefore be possible to evaluate expression of the AR04 
gene in an aro4, gcn4 host in the presence of an AR03 gene, whilst 
the reverse is not possible. 
• 	The cloning steps were designed to be as rapid, simple and cheap as 
possible by avoiding partial digestions, filling in of cohesive ends, 
intermolecular blunt-ended ligations and isolation of bands on 
agarose gels and by using directional cloning where possible. 
• 	The sizes of fragments containing genomic ARO gene sequences 
were kept to a minimum given the fulfilment of the first two criteria 
above. 
The source and extent of the genomic sequences used in the construction of the final 
plasmids are shown in Table 3-1, while the final strategy adopted is illustrated in 
Figure 3-1. Maps of source plasmids and the cloning vectors used are given in 
Figures 3-2 - 3.7. They show relevant features such as restriction sites and coding 
regions of genes. Some selective disruptions to restriction sites within the yeast 
vector, pRS416, and upstream of the AR02 gene were necessary. Also, some 
preliminary manipulations involving the fragment containing the AROJ gene were 
necessary for its incorporation into the final plasmids, pPH28 and pPH30. These two 
plasmids contain all four ARO genes on fragments which should have all sequence 
features required for 'wild-type' expression. A map of pPH28 is given in Figure 3-8. 
The plasmids should be stable when maintained in media without uracil. The plasmids 
will allow transfer of a 12.5 kb XhoL/NotI 'ARO gene cassette' from the URA3 
plasmid pRS416to the homologous centromeric plasmids pRS413-5 if a different 
selectable marker is required, or to pRS403-6 for integration of sequences into the 




AR03 DAHP synthase 
inhibited by 
phenylalanine 
AR04 DAHP sthase 
tyrosine inhibition 
AROIC, AROM complex 
A,B,E,D 
AROJC DHQ synthase 
ARO1E 3-dehydroquinase 
00 	ARO1D SDH 
AROJB Shikimate kinase 
AROJA EPSP synthase 
AR02 Chorismate 
synthase 
DNA Coding Source Amount 5'-UT 3'-UT 
sequence sequence plasmid' of DNA sequence sequence 
accession length cloned used used Promoter sites datad Reference 
number (bp)' (bp) (bp)' (bp)' 
 1113 pME63I 1720 232 375 GCREs: —180 - —188 (-ve orientation) Paraviciniet 
TATA sites: 	—210--207,-156 - -151,-138 -- al. (1988) 
134, —88 - —85, —51 - —48,-45 - —42, —9 - —6 
X61107 1113 pME1199 1903 546 244 GCREs: —312--304 Kunzleretal 
(1992) 
X13802 4767 pMEI73 6489 912 810 GCREs: —531--523,-410--402,-224--216, Duncan etal. 
X13803 —196--188 (1987, 1988) 
X06077 TATA sites: —138 - —132 
Y00313 
X60190 1131 pZH2 1742 389 226 GCREs: —326--318,-218--210,-143--135 Jones etal. 
TATA sites: —105 - —100, —87 --82 (1991) 
Table 3-1 	ARO genes encoding enzymes of the shikimate pathway 
The table shows some details of the ARO genes which are cloned into the same plasmid in this study. a  The coding sequence length includes the termination codon. 
b The source plasmid indicates the plasmid used to obtain the cloned fragment. C  The number of bases from the 5'- and 3'-UT regions cloned into the final plasmid, 
pPH28, are shown. Those sites suspected or, in some cases, known to participate in the transcription of genes at basal levels (TATA) and during activation by the 
transcriptional activator GCN4 (GCREs), are shown. 
Figure 3-1 	Cloning strategy 
This diagram summarises the cloning steps planned to create pPH28 and pPH30, each 
bearing a copy of the four ARO genes. Reference may also be made to the 
Plasmid/Strain Card contained in the back pocket. 
Briefly, pZH2 contains AR02 which is incorporated (via pK19) into pRS416 
(modified) to give pPH29. AR03 and AR04, derived from pME631 and pMEll 99 
respectively, are then introduced sequentially to give pPH22 and pPH23. ARO1, 
derived from pME173 is incorporated (via pKl9) to give pPH28 and pPH30 
(different orientations ofAROl). 
pRS416 
destroy Sail 
site in multiple 
cloning site 
destroy Sacl 







Figure 3-2 pME173, the AROJ source plasmid 
BamiHi sites destroyed in previous cloning steps are shown in brackets. The cloning 
vector is pAT153. The ARO1 fragment is indicated (white box). Both the ampicillin 




Figure 3-3 pZH2, the AR02 source plasmid 
BamHI sites destroyed in previous cloning steps are shown in brackets. The cloning 
vector is YEpl3. The AR02 fragment is indicated (white box). Both the ampicilhin 
resistance gene (ampr), the yeast selectable marker, LEU2, and the AR02 coding 








Figure 3-4 pME631, the AR03 source plasmid 
The cloning vector is pUC1 8. The AR03 fragment is indicated (white box). Both the 





Figure 3-5 pME1199, the AR04 source plasmid 
The cloning vector is pGEM-7Zg+). The AR04 fragment is indicated (grey box). 





Figure 3-6 	pK19 - general bacterial cloning vector 
The kanamycin resistance gene is shown as a black arrow. 
mdiii 
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Figure 3-7 	pRS416, a single-copy yeast plasmid 
This plasmid contains autonomously replicating and yeast centromeric and 
autonomously replicating sequences (hashed box). Both yeast (URA3) and bacterial 





Figure 3-8 pPH28, the 'ARO' plasmid 
This plasmid contains yeast centromeric and autonomously replicating sequences 
(hashed box). Both yeast (URA3) and bacterial (ampicillin resistance) selectable 
markers are shown as black arrows. The plasmid, pPH30 is identical except for 
reverse orientation of the AROJ gene. 
KpnI 
ARS/CEN 	 I (Sail) 
(SacI) 	 //jCiaI/Nari) 
Sail ArnpR 	ura3 
pPH28 	 i nd III 
17243 bp 










permutation of individual or multiple gene disruptions using the restriction enzymes as 
defined in Table 3-2. These manipulations are predicted to cause premature chain 
termination well toward the 5' end of the genes, as shown. Thus the 'enzyme 
multiplier' may be independently varied for each of the four enzymes. 
3.1.2 	Plasmids constructed 
During construction and validation of each plasmid, their predicted sequences were 
generated on computer using SEQED (UWGCG). This allowed the prediction of 
restriction maps which guided the restriction digests used to screen transformants. 
Miniprep plasmid preparations were validated by restriction digests, designed to 
discriminate between the required recombinant plasmid, the donor plasmids and/or 
vector, and other likely but unwanted recombinants. The cloned fragments were 
validated by running the same fragment from the parent plasmid in adjacent lanes. 
The orientations of fragments (where necessary) were determined by restriction 
analysis using a known asymmetric restriction site within the fragment. Restriction 
sites destroyed by filling in (e.g. BamHT) of cohesive ends often generate new 
restriction sites (e.g. ClaI in dam host strains). This allowed further confirmation of 
the resulting construct in some cases. Finally the retention of sites to be used in future 
cloning steps was confirmed. After final selection of transformants, single colonies 
were used to generate glycerol stocks for storage at —70 °C and to produce purified 
plasmid DNA from 100 ml cultures, prior to the next cloning step. 
Construction of pPH16 and pPH17 from pRS416 
Destruction of the Sail and Sacl sites in pRS416 allows the use of these enzymes to 
disrupt the AR02 and AROJ genes respectively in the final plasmid, if required. 
The Sail site in pRS416 was cut, filled in by incubation with Kienow fragment and the 
four deoxyribonucleotide triphosphates (dNTPs), and the resulting blunt ends ligated. 
In order to reduce the number of transformants retaining an unmodified Sail site, the 
re-ligated mixture was digested with Sail prior to transformation into E. co/i CB-5 1. 
Transformants tested gave the desired fragment sizes following digestion with Sail 
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Predicted length of 
Gene Enzyme Normal protein Unique restriction truncated protein Comment 
length (aa) site (aa) 
DAI-IP synthase 
AR03 (inhibited by 370 Narl 183 
phenylalanine) 
AR04 DAHP synthase 370 SphI 20 
(inhibited by tyrosine) 
AROJ AROM complex 1588 SexAl 90 SexAI is predicted to give 
loss of all activities. 
00 
Sac! 818 Although Sacl disrupts only 
00 the final three activities, the 
entire complex may be non- 
functional 
AR02 Chorismate synthase 376 Sail 38 
Table 3-2 	Selective gene disruption by restriction digest 
The table above shows the restriction sites (unique in the plasmids pPH28 and pPH30) which are predicted to produce early chain termination of any combinations of 
the four ARO genes. This may be achieved by cutting with the appropriate restriction enzyme, blunt-ending with either Klenow fragment or T4 polymerase in the 
presence of 4 dNTPs, re-ligation and transformation. Transformants can be selected by cutting with the same enzyme prior to transformation. 
and ScaT. One of these transformants was used to generate a glycerol stock and 
plasmid DNA, called pPHJ6. 
The SacI site GIpPH 16-was destroyed in a similar manner. Attr digestion with Sad, 
T4 polymerase was used to digest 3' overhangs in the presence of the four dNTPs. 
DNA from transformants was analysed by digestion with SacI and ScaI. A 
transformant showing the required fragment sizes was used to generate a glycerol 
stock and plasmid DNA, called pPH17. 
Construction of pPH18 and pPH19 
Prior to the cloning of the AR02 fragment into the yeast shuttle vector, pRS416, it 
was necessary to destroy the BamHI site which lies about 350 bp upstream of the 
start of the coding sequence, so that a BamHI site within the multiple cloning site of 
the plasmid, pPH17, could be used at a later stage for the insertion of a 
Hindllh/BamHI fragment containing the AR03 gene and for the insertion of a Bcll 
fragment containing the AR04 gene. Since the unwanted BamHI site lies upstream of 
all three putative GCRE as well as two possible TATA elements, its modification was 
judged to be unlikely to affect normal transcription. 
However, the AR02 donor plasmid, pZH2, contains other BamI{1 sites. Therefore, a 
3.22 kbp SphI/SacI fragment containing AR02 was transferred from pZH2 to the 
general cloning vector, pKl9 (Pridmore, 1987). pZH2 was digested with SacI and 
SpliT. This reaction was ligated with SacI/SphI digested pKl 9. E. coil CB-51 cells 
were transformed with kanamycin selection. Transformants gave DNA which showed 
the required fragment sizes when digested with SphJJSacI or Hindu. One of these 
was used to give pPH18. 
The single BamHE site in pKl 8 was destroyed by BamHI digestion, filling in with 
Kienow fragment in the presence of 4 dNTPs, ligation, re-digestion with BamI{l and 
transformation in E. coil CB-51 under selection on LB-kan. A transformant giving 
the desired pattern of fragment size after digestion with BamHIJEcoRI, SaiI/Hindffl 
and SaclJSphI, using pZH2 and pPH18 as controls was selected to give pPH19. This 
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also showed the appearance of a predicted ClaI site, confirmed by digestion with C/al 
and EcoRl. 
Construction of pPH29 and pPH20 
It was originally intended to transfer a 1.74 kb NarI/Hindffl fragment containing the 
AR02 gene from pPH19 into the ClalJHindffl site ofpPHl7 to give pPH20. This 
strategy involved the disruption of the NarI site during cloning and allows the use of 
another Narl site to disrupt the AR01 gene in the final plasmid. However, the close 
proximity of the C/al site and Hindffl sites within pPH17 inhibited efficient digestion, 
even with sequential digestion, and an alternative strategy was devised whereby a 3.49 
kbp NarI fragment was first transferred to the C/al site ofpPHl 7, to give pPH29. 
Removal of 2 adjacent HindIII fragments (1.14 kbp and 0.61 kbp) by subsequent 
digestion with HindIII and intra-molecular ligation would yield pPH20. 
pPH19 was digested with NarI and ligated with phosphatase-treated Gal-digested 
pPH17. Ligation mixtures were transformed into E. coli JM109 cells and selected on 
LB-amp. A transformant giving the required insert and orientation of fragment as 
determined by digestion with HindIll, XholJBamHl and XhoJJBamHJJHindIII was 
designated pPH29. 
This was digested with HindJII and religated at a reduced concentration. After 
further digestion with SacI to reduce unmodified transformants, E. co/i JM109 cells 
were transformed with selection on LB-amp. Transformants were tested by 
HindllhJXhoI digestion. All gave the required fragment which is 20 bp longer than the 
HindIII/NarI fragment from pPH19. One of these transformants was used as pPH2O. 
These are the first plasmids constructed in this series to contain an ARO gene (AR02) 
cloned into a pRS416 derivative. 
Construction of pPH22 (contains AR02,3) 
Here, a 1.73 kbp HindfflIBamIil fragment containing the AR03 gene from pME63 1 
was cloned into the Hindffl/BamIH sites of pPH20 to give pPH22. 
pME631 was simultaneously digested with HindJll and BamHI (and EcoRI to cut the 
vector fragment) and ligated with HindffllBamHl-digested pPH20. The reactions 
were transformed into E. coil 1M109 cells and transformants selected on LB + 
ampidilhin. One transformant giving the required restriction fragments when digested 
with HindTIJJBamHT was called pPH22. This plasmid is predicted to contain the 
AR02 and AR03 genes. 
Construction of pPH23 (contains AR02, AR03, AR04) 
A 1.90 kbp BcfI fragment from pMEl 199 was cloned into the BamHl site of pPH22, 
as follows. 
pME 1199 was propagated in the dam host E. coil CB-5 1 prior to restriction with 
MI. This was required because BclI is sensitive to dam methylation (where adenine 
bases are methylated within GATC sequences). pPH22 was digested with BamHJ and 
then phosphatase treated. This was ligated with pMEl 199 digested with BciI, EcoRI 
and Sad. E. coli JM109 were transformed with selection on LB + ampidilhin. A 
transformant which showed the required restriction pattern with HindIll/XbaI and 
HindIII/SphI digestion was used as pPH23. Only one orientation of the BclI fragment 
within pPH22 was obtained. This plasmid contains the AR02, AR03 and AR04 
genes. 
Construction of pPH24 (contains AROJ) 
It was necessary to manipulate an AROJ fragment into a vector in such a way as to 
remove it as a Hindu! fragment for cloning into pPH23. pME 173 was therefore 
digested with SspI/SphI and this reaction was ligated with SmaI/SphI digested pKl9. 
White recombinant transformants were selected on LB + kanamycin + X-GaIIIPTG. 
A transformant giving the predicted fragment sizes with digestion with Hindllh/SphI, 
was designated pPH24. 
It was necessary to destroy an SphI site within a 7.02 kbp HindIII fragment so that 
the SphI site in AR04 could be used to selectively disable the AR04 gene. pPH24 
was therefore digested with SphI and subsequently treated with T4 polymerase in the 
presence of dNTPs to digest 3' overhangs. Religation and transformation into E. coil 
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XL! cells gave transformants which gave the required fragments after digestion with 
SphVEcoPJ. One was used to generate pPH27. 
Construction of pPH31 (contains AROJ) 
A 7.5 kbp NarI fragment from pPH27 bearing the AROJ gene was cloned into the 
ClaI site of pRS4 16 in order to produce a yeast plasmid containing only the AR01 
gene. This was achieved by digesting pPH27 with NarI and pRS416 with C/al. The 
vector was dephosphorylated with alkaline phosphatase. After ligation of the 
products and transformation of E. coli XL1 cells with selection on LB + ampicillin, 
transformants were obtained which showed the required pattern of restriction 
fragments after digestion of plasmid DNA with SalI/BamHI, EcoPJ and Hindffl. A 
transformant was used to generate a glycerol stock and plasmid DNA, called pPH3 1. 
Construction of pPLI 28 and 30 (contains AR01, AR02, AR03, AR04) 
It was now possible to construct a plasmid containing all four ARO genes by 
transferring a 7.02 kbp HindllI fragment from pPH27 into the Hindill site of pPH23. 
pPH23 was digested with Hindffl and treated with alkaline phosphatase. It was 
ligated with pPH27 digested with HindIll. After ligation and transformation into E. 
coli XL1 cells, using selection on LB + ampidilhin, transformants were analysed with 
EcoRI/ BamHT/HindJII. All samples showed the required restriction pattern. Further 
analysis with PstI defined the orientation of the Hindffl fragment containing the 
AROJ gene. Two transformants showing opposite orientations of this fragment were 
used to generate glycerol stocks and plasmid DNA, and were called pPH28 and 30. 
The map of pPH28 wa previously shown in Figure 3-8. 
3.1.3 	Summa 
Both of the plasmids pPH28 and pPH30 are designed to show the features defined in 
the cloning strategy. They should contain the coding regions, promoter sequences 
and downstream sequences required for normal expression from the chromosome of 
all the genes encoding enzymes of the shikimate pathway. They are expected to 
maintain a low copy number (possibly of! copy) within yeast cells in a stable manner 
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under the control of the ARS/CEN sequences. Each of the AROJ-4 genes may be 
disabled selectively by disruption (blunt-ending) of the Sad, Sail, NarI or SphI 
restriction sites respectively. They can be propagated within K coli using ampidilhin 
resistance and can be transformed and selected in a yeast strain carrying a ura3 
mutation by growth on media lacking uracil. 
Table 3-3 shows the salient features of the plasmids constructed. 
The following section reports how plasmids (pPH20, 22, 23, 28 30 and 31) containing 
various combinations of the ARO genes were used to complement aro mutations in 
various strains of yeast. 
3.2 	ComDlementation of aro null mutations 
Strains containing null mutations within genes encoding enzymes of the shikimate 
pathway may be used to test the identity and partial functionality of genes borne upon 
the plasmids pPH20, 22, 23, 28 and 30, by transformation and determination of 
growth requirements. Table 3-4 shows the strains used and which mutations they 
bear. It was first necessary to confirm their identity. 
3.2.1 	Strain verification 
All strains used were verified for their nutritional requirements by growing strains in 
YEPD followed by transfer into 'drop-out' media, where one nutrient was omitted. 
Growth was noted. The results for RH1 129, R111181, R111182, R111610, RH1220 
and RHl38O are shown in Table 3-5. RH1129,RH1181,RH161O,RHl22Oand 
RH13 80  showed growth requirements which are consistent with their designated 
genotypes. In contrast, RH1 182 gave no growth on media lacking any of the 
following nutrients - phenylalanine, tryptophan, tyrosine, adenine, uracil or leucine, 
and poor growth when lacking methionine. This was not consistent with its given 
genotype. Auxotrophy for lysine was expected but not observed whilst auxotrophy 
for methionine was not expected but was observed, although this mutation appeared 















pPH16 ampicillin URA3 pRS416 with Sail site destroyed 4902 
pPH17 ampicillin UREI3 pRS416 with Sail and SacI sites 4898 
destroyed 
pPH18 kanamycin 2 Sacl/SphI fragment from pZH2 5840 
cloned in SacIJSphI site of pK19 
pPH19 kanamycin 2 pPH18 with BamHI site destroyed 5844 
upstream of promoter in AR02 
pPH20 ampicillin URA3 2 pPH29 after removal of HindlIl 6634 
fragments 
pPH22 ampicillin URA3 2,3 HindffllBamHl fragment (AR03) 8324 
from pME63I cloned into 
HindllhIBamHl site of pPH20 
pPH23 ampicillin URA3 2,3,4 Bcll fragment (AR03) of 10223 
pMEl 199 cloned into BamHI site 
of pPH22 
pPH24 kanamycin 1 SspIJSphI fragment (AROJ) from 9872 
pME 173 cloned into SmaIJSphI 
site ofpKl9 
pPH27 kanamycin 1 pPH24 with SphI site destroyed 9868 
pPB28 ampicillin URA3 1,2,3,4 Hindffl fragment (AROJ) of 17243 
pPH27 cloned into Hindffl site 
of pPH23 
pPH29 ampicillin URA3 2 Narl fragment (AR02) from 8385 
pPH19 cloned into ClaI site of 
pPH1 7 
pPH30 anipicillin URA3 1,2,3,4 Hindffl fragment (AROI) of 17243 
pPH27 cloned into HindIll site of 
pPH23 - frag reversed cf. pPH28 
pPH31 ampicillin URA3 1 Narl fragment (AR01) from 12400 
pPH27 cloned into ClaI site of 
pRS416 
Table 3-3 	Details of plasmids constructed during this study 
The plasmid pPH28, shown in boldface was used in future experiments in order to 
evaluate the universal method. 
For easy reference, some of these data are also contained on a card in the inside back 
cover of volume 2, along with data on the yeast strains used. 
Strain Mating aro ftp other mutations 
type 
RH1220 a aro3, aro4 leu2-2 
RH1380 a aro4-1 ura3-52, gcn4-101 
RH1129 a arolC trp5 leul, hom2, ade6, lysi, ura3, arg4-1, thri, his6, met], 
gal2 
RH1181 a arol trpi ura3 and/or ura4, his4-15, can], ade2, karl-i 
RH1182 a arol trpl ura3 and/or ura4, leu2, lysla,  can], ade2, karl-i 
RH1610 a aro2 
Table 3-4 	Yeast strains used to monitor functionality of cloned ARO genes 
a 
Nutrient requirement for growth as determined in this work showed that this strain was not auxotrophic for lysine, but was auxotrophic for 
methionine (see text and Table 3-5) 
For easy reference, these data are also contained on a card in the inside back cover of volume 2, along with data on the plasmids used. 
Media lacking particular nutrients 
Strain Relevant genotypic markers 
RH1220 aro4, leu2 
RH1380 ura3, gcn4 
RH1129 arol, trp5, leul, hom2, ade6, lysi, ura3, 
arg4, thri, his6, met], 
RH1181 arol, trpl, ura3 and/or ura4, his4-15,, ade2, 
RH1182 arol, tip], ura3 and/or ura4 leu2, lyslt', 
aN ade2, 
RH1610 aro2 
FWYAdU L T H M K R - 
+ - 	- nd - nd nd nd nd nd + + a 
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Table 3-5 	Testing auxotrophy of aro strains 
Strains were grown to about 0D546 = 1 in 10 ml of permissive media. 20 tl were then transferred into 10 ml of media lacking one of each of 
the nutrients specified above. These were then cultured until the permissive media (-) reached 1 unit 0D546. Cultures were then scored for 
growth. Visible growth approximating growth in permissive media +, invisible growth - , poor growth visible -/+. The concentrations of 
the nutrients used are given in Chapter 2. 
a permissive media included F,W,Y,U and R only; b  Growth properties suggest that this strain may be LYS1, met (see text), C  permissive 
media included F,W and Y only. 
RH13 80  showed a complex pattern of growth requirements, which are illustrated in 
Table 3-6. Its absolute requirement for uracil is consistent with its ura3 designation. 
Only slow growth is observed in the absence of phenylalanine, tryptophan and 
tyrosine. This is attributed to a combination of the aro4 and gcn4 mutations. 
Because basal expression (non-starvation conditions) of the AR03 gene is dependent 
upon GCN4 (Paravicini, etal., 1989a), the DAHP synthase activity in RH1380 is very 
low and, in the absence of all three aromatic amino acids, there is only sufficient flux 
through the shikimate pathway to support low growth rates. 
When phenylalanine is included in the media, however, growth became undetectable 
Thus, the reduced activity of the AR03 gene product (phenylalanine inhibitable 
DAHP synthase) is sufficiently inhibited by phenylalanine to render the strain 
auxotrophic for both tyrosine and tryptophan. Thus the aro3, gcn4 background only 
appears to provide sufficient flux for (slow) growth when phenylalanine is not present 
in the medium. These growth characteristics were useful for the purposes of 
monitoring the activity of AR03 and AR04 cloned into the plasmids constructed, as 
detailed in section 3.2.2. 
In summary, the growth characteristics of the strains described above are consistent 
with their designated genotypes as given in Table 3-4 with the exception of RH1182 
where weak methionine auxotrophy replaces lysine auxotrophy. 
3.2.2 	Transformin2 strains with ARO plasmids 
Yeast strains having mutations in genes encoding enzymes of the shikimate pathway 
were transformed with plasmids bearing combinations of these genes, in order to 
confirm the identity of the cloned genes and to test their functionality. The results are 
summarised in Table 3-7. 
RE11129 (arol etc.) 
Because RH1 129 had been designated ura3, selection of transformants using media 
lacking uracil was used. However no transformants were obtained with pRS4 16, 
pPH20, pPH22, pPH28 or pPH31. Since RH1380 carries a ura3 mutation which is 
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Media containing the Growth 
following nutrients indication 
F W 	Y U + 
F W 	Y - 
W 	y U + 
F Y U - 
F W U - 
Y U + 
W U + 
F U - 
U 
Table 3.6 	Testing growth requirements of RH1380 
The growth ofRHl38O (aro4, ura3, gcn4) is tested in the media given above where 
each nutrient in turn is omitted or where two or three of the aromatic amino acids are 
omitted. The concentrations of the nutrients are as described in Chapter 2. + 
indicates normal growth, +1- indicates slow growth, - indicates no detectable growth 
compared to control 
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Strains Plasmids transformed (with selectable markers) 
pZH2 pPH20 pPH22 pPH23 pPH28 pPH30 pPH31 	pRS416 
relevant markers Selection on AR02 AR02 AR02, 3 AR02, 3,4 AROJ,2, 3,4 AROI, 2,3,4 AROJ 	URA  
media LEU2 URA3 URA3 URA  URA  URA  URA  
lacking 
RH1129 arol uracil - - - 
ura4? F,Y - - + + + 
RH1181 arol uradil - - 
ura4? F,Y - - + + + 
RH1182 arol uracil - - 
ura4? F,Y - - + + + 
RH1610 aro2 F,Y,W + + + + + + - 
RH1220 aro3aro4 F, Y, W - + + + - 
RH1380 aro4, gcn4, ura3 uradil + + + + + 	+ 
Table 3-7 	Transformation of aro strains with 4R0 plasmids constructed 
Various strains (with their relevant auxotrophic markers) are transformed with various plasmids (with specific ARO or URA genes). Blanks 
indicate that a particular transformation was not attempted. All transformations included appropriate positive (growth of host strain on non-
selective media) and negative (host strain plated onto selective media without plasmid in transformation) controls. Note that RH1129, 
RH1181 and RH1182 are given a ura4? designation to account for lack of complementation by URI43 plasmid (see text). 
complemented by pRS416, pPH22, 23, 28, 30 and 31, it was concluded that uracil 
auxotrophy in RH1 129 arises through the mutation at another locus. Since RH! 181 
and RH1 182 were supplied from the same source with a ura3 and/or ura4 
designation, it seems reasonable to suppose that this mutation may be ura4. 
Subsequent transformations of this strain with selection on media lacking 
phenylalanine and tyrosine show that plasmids pPH28, 30 and 31 convert 
phenylalanine and tyrosine auxotrophy to prototrophy, whilst pPH22 and 23 do not. 
This is entirely consistent with the prediction that only the former bear ARO1. All 
transformants required uracil in the medium when their nutritional requirements were 
tested by replica plating, further confirming that this strain's uradil auxotrophy arises 
through mutation of a gene other than URA3. 
R111181 (arol etc.) and RB1182 (arol etc.) 
Neither of these strains were converted to uracil prototrophy by transformation with 
pPH22 and pPH23. Similar conclusions to those for RH1 129 can be drawn, 
regarding the nature of the mutation giving rise to uracil auxotrophy. When 
transformants were selected on media lacking tyrosine and phenylalanine, pPH28, 30 
and 31 gave many colonies (which still showed uracil auxotrophy) whilst pPH22 and 
23 did not give transformants. These results support those above and confirm the 
presence of a functional AR01 gene in plasmids pPH28,30 and 31, as predicted. 
R111610 (aro2) 
In an initial experiment conducted during plasmid construction, the functionality of 
the first ARO gene (AR02) cloned into the yeast plasmid pRS416, was tested by 
transformation of the aro2 mutant RH1610 with pPH20 and pZH2. Both plasmids 
gave complemention of the mutation on media lacking the three aromatic amino acids. 
This confirmed the presence of a functional AR02 gene and suggested that the system 
used was likely to be appropriate for carrying and expressing functional ARO genes. 
Competent RH1 610 were later incubated with pPH20, 22, 23, 28, 30 and 31. All 
these plasmids, except for pPH3 1, gave transformants on media lacking the three 
aromatic amino acids. This was entirely consistent with predictions. pPH3 1 bears 
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only the ARO1 gene while the others all contain AR02 in various combinations with 
the other ARO genes. The results suggest, therefore, that AR02 is functional in all 
plasmids of this series. 
R111220 (aro3, aro4) 
RH 1220 was transformed with plasmids pPH20, 22, 23, 28, and 31. Only those 
plasmids expected to bear AR03 and/or AR04 (namely pPH22, 23 and 28) gave 
transformants on media which lacked the three aromatic amino acids. Since pPH22 
(AR02, AR03) gives conversion from auxotrophy, this confirms that the AR03 gene 
is functional in this plasmid and that one of the two genes, AR03 or AR04, is 
functional in plasmids pPH23 and 28. 
RH 1380 (aro4, gcn4, ura3) 
RH1380 give transformants with pPH22, 23, 28, 30 and 31 when selected on Ura 
media, as expected. Selection on trp media was poor because of slow background 
growth of transformed cells. However, the functioning of ARO4 may be 
independently established by monitoring the growth of these transformants in defined 
media (see below). 
Distinguishing AR03 and AR04 activities on the basis of growth characteristics 
In section 3.2.1 it was observed that growth ofRHl38O (aro4, gcn4, ura3) was 
inhibited in media lacking tyrosine and/or tryptophan but containing phenylalanine. 
This was interpreted in terms of the inhibition by phenylalanine of the enzyme (jthe-
inhibitable DAHP synthase) encoded by AR03, whose basal expression is almost 
entirely dependent upon GCN4. Those plasmids containing AR04 should rescue 
growth on media containing phenylalanine but lacking tryptophan +1- tyrosine, in 
contrast to plasmids containing only AR03. 
Transformants were plated onto solid media lacking uracil and replica-plated onto 
various media. Growth was noted relative to the growth of positive and negative 
controls. The results are shown in Table 3-8. They show clearly that all 
transformants grow without difficulty in all media with the exception of pPH22 
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- 	- 	- 	- 	- 	- 	- 	+ 
+ + + + + + + + 
+ 	+ 	+ 	+ 	+ 	+ 	+ 	+ 
+ + + + + + + + 
MV (+IJ)8 + 
- 	F 	W 	Y 	WY 	FY 	FW 	FWY 	Comment' 
RH1380 	no plasmid 	+1— 	- 	+ 	+ 	+ 	- 	- 	+ 	Uracil present 
aro4, gcn4, ura3 pPH22 -4-I— - + + + - - + Uracil absent 
	
t_j
pPH23 	 + 	+ 	+ 	+ 	+ 	+ 	+ 	+ 	Uracil absent 
pPH28 + + + + + + + + Uracil absent 
pPH30 	 + 	+ 	+ 	+ 	+ 	+ 	+ 	+ 	Uracil absent 
Table 3-8 	Growth of aro4 +1— aro3 mutants and AR03,4 transformants 
Transformants were replica-plated onto various media as shown. Normal, slow or insignificant growth (with respect to controls) are 
denoted by + , +1— or -, respectively. 12 independent transformants for each strain/plasmid pairing were used. The results shown were 
obtained by all transformants tested. The results for transformants of RH1220 are shown so that the effect of the gcn4 mutation can be seen 
by comparing RH1220/pPH22 with RH1380 (both strains being AR03, aro4). 
8 Untransformed RH 1380 requires uracil in all media. It is therefore included in all drop-out media used for this (untransformed strain). 
Both strains when transformed have no requirement for uradil. Therefore, this nutrient is omitted in order to maintain selection. 
confirmed as carrying a functional AR04 gene. The pPH22 transformant matches the 
growth characteristics of the untransformed strain, except for uracil prototrophy. It 
was therefore concluded that AR03 on pPH22 was functional (it rescues the aro3, 
aro4 mutations in R111220) and that AR04 is functional in pPH23, 28 and 30 
because they rescue 'wild-type' phenotype on specific media from the phenotype given 
by the background AR03, aro4, gcn4 genotype. 
3.3 	Summa 
Strains carrying mutations in the ARO genes have been examined for their nutritional 
requirements. These are, in general, consistent with their designated genotype. Only 
RH! 182 gave a conflicting result where a requirement for methionine was observed 
rather than for lysine, but this did not reflect upon the significance of the results 
obtained. 
It was possible to detect the aro4 mutation in RH1380 in the presence of AR03 in a 
gcn4 background by culturing in MV+F, MV+FY or MV+FW. In these cases, 
growth was very slow or undetectable. 
These strains were used in transformations with the plasmids pPH20, 22, 23, 28, 30 
and 31 to test whether their genes could rescue their corresponding mutations. Since 
these p!asmids used the URA3 selective marker, it was also possible to test the 
presence of ura3 mutations in RH1 129, RH1 181, RH1 182 and R111380. Only 
RH1380's auxotrophy for uracil could be converted by transformation with these 
plasmids. 
It was possible to rescue all arol mutants (RH1 129, 1181 and 1182) with all plasmids 
containing AR01 (pPH28, 30 and 31) and the aro2 mutant (RH1610) with plasmids 
bearing the AR02 gene (pPH20, 22, 23, 28 and 30), as predicted. AR03 and AR04, 
the genes encoding the two isoenzymes of DAE{P synthase, are more difficult to 
monitor. However, AR03 on pPH22 and AR04 on pPH23, 28 and 30 are positively 
confirmed. The presence of AR03 on pPH23, 28 and 30 may be confirmed by 
measuring phenylalanine-inhibitable DAHP synthase activity in transformants or by 
103 
disruption of the AR04 genes in pPH23, 28 and 30 followed by transformation into 
R111220. However, there is no reason to suspect that the cloning of AR04 and ARO1 
into pPH22 should have disturbed expression of ARO3. 
Since enzyme activities at a small fraction of wild-type levels may lead to phenotypic 
responses indistinguishable from those of a wild-type strain, it should be stressed that 
the rescue of mutations here does not yield any information regarding the level of 
expression from the plasniid encoded genes. Since the rationale for the method 
employed within this project depends upon large changes in enzyme activities, the 
suitability of the plasmid constructs described here can only be evaluated by 
measuring enzyme activities under similar conditions to those that will be used in 
future physiological experiments. These data are presented in Chapter 4, whilst the 




Construction and characterisation of transformed 
strains 
Chapter 3 described the construction of a plasmid, pPH28, which bears the four genes 
(AROJ-4) encoding the enzymes of the shikimate pathway, and the subsequent 
demonstration of their function in strains carrying mutations in these genes. 
The experimental strategy of this thesis requires the overexpression of the ARO genes, 
encoding enzymes of the shikimate pathway, by specific factors. In order to assess 
the suitability of the constructed plasmid, pPH28, appropriate strains were 
transformed with pPH28 (and other plasmids of this series) and activities of DAHP 
synthase, SDH and chorismate synthase measured, compared to wild-type levels, and 
expressed as enzyme multipliers. Furthermore, it was necessary to overexpress these 
enzymes in strains bearing the multi-copy plasmid pME554 (Niederberger et al., 
1984) used to overexpress all five enzymes of the tryptophan pathway. This required 
the isolation of a ura3 derivative of the trpl-5 quintuple null mutant, RH1207 
(Niederberger et al., 1992; Prasad et aL, 1987) in order to select pPH28 
transformants. 
It was also necessary to undertake a partial characterisation of RH1207, the reference 
strain RH805 and the multi-copy plasmid, pME554. This includes the determination 
of the activities of the enzymes anthranilate synthase and tiyptophan synthase in these 
and other control strains before and after transformation with pME554 and/or pPH28 
(and its precursors). 
4.1 	tip strains and TRP plasmids 
Table 4-1 gives details of the strains discussed in this chapter. The same data are 






Mating 	iwo 	Irp 	 other mutations 	 source or reference 
type 
RH805 	not 	 aat2 	 Kradolfer et al., (1982) 
defined 
RH1207 	not 	 trpl, lrp2, 	leu2, aat2 	 Prasad et al., (1987) 
defined trp3, Irp4, trp5 
RH1220 a aro3, aro4 leu2-2 G. Braus 
RH1380 a aro4 ura3-52, gcn4-101 G. Braus 
RH1 129 a aroiC trp5 leul, hom2, ade6, lysi, ura3, arg4-1, thri, his6, met], G. Braus 
gal2 
RH1181 a arol trpl ura3 and/or ura4, his4-15, cani, ade2, karl-i G. Braus 
RH1 182 a arol trpl ura3 and/or ura4, leu2, 1y51a,  can], ade2, karl-i G. Braus 
RH1610 a aro2 G. Braus 
Table 4-1 	Yeast strains used to assess over-expression of enzymes from TRP and ARO plasmids 
a Nutrient requirement for growth as determined in this work showed that this strain was not auxotrophic for lysine, but was auxotrophic for 
methionine (see text). For easy reference, these data are also given on a card in the inside back cover of this volume, along with data on the 
plasniids used. 
The strain RH805 contains an aat2 null mutation. The AA T2 gene encodes the high 
affinity aromatic amino acid transferase which catalyses the catabolic conversion of 
tryptophan to tryptophol (Kradolfer et al., 1982). This mutation was introduced in 
order to allow increased intracellular accumulation of tryptophan and to allow a more 
valid determination of flux to tryptophan, when the rate of tryptophan breakdown 
becomes smaller compared to the measurable rates of accumulation into free 
tryptophan pool and tryptophan in protein. 
RH1207 is a derivative of RH805 which bears quintuple null mutations in the genes 
encoding enzymes of the tryptophan pathway. It also bears a 1eu2 mutation. This 
strain has previously been used as a host for the TRP plasmids, pME554 and pME559 
(Prasad et al., 1987; Niederberger et al., 1992). 
The multi-copy plasmid, pME554 (Niederberger etal., 1984), derived from the 2-
micron yeast episome, contains a copy of the five TRP genes and gives 
overexpression of the five enzymes by factors of about 25-50 (Niederberger etal., 
1992). 
4.1.1 	Verification of R11805 and R111207 
Both of these strains showed nutrient requirements consistent with their genotypic 
designation. Thus, RH805 shows no auxotrophy. It grows well on MV medium. 
RH12O7, on the other hand, requires leucine and tryptophan for growth on MV 
medium. Furthermore, RH1207 could be transformed with pME554 using selection 
on media lacking tryptophan. These transformants still required leucine for rapid 
growth. This result was entirely consistent with the findings of Prasad etal. (1987), 
who declared that pME554 and pME559 both contained a LEU2d allele with a 
defective promoter. 
The activities of anthranilate synthase and tryptophan synthase, encoded by TRP213C 
and TRP5 respectively, were determined in RH805 and RH1207. The results are 
shown in Table 4-2. There are detectable levels of both anthranilate synthase and 








Anthranilate synthase 	Tryptophan synthase 
nmol 	mg protein 
RH805 MV + LVFY(loo) 0.07 1.1 
RH1207 MV + LVFY(100) + W(40) 0.00 0.0 
RH1207 	pME554 MV+LVFY(100) 415 29.4 
Table 4.2 	Enzyme activities in RH805 ('wild type') and 11111207 (trpl-5) strains 
in RH805. RH1207 shows no detectable activities of these two enzymes, and was 
subsequently used as a negative control for these assays. 
4.1.2 	Verification of Diasmid DME554 
The identity ofpME554 was confirmed by restriction digestion with Hindffl, EcoRI 
and BamHI (and combinations of these enzymes) and comparison of the fragment 
sizes obtained, with the plasmid map as published (Niederberger et a!, 1984). When 
RH 1207 was transformed with pME554, the plasmid complemented the five null 
mutations of genes of the tryptophan pathway, allowing growth on media lacking 
tryptophan. Transformants gave large anthranilate synthase and tryptophan synthase 
activities compared to the wild-type activities in RH805 (see Table 4-2). The specific 
activity of anthranilate synthase was 4.15 nmol • min d . mg protein', representing an 
enzyme multiplier of 59 with respect to the wild-type, whilst the specific activity of 
tryptophan synthase was 29.4 nmol min' mg protein', representing an enzyme 
multiplier of 27. This confirmed that pME554 bears the genes TRP2, TRP3 and 
TRP5 and suggests that this plasmid is maintained at high copy number. The activities 
of the other enzymes of the pathway, encoded by the genes TRPJ, TRP4 and TRP3C 
were not determined. For the purposes of this thesis, it was assumed that similar 
levels of overexpression were obtained for these enzymes relative to the factors 
obtained for anthranilate synthase and tryptophan synthase and comparable to the data 
of Niederberger et al, (1984). 
4.2 	Construction of a ura3 derivative of RH1207 
The experimental protocol demands the introduction of both pME554 and pPH28 into 
the same strain. In order to maintain selection on the ARO plasmid, pPH28, it was 
therefore necessary to introduce a ura3 mutation into RH1207. This was achieved by 
growing RU1207 to late exponential phase and plating onto medium containing 5-
fluoro-orotic acid (5-FOA) as well as uracil. Resistance to 5-FOA occurs in ura3 
and, to a lesser degree, in ura5 mutants, possibly because the enzymes encoded by 
these genes may lead to the conversion of 5-FOA into 5-fiuoro-UIMP (Boeke et al., 
1984). Resistant colonies are therefore likely to be ura3. Colonies selected in this 
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manner were tested for their requirement for leucine, tryptophan and uracil in the 
media. Nine colonies which showed auxotrophy for all three nutrients were scored 
for reversion to uracil prototrophy by culture to mid exponential phase and 
subsequent transfer to media lacking uradil. The suitability of one such colony which 
gave least reversion, HK1, was also tested for its ability to be transformed with 
pME554 and pPH28. These plasmids gave transformants which showed prototrophy 
with respect to tryptophan and uracil respectively. This suggests that the genotype of 
HK1 is aat2, leu2, trpl, trp2, trp3, trp4, trp5, ura3. 
4.3 	Transformation of trp strains with TRP and ARO 
plasmids 
Attempts were made to transform RH1207 and HK1 with various combinations of the 
plasmids, pPH28, pPH30 and pPH3 1 and pME554 or a similar plasmid, pME559, 
which harbours an allele of TRP2 (TRP2jz,) which shows resistance to feedback 
inhibition by tryptophan (Prasad et al., 1987). 
RH 1207 was successfully transformed with pME554 using selection on media lacking 
tryptophan. The transformation was most efficient when phenylalanine and tyrosine 
were included in the media. Attempts to transform with pME559 were unsuccessful, 
using different media such as SC medium and MV medium + LV (100 p.g mf) with 
concentrations of tyrosine and phenylalanine varying between 0 and 100 pg ml'. This 
is in accordance with reports which emphasise the instability ofpME559 even when 
grown in the presence of phenylalanine and tyrosine (P. Niederberger, personal 
communication). Two mechanisms whereby phenylalanine and tyrosine may stabilise 
transformants containing a multi-copy TRP plasmid are possible. Firstly, 
phenylalanine and tyrosine together inhibit both isozymes of DAHP synthase, the first 
enzyme of the shikimate pathway. This may result in a reduced flux within the 
pathway, leading to partial starvation for tryptophan. Cells bearing a multi-copy TRP 
plasmid may have a growth advantage over cells which have a low copy number or 
lack the plasmid altogether. Secondly, decreased flux to tryptophan by the same 
mechanism may lead to insufficient excretion of tryptophan to support the growth of 
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cells which have lost the plasmid at mitosis. In the absence of phenylalanine and 
tyrosine cells containing low copy plasmid or lacking plasmid altogether may have a 
growth advantage over cells containing many copies of the plasmid, especially when 
tryptophan is present in the medium. 
HK1 was transformed with pPH28, pPH30 and pPH31 under Ur& selection. This 
confirmed that HK1 contained a ura3 mutation. It was also transformed with 
pME554 using media lacking tryptophan. Attempts to transform with pME559 were 
unsuccessful. 
Strains containing both an ARO plasmid and a TRP plasmid were generated by 
transforming HK1/pME554 with the ARO plasmids, pPH28, pPH30 and pPH3 1, 
using medium lacking uradil and tryptophan, to yield the transformants designated 
HK1/pME554/pPH28 etc. 
Prior to further analysis, the plasmids were rescued from transformed strains 
(}{Kl/pME554, }{Kl/pPH28 and HK1/pME554IpPH28) by transformation of 
competent E. coli with plasmid preparations from cultures. as described in Section 
2.5.6. Distinctive patterns of restriction fragments from plasmid preparations from 
transformants showed that pME554 had been rescued from HK1/pME554 and 
HK1/pME554/pPH28 and that pPH28 was rescued from both }{Kl/pPH28 and 
HK1/pME554/pPH28 
4.4 	Enzyme activities in host strains and transformants 
The ability of pME554 and pPH28 to increase the activity of enzymes encoded by 
genes cloned on these plasmids is clearly important for the experimental strategy 
implicit in the universal method. This section reports upon the various enzyme 
activities obtained in different strains/plasmid pairings and in different media. Strains 
were grown to an 0D 546 of about 1 and cells permeabilised as described in Chapter 2. 
Specific calibrated assays and protein determinations on these cell preparations 
allowed the determination of specific activities. 
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4.4.1 	Overexpression of enzymes of the tryptophan pathway 
Two assays were performed to assess the degree to which enzymes of the tryptophan 
pathway may be overexpressed in strains bearing the multi-copy plasmid, pME554. 
Preliminary results were presented in section 4.1.2. 
Anthranilate synthase 
The activities of anthranilate synthase in various strains are summarised in Table 4-3. 
RH1207, I{Kl and HK1/pPH28 showed no detectable activity, consistent with a null 
mutation in the TRP2 and TRP3 genes. The 'wild-type' strain, RI]:805, gave an 
activity of 0.07 nmol • min -' 'mg protein'. Cells transformed with pME554 and cells 
transformed with both pME554 and pPH28, pPH30 or pPH3 1 all gave anthranilate 
synthase activities which were larger than wild-type by factors of about 40 - 60. This 
is in reasonable agreement with the results of Niederberger and colleagues who 
achieved enzyme multipliers of between 19 and 50 (Niederberger et al., 1984; Prasad 
et al., 1987; Niederberger et al., 1992) when anthranilate synthase activity was 
overexpressed on pME554 and pME559. Thus, pME554 clearly encodes TRP2 and 
TRP3 and is replicated at high copy number. 
Tryptophan synthase 
Similar results are obtained with assays of tryptophan synthase activity as shown in 
Table 4-3. RH1207 and HK1 strains and those transformed with the ARO plasmid 
pPH28 gave no detectable activity. The 'wild-type' strain, RH805 gave a specific 
activity of 1.1 nmol • min' mg protein 1 , while the strains transformed with pME554 
gave greatly increased specific activities of between 25 and 40 nmol ' mm 4 mg 
protein', representing enzyme multipliers of between about 21 and 36. 
General control 
The activities of both anthranilate synthase and tryptophan synthase in RH805 were 
unchanged when cells were grown in MV medium. Thus the phenomenon of 'general 
control', where some biosynthetic enzymes are derepressed under starvation 
conditions, was not observed. The fact that the activity of anthranilate synthase and 
tryptophan synthase in the gcn4 strain, RH1380/pPH28, did not change either, was 
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Anthranilate synthase Tryptophan synthase 
Strain Plasm Id Media  
nmol mind mg protein' 
RH805 MV 0.06 1.2 
RH805 MV+LVFY(100) 0.07 1.1 
RH1207 MV+LVFY(100)+W(40) 0.00 0.1 
nxi MV + LVFY(100) + UW(40) 0.01 0.0 
RH1207 pME554 MV+LVFY(100) 3.60 24.7 
HK1 pME554 MV-4-LVFY(100)+U(40) 2.82 39•9 
HK1 pPH28 MV + LVFY(100) + W(40) 0.00 0.0 
HK1 pME554/pPH28 MV + LVFY(100) 2.80 38.0 
RH1380 pPH28 MV 0.06 1.4 
RH1380 pPH28 MV + LVFY(100) 0.08 1.2 
Table 4.3 	Activities of anthranilate synthase and tryptophan synthase 
therefore not significant. The failure to find the expected increases in enzyme activity 
when strains were grown in MV is not understood. It is possible that effects may be 
observed at higher cell densities. 
4.4.2. 	Overexnression of enzymes of the shikimate pathwa 
The expression of enzymes of the shikimate pathway in untransformed and 
transformed cells was also measured. In this case, it was important to show that all 
four cloned genes were expressed at levels comparable with their chromosomal 
homologues. Thus, the specific activities of DAHP synthase (both phenylalanine 
inhibitable and tyrosine inhibitable, encoded by AR03 and AR04, respectively) and 
chorismate synthase (encoded by AR02) were determined. AROJ was investigated by 
the assay of SDH activity only, which represents the third activity of the penta-
functional AROM complex. 
DAHP synthase 
Activities of DA}{P synthase are shown in Table 4-4. Strains which contain null 
mutations in the AR04 or in both AR03 and AR04 genes show appropriately reduced 
activities compared to the wild-type activities. Thus, strain RH1220 which contains 
null mutations in both genes shows no detectable activity, whilst strain RH13 80  which 
contains an aro4 null mutation shows reduced activity compared to those strains, 
R11805, RH1207 and HK1, carrying the wild-type allele. 
In order to determine the contribution of DAHP synthase encoded by AR03 and/or 
AR04 genes, the assays are performed in the presence of 1mM phenylalanine or 3mM 
tyrosine in order to inhibit the activities of the AR03 and AR04 encoded DAIiP 
synthases, respectively. It was not possible to find concentrations of tyrosine and 
phenylalanine that gave complete but specific inhibition of AR04 and AR03 activities, 
respectively, such that addition of the two separate activities resulted in the activity 
obtained in the absence of both phenylalanine and tyrosine. Indeed, the use of both 
tyrosine and phenylalanine in the assay did not abolish activity altogether. Together, 
these data suggest that there was incomplete inhibition of individual activities and/or 
114 
DAHP synthase activity 
nmol mind mg protein' 
pheiflhiba (AR03) tyrinhibb (AR04) phe-inhibited + tyr- Strain 	Plasmid Media 
_________________________  inhibited 
RH805 MV 145 184 259 
RH805 MV+LVFY(100) 238 158 280 
RH 1220 MV + LVFY(100) + W(40) 0 0 0 
RH1220 pPH22 MV+LV(100) 323 39 228 
RH1220 pPH23 MV+LV(100) 247 110 369 
RH1220 pPH28 MV+LV(100) 524 264 701 
R111380 pPH22 MV+LV(100) 170 46 197 
RH1380 pPH23 MV+LV(100) 174 281 473 
RH1380 pPH28 MV 515 507 952 
RH1380 pPH28 MV+LVFY(100) 1039 668 1369 
HK1 MV + LV(100) + UW(40) 123 220 283 
IIK1 pPH28 MV + LVFY(100) + W(40) 553 369 615 
HK1 pME554/pPH28 MV+LVFY(100) 786 416 818 
HK1 pME554/pPH31 MV+LVFY(100) 197 165 304 
Table 4.4 	Overexpression of AR03 and AR04 encoding DAHIP synthase 
The activity of DAHP synthase is assayed in three ways, as described in Chapter 2. a  Activity of the AR03 gene product. The assay 
mixture includes the addition of tyrosine in order to inhibit the activity of the tyrosine inhibited DAHP synthase. b  Activity of the AR04 
gene product. The assay mixture includes the addition of phenylalanine in order to inhibit the activity of the phenylalanine inhibited DAUP 
synthase. C  Activity of total DAHP synthase activity. No phenylalanine or tyrosine added to the assay mixture. 
partial inhibition of the other activity. The relatively high errors incurred during this 
assay may also contribute to non-additivity of the component activities. 
Within these limitations, however, the results obtained were consistent with those 
predicted from the particular mutations of the strains. Thus, the strains RH805, 
RH1207 and HK1 showed both phenylalanine and tyrosine-inhibitable activities, 
whereas RH1380 showed low AR04 activity and RH1220 showed no detectable 
activity at all. 
When strains were transformed with the ARO plasmids, pPH22, 23 and 28, there were 
increases in the phenylalanine-inhibited DAJ{P synthase activities (AR03), as 
expected, while strains transformed with pPH23 and 28 also showed an increase in the 
tyrosine-inhibited DAI{P synthase (AR04) relative to untransformed strains. This 
confirmed that pPH22, 23 and 28 carry an expressed copy of the AR03 gene while 
pPH23 and 28 carry, in addition, an expressed copy of the AR04 gene. There was, 
however, no increase in activity when HK1 was transformed with pPH3 1, confirming 
that the increases in DAI{P synthase activities are not caused by transformation of a 
similar plasmid which does not bear copies of either AR03 or AR04. 
The enzyme multipliers in I{K1/pME554/pPH28 relative to RH805 grown on a 
similar medium were 2.9 for the total DAHP synthase activity and 3.3 and 2.6 for the 
phenylalanine and tyrosine inhibited isoenzymes, respectively. 
As with enzymes of the tryptophan pathway, there was no evidence of derepression 
when strains were grown in MV medium. Furthermore, the phenylalanine-inhibitable 
enzyme (encoded by AR03) was detected in the gcn4 mutant, RH1 380, in all growth 
media. This is in contrast to the results of Paravicini et al. (1989a) who showed that 




The activities of SDH in various strains are shown in Table 4-5. The strains carrying 
an arol mutation showed various activities. Strains RH 1181 and RET 1182 both gave 
no detectable activity. In contrast, RH1 129 gave normal activity. 
Strains transformed with pPH28, 30 and 31 show increased activities of this enzyme. 
The factor by which the enzyme is overexpressed varies between 2 and 7 depending 
on the strain and the particular transformant. Strains transformed with plasmids 
pPH20, 22 and 23 did not show increased SDH activity (data not shown) 
As with all the enzymes assayed, no increase in activities were noted in RH805 when 
grown in MV compared to growth in richer media. 
Chorismate synthase activity 
The results obtained in chorismate synthase assays are shown in Table 4-6. They 
show similar trends as described for DAHP synthase and SDH. The aro2 mutant 
RH 1610 is defined as having no activity and did not give a significantly greater value 
than assays stopped at zero time. RH805, RH1207 , HK1 and all transformants 
bearing only pM1E554 gave activities between 23 and 46 nmol ' min' • mg protein 1 . 
However HK1 transformed with pPH28 or pPH30 gave values of between 76 and 
102 nmol ' min' • mg protein 1 . These increases in chorismate synthase activity 
suggest that chorismate synthase is expressed from these plasmids. The transformant 
containing pPH3 1 (bearing the AROJ gene only) gave a value of 40 nmol • min' mg 
proteiif' which confirms that the overexpression is not a general effect of 
transformation with a URA3 plasmid. 
As before, no increases in activities were noted in RH805 when grown on MV or 
richer media. 
4.5 	Discussion and summary 
The data reported in this chapter support both the genotypic designations of the 
strains used in experiments to be reported in the following chapters, and the identity 
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Strain 	Plasmid Media 
MV 
MV + LV(100) 
MV + LVFY(100) 
MV + LV(100) + W(40) 
MV + LVFY(100) 
MV + LVWAURKHMT + FY8 
MV + LVWAURKHMT 
MV + LVWAURKHMT + FY8 
MV + LVWAURKHMT 
MV + LVWAURKHMT + FYa 
MV ± LVWAURKHMT 
MV + LV(100) + UW(40) 
MV + LVFY(100) + U(40) 
MV + LV(100) + W(40) 
MV + LV(100) ± W(40) 
MV + LV(100) + W(40) 
MV + LVFY(100) 
Shikimate 
dehydrogenase 














































HK1 pPH3 1 
pME554/ 
pPH28 
Table 4.5 Shikimate dehydrogenase activities 
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Chorismate 
Strain 	Plasmid Media synthase 
nmol' min' • mg 
protein' 
RH805 MV 34 
RH805 4\J + LVFY(100) 45 
RH1207 35 
RH1207 	pME554 MV+LVFY(100) 23 
RH161O 0 
RH1610 	pPH28 65 
HK1 46 
HK1 	pMIE554 MV + LVFY(100) + U(40) 28 
HK1 pPH28 MV + LVFY(100) + W(40) 93 
HK1 	pME554/pPH28 MV + LVFY(100) 102 
HK1 pME554/pPH30 MV + LWY(100) 76 
HK1 	pME554/pPH3 1 MV + LVFY(100) 40 
Table 4.6 Chorismate synthase activities 
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of the plasmid constructions used. Thus pME554 gave overexpression of the 
enzymes of the tryptophan pathway by a large factor, while plasmid pPH28 gave a 
modest overexpression of the enzymes of the sbikimate pathway. Together, these 
plasmids would appear to be adapted to the requirements of the universal method, as 
defined in Chapter 1. 
The measured activities of anthranilate synthase and tryptophan synthase suggest a 
reliable overexpression of these enzymes from pIME554 by factors of between 20 and 
60. Because of previous work (Niederberger etal., 1984; Prasad etal., 1987; 
Niederberger et al., 1992) demonstrating the overexpression of all five enzymes from 
this plasmid by similar factors, further work conducted here assumes that the activities 
of the other three enzymes, phosphoribosyl-anthranilate transferase, phosphoribosyl-
anthranilate isomerase and indolyl glycerophosphate synthase are raised by factors of 
an approximately similar magnitude. The two enzyme assays conducted here are thus 
taken to be representative of the overexpression of all five activities from the TRP 
plasmid, pME554. 
For the AROJ-4 genes, the data in this (and the previous) chapter confirm that pPH28 
carries a functional copy of each and that they are expressed, giving modest (two to 
seven-fold) increases in activity. There is one reservation. The constituent activities 
of the penta-functional AROM complex have not been independently measured. 
However, SDH is the final (C-terminal) activity on the complex (Duncan etal., 1987) 
Therefore, the demonstration of this activity supports the assumption that the entire 
protein is expressed. In strains transformed with pPH28, the increases in DAHP 
synthase and chorismate synthase activity were less than those of SDH. Also, there 
was considerable variation between different strain/plasmid combinations. This may 
reflect a variation in the number of plasmids carried by a particular cell. Individual 
colonies may be expected to bear one or a low number of plasmids. Alternatively, the 
pattern of expression from the plasmid-borne gene may be altered with respect to the 
chromosomal gene. This may lead to increased or decreased expression which may 
depend upon growth conditions. In the cases presented here, and assuming that the 
plasmids are present in single copy, the plasmid-borne genes appear, in general but 
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particularly in the case of SDH, to give rather greater levels of expression than do the 
chromosomal homologues. If this were the case, then this situation may arise in two 
ways. Firstly, there may be structural differences between chromosomal and plasmid 
DNA. Secondly, the role of 5' and 3' flanking regions distal to those cloned has not 
been characterised. Both of these factors may lead to differential patterns of 
expression and regulation. 
It is noteworthy that neither the chromosomal nor plasmid borne copies of the genes 
of the shikimate and tryptophan pathways showed derepression on MV medium 
relative to their basal expression on richer media containing other nutrients and amino 
acids. Unfortunately therefore, it was not possible to confirm that the plasmid-borne 
genes were able to show GCN4-dependent transcriptional activation. it is likely that 
further experiments using higher cell densities and/or the use of tryptophan analogues 
would allow this analysis. Nevertheless, with the analysis of the gcn4 mutant, 
RH1380, it was possible to confirm that significant AR03-dependent DAI{P synthase 
activity was obtained in the absence of GCN4. 
Having demonstrated that pME554 and pPH28 give increases in activities which were 
approximately as expected (and required), in subsequent experiments only anthranilate 
synthase and SDH activities were used to monitor the presence or absence of the 
plasmids and to reflect the likely activities of the other enzymes of the tryptophan and 
shikimate pathways. 
Before describing the effect of these plasmids upon the concentrations and fluxes in 
the aromatic amino acid biosynthetic pathways, the stability of the plasmids and 
enzymes activities dependent upon them are considered in the next chapter. 
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Chapter 5 
Plasmid stability and enzyme activity 
Chapters 3 and 4 described the construction of a single-copy plasmid, pPH28, which 
bears the four genes encoding enzymes of the shikimate pathway, and the 
characterisation of both this plasmid and pME554, a multi-copy plasmid bearing the 
five genes encoding enzymes of the tryptophan pathway, by complementation of 
corresponding mutations and the determination of specific enzyme activities. It was 
confirmed that pPH28 increased the specific activities of the enzymes of the shikimate 
pathway by factors of 2-5, relative to the reference strains and that pME554 increased 
specific activities of the tryptophan pathway by factors of between 20 and 70. 
The experimental analysis of the relationship between enzyme activity and the 
production of the aromatic amino acids tryptophan, phenylalanine and tyrosine 
demands that these enzyme levels should be maintained for the duration of culture. 
This chapter describes some initial investigations which were undertaken to evaluate 
the stability of the TAP and ARO plasmids and the overexpression of enzymes 
encoded by these plasmids under different culture conditions. 
Previous work (Fantes et al., 1976; Miozzari et al., 1978a; Prasad et al., 1987) and 
pilot studies during this project suggested that wild-type cells contain very low 
concentrations of tryptophan. Because of the limitations in the sensitivity of the 
tryptophan assay employed here, it was therefore desirable to delay flux estimations as 
late as possible during culture. However, some partial or complete loss of plasmid 
may occur through variation in copy number or expression levels, unequal segregation 
(including random drift) at mitosis, or loss of selection for the plasmid as tryptophan 
is excreted into the medium. In order to make an informed decision as to the 
optimum time at which tryptophan, tyrosine and phenylalanine fluxes should be 
measured, it was therefore necessary to evaluate 
the stability of the plasmid over time 
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. 	the variation in enzyme activity over time 
These experiments were carried out in selective and non-selective media. In addition, 
because of previous work which suggests that the presence of phenylalanine and 
tyrosine in the medium is important for the stability of the TRPplasmids (Prasad, et 
al., 1987), experiments were undertaken in both the presence and absence of these 
two amino acids. 




Cultures were maintained in exponential phase (0D 546<1 .5) by daily sub-culture, over 
a period of four days. 0D 546 was monitored and cell samples were appropriately 
diluted in MV + LV(l00) medium and plated on selective and non-selective media. 
Cells were also collected for enzyme activities and protein determination. The details 
of the experimental protocol are given in Chapter 2. For selective and non-selective 
conditions of culture, HK1/pME554 was grown without and with tryptophan (40 p.g 
m1'), HK1/pPH28 was grown without and with uracil (40 gg m1) and the double 
transformant, HK1/pME554/pPH28 was grown under four conditions; (i) both uracil 
and tryptophan were contained in the medium (no selection), (ii) uracil or tryptophan 
were present in the medium (single selection) and (iii) both uracil and tryptophan 
were omitted (double selection). 
5.1 	Stability of pMIE554 and pPII28 in media lacking 
phenylalanine and tyrosine (MV + LV) 
The strains were cultured in MV medium containing leucine and valine at 100 jtg m1 1 
(MV + LV(100)). HK1/pME554 required uradil added (40 .tg m1) while 
F[K1/pPH28 required tryptophan added (40 tg m1) for growth. 
HK1/pME554/pPH28, the 'double' transformant required no addition to MV + 
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LV(100). The percentages of all cells growing on the various plates are plotted 
graphically in Figures 5-1, 5-2 and 5-3. 
	
5.1.1 	Stability of the TRP Diasmid pME554 
The stability ofpMIE554, is represented in Figure 5-1. There was no apparent loss in 
cells bearing pME554 from either RKl/pME554 or in HK1/pME554/pPH28 when 
selection (media without tryptophan) was enforced daily, despite considerable 
variation from day to day. Estimates of prototrophic cells lay between 64% and 
103% of total cells. The variation did not seem to be correlated with the 0D 546 of 
cells, or upon the size of inoculum for the following day's culture, nor upon the 
dilution used to plate out samples (data not shown). The variation between triplicate 
plates and average count was usually less than 10%, but was occasionally higher. 
This variation may be large enough to explain the discrepancy between the proportion 
of Trp cells found on successive days under selective conditions. 
When selection is relaxed, by addition of tryptophan in the medium, the percentage of 
Trp cells drops away rapidly with a half-life of approximately 24 hours. Figure 5-1 
shows that the rate of loss ofpME554 is similar in both the single transformant and in 
the double transformant, regardless of selection on pPH28. The semi-logarithmic 
plots show a constant rate of loss of plasmid from the cells. The gradient allows an 
estimation of 0.07 generation 1 to be the made for the mitotic instability (see Table 5-
1A), as described in Chapter 2. Since this coefficient is similar for the single and the 
double transformant under both culture conditions without tryptophan selection, this 
result provides no evidence that the presence of the ARO plasmid, pPH28, stabilises 
the maintenance of the TRP plasmid, pME554. 
5.1.2 	Stability of the ARO plasmid pPH28 
The stability of pPH28 is illustrated in Figure 5-2. The results show, complete 
stability of the plasmid under selective conditions (where uracil is omitted from the 
medium). In non-selective culture conditions, where uracil is included at 40 j.tg mF', 
plasmid is progressively lost though at a significantly lower rate than the multicopy 
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Figure 5-1 Stability of pME554 in HK1/pME554 and 
HK1/pME554/pPH28 in MV+ LV(100) 
A. Linear plot B. Semi-logarithmic plot 
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Figure 5-2 Stability of pPH28 in HK1/pPH28 and 
IIK1/pME554/pPH28 in MV + LV(100) 
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Figure 5-3 Stability of pME554/pPH28 in HK1/pME554/pPH28 
in MV + LV(100) 
A. Linear plot B. Semi-logarithmic plot 

































Host strain for pME554 	HK1/pME554 	 HK1/pME554/pPH28 
Non-selective medium MV+LV+W+U MV+LV+W-U MV+LV+W+U 
used  
Mitotic instability 	 0.07 	 0.07 	 0.07 
B 
Host strain for pPH28 	HK1/pPH28 	 HK1/pME554IpPH28 
Non-selective medium MV+LV+W+U MV+LV-W+U MV+LV+W+U 
used  
Mitotic instability 	 0.02 	 0.02 	 0.02 
C 
Host strain for both 	 HK1/pPH28/pPH28 
plasmids 
Non-selective medium MV+LV+W-U MV+LV-W+U MV+LV+W+U 
used 
'Mitotic instability' 	1 0.08 	 0.03 	 0.08 
Table 5-1 	Mitotic stability of pME554 and pPH28 in single and 
double transformants in non-selective media lacking 
phenylalanine and tyrosine 
A. pME554 in single and double transformants, B. pPH28 in single and double 
transformants, C. Loss of double prototrophy in the double transformant when 
grown upon 3 different types of non-selective media 
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plasmid, pME554. The semi-logarithmic plot shown in Figure 5-2 allows an 
estimation of 0.02 generation' to be made for mitotic instability (Table 5-1B) 
These results show that the centromeric ARO plasmid, pPH28 is more stable than the 
multi-copy TRP plasmid, pME554, as expected. The level of stability for pRS316, 
using the URA3 marker was 0.01 generation 1 (Sikorski and Hieter, 1989). Loss 
might occur because of genetic instability within the plasmid itself. Possible defects 
may occur in the replication of the plasmid prior to mitosis or the segregation of the 
plasmid between the mother and daughter cells. There is also the possibility of 
phenotypic effects, whereby cells carrying the plasmid may have a lower growth rate 
than that of untransformed cells. This factor is thought to be present here in the case 
of the single transformant, HK1/pPH28 reverting to untransformed cells, HK!. The 
observed growth rate of single transformants was significantly lower than the wild-
type cells, RH805, the trpl-5 strain, RH1207 and its ura3 derivative, HK1 as 
discussed in Chapter 4. The difference in growth rate would certainly contribute to a 
decrease in the observed stability of this plasmid, compared to the stability of a similar 
centromeric plasmid which does not lead to such a reduction in growth rate. The 
possibility that it is the loss of plasmid which contributes to the slow growth rate in 
selective media may be discounted by the observation that the rate of growth of the 
single transformed cells is no different under selective conditions (media lacking 
uracil) than it is under non-selective conditions (media containing uracil), when grown 
over a short time intervals where loss of plasmid is not sufficient to alter the observed 
growth rate. 
5.1.3 	Stability of the Trp Ura' phenotype (pME554 + pPH28) 
The stability of both plasmids together is determined by plating double transformants 
upon medium lacking both uracil and tryptophan. This is repeated for all four media 
used for the double transformant. 
The data are illustrated graphically in Figure 5-3. As expected, the two plasmids were 
both stable under selective conditions (both tryptophan and uradil lacking). When the 
double transformant was grown in the presence of tryptophan, then the loss of uradil 
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+ tryptophan prototrophy closely followed the loss of pME554. Again the semi-
logarithmic plot gives an estimate of the rate of loss of prototrophy. The value 
obtained, 0.08 generation4 (Table 5-i c) is similar to the value obtained for the loss of 
pME554 in both the single transformant, I{Kl/pME554 and in the double 
transformant (independent of the ARO plasmid). Similarly, the rate of loss of uracil + 
tryptophan prototrophy in the presence of uracil only closely matches that obtained 
for the loss of uracil prototrophy alone in both the single transformant, HK1/pPH28 
and in the double transformant (independent of the TRP plasmid). The value of 
'mitotic instability in this case was 0.03 generation', which is slightly greater than that 
for the loss of pPH28 from the single transformant and the double transformant (see 
Table 5-1). 
Together, these results support the view that the two plasmids are maintained and lost 
independently of each other. 
Finally, the rate of loss of double prototrophy in the presence of both tryptophan and 
uracil, 0.08 generation', matches the loss of pME554 alone, as expected. 
5.1.4 	Enzyme activities 
The data presented in this chapter so far, of course, give no indication of either the 
copy number of the plasniid within prototrophic cells nor of the level of expression 
occurring from the plasmid-borne genes. To evaluate these questions, the activities of 
anthranilate synthase and SDH were assayed on each day. The results are illustrated 
graphically in Figure 5-4 and 5-5 
Anthranilate synthase 
Figure 5-4 shows the changes in anthranilate synthase activity over time in all 
cultures. It shows that the level of anthranilate synthase activity parallels the loss of 
plasmid pME554 (Figure 5-1) in all cultures. Thus during culture in media lacking 
tryptophan, there is no apparent loss in enzyme activity over time. This suggests that 
the copy number of the plasmid is also being maintained under selective conditions. 
Moreover, during relaxation of selection, there is a similar parallel between the loss of 
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Figure 5-4 Anthranilate synthase activity in single and double 
transformants +1- selection in MV + LV 
A. Linear plots. Note that the activities of HK1/pPH28 was zero in both media at all 
time points, since this strain has quintuple tip mutations and requires tryptophan in the 














































Figure 5-5 	Shikimate dehydrogenase activity in single and double 
transformants +1- selection in MV + LV 
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tryptophan prototrophy and anthranilate synthase activity. Comparing the semi-
logarithmic plot for anthranilate synthase activity and loss of tryptophan prototrophy 
gives an indication of the degree of correspondence between the two processes. 
Enzyme activity loss over the first 48 hours appears to be at a similar rate to the loss 
of prototrophy (0.08/generation). Therefore, to a first approximation, the average 
copy number may remain constant over this phase of the culture. After 48 hours 
however, anthranilate synthase activity appears to be lost at a faster rate than 
prototrophy. It might be concluded that copy number ofpME554 diminishes from 
this point. However, since the levels of anthranilate synthase activity are very low, 
there is an increase in the errors which may be assigned to these measurements. A 
resolution of this point requires a further study using more samples to reduce error in 
prototrophy estimations and more frequent sampling for enzyme determinations. 
Shikimate dehydrogenase 
The changes over time in the activity of SDH, encoded by AR02, are shown in Figure 
5-5. Firstly, it can be seen that strains HK1/pPH28 and HK1/pME554/pPH28 show 
increased levels of SDH relative to the strain (}{Kl/pME554) not transformed with 
pPH28. The factor by which enzyme levels are increased range from 2-5. 
Under selective conditions, there is no observed reduction in SDH activity over time, 
as expected. This result suggests that the copy number of pPH28 remains stable and 
that the level of expression from the plasmid-borne gene remains constant. Neither 
was there any change in SDH activity over time in the strain RK1/pME554. This was 
as expected, since expression occurs entirely from the chromosomal gene. On the 
other hand when selection was relaxed in strains bearing pPH28, a different pattern 
emerged from that observed with pME554 and anthranilate synthase activity. No 
significant loss of SDH activity was observed as the strains lost plasmid over time. It 
is impossible to ascertain the contribution of factors such as differential instability of 
URA3 and AR01 mRNA or the corresponding proteins, if indeed, the result were 
repeatable. Measurement of other enzymes encoded by the other genes on pPH28 
might resolve this question. 
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5.1.5 	Summary 
Single and double transformants bearing pME554 and/or pPH28 were cultured under 
all relevant selective and non-selective conditions. 
The results show 
. 	that the plasmids were retained under selective conditions. 
that the multi-copy TRP plasmid, pME554, was lost when selection 
was relaxed: mitotic instability was estimated at about 0.07 - 0.08 
generation 
that the single-copy centromeric ARO plasmid, pPH28, was lost at a 
slower rate: instability was estimated at about 0.02 generation' . 
that anthranilate synthase activity matches the loss of plasmid very 
closely, at least over the first two days. This suggests that copy 
number for pME554 is maintained. 
5.2 	Stability of pME554 and pPH28 in media 
containing phenylalanine and tyrosine (MV + LVFY) 
The previous work of Niederberger and colleagues showed that the stability of TRP 
plasmids was improved in media containing phenylalanine and tyrosine, even under 
selective conditions. Since it was deemed highly desirable to be able to measure 
fluxes to tyrosine and phenylalanine in order to evaluate the universal method, it was 
important to evaluate if the omission of phenylalanine and tyrosine from the media 
would lead either to unacceptable losses in stability or to losses in the enzyme 
activities encoded by the plasmids. The rate of loss of the multi-copy TRP plasmid, 
pME554, and of anthranilate synthase activity was therefore of particular interest. 
The protocol for this series of cultures is identical to that for the previous section 5.1 
except that phenylalanine and tyrosine were added to all media at a concentration of 
100 j.tg ml'. 
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The results of the plate counts expressed as percentage of total cells possessing 
prototrophy for uradil and/or tryptophan are shown graphically in Figures 5-6, 5-7 
and 5-8. 
	
5.2.1 	Stability of the TRP nlasmid. nME554 in MV + LYFY 
The data relating to the loss ofpME554 are shown in Figure 5-6. Under selective 
conditions, the plasmid is maintained. As with media lacking phenylalanine and 
tyrosine, although there is considerable variability in the percentage of cells with 
tryptophan prototrophy, there appears to be no downward trend. When selection is 
relaxed, a progressive loss of prototrophy occurs after an apparent initial 'lag' phase 
in the first 24 hours. As shown in Table 5-2, the rates of loss in the case of both the 
single transformant and of the double transformant lacking selection of both uracil and 
tryptophan prototrophy are similar (0.08 and 0.07 generation', respectively) to that 
for the loss of plasmid in media lacking phenylalanine and tyrosine. For the plasmid in 
the double transformant under conditions of selection for the ARO plasmid, pPH28 
the rate of loss was 0.06. This may represent a small reduction in the rate of loss of 
plasmid but further experiments would be needed to achieve results showing statistical 
significance. If the result were confirmed, it may provide evidence that the presence 
of the ARO plasmid overexpressing the enzymes of the shikimate pathway was able, 
under some conditions, to stabilise the multi-copy TRP plasmid. An apparent 
improvement in the stability ofpME554 in the double transformant under uracil 
selection could arise through the slower growth rate observed with HK1/pPH28. 
This could allow an increase in proportions of cells containing pME554 over those 
which do not. 
5.2.2 	Stability of the ARO plasmid DPH28 in MV + LYFY 
Graphs showing the loss of uradil prototrophy are shown in Figure 5-7. There was no 
apparent loss of pPH28 during uracil selection, as expected. When selection was 
relaxed however, plasmid was lost progressively. The rates of plasmid loss per 
generation are shown in Table 5-2. The rates of loss of pPH28, 0.02 generation', 
obtained in the single transformant and in the double transformant grown under 
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Figure 5-6 Stability of pME554 in IIK1/pME554 and 
HK1/pME554/pPH28 in MV + LYFY(100) 
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Figure 5-7 Stability of pPH28 in IIK1/pPH28 and 
IIK1/pME554/pPH28 in MV + LYFY(100) 
A. Linear plot B. Semi-logarithmic plot 
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Figure 5-8 Stability of pME554/pPH28 in IIK1/pME554/pPH28 
in MV + LYFY(100) 
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Host strain for pME554 	HKI/pME554 	 HK1/pME554/pPH28 
Non-selective medium MV+LVFY + W + U MV+LVFY + W - U MV+LVFY + W + U 
used 
Mitotic instability 	1 0.08 	 0.06 	 0.07 
'1 
Host strain for pPH28 	HK1/pPH28 	 HK1/pME554/pPH28 
Non-selective medium MV+LVFY + W + U MV+LVFY - W + U MV+LVFY + W + U 
used 
Mitotic instability 	1 0.02 	 0.02 	 0.05 
C 
Host strain for both 	 FIK1/pPH28/pPH28 
plasmids  
Non-selective medium MV+LVFY + W - U MV -I-LVFY - W + U MV+LVFY + W + U 
used  
'Mitotic instability' 	1 0.06 	 0.01 	 0.10 
Table 5-2 	Mitotic stability of pME554 and pPH28 in single and 
double transformants in non-selective media 
containing phenylalanine and tyrosine 
A. pME554 in single and double transformants, B. pPH28 in single and double 
transformants, C. Loss of double prototrophy in the double transformant when 
grown upon 3 different types of non-selective media 
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tryptophan selection is similar to the result obtained for the stability in media lacking 
phenylalanine and tyrosine. However, there appears to be an increase in instability of 
pPH28 under conditions where the selection of pME554 is also relaxed. The 
instability for pPH28 under these conditions was 0.05 which is about half the value 
obtained for the loss ofpME554. This result seems to complement the increased 
stability ofpME554 in the double transformant when selection for pPH28 was 
maintained and suggests that there is an interaction between the two plasmids such 
that maintenance of selection on pPH28 increases the stability of pME554 and 
relaxing the selection on pME554 decreases the stability of pPH28. However, the 
results may also be explained by the fact that the growth rate of HK1/pPH28 is 
significantly lower than both HK1/pME554 and HK1/pME554/pPH28. This means 
that cells losing pME554 from the double transformant become slower growing and 
therefore are outgrown by cells containing both plasmids, pME554 and no plasmids. 
With both uradil and tryptophan in the media, when the percentage of Trp, Ura cells 
are diminishing, and the Trp,Ura cells are slow growing, the proportion of Ura cells 
may fall particularly rapidly. 
5.2.3 	Stability of the Trp'. Ura' phenotype (ME554 + pPII28) 
Graphs showing the trends in these data are shown in Figure 5-8. 
This shows an apparent lag phase of at least 24 hours prior to loss of plasmid. 
Thereafter, the rates of loss of either/both plasmid(s) (as represented by the loss of the 
Trp, Ura phenotype) calculated from the semi-logarithmic plots are given in Table 
5-2. The rate for the loss of either plasmid when uracil selection is relaxed, 0.01 
generation', is similar to the loss of pPH28 from the double transformant under the 
same conditions. it is therefore likely that the value for the rate of loss of the Trp, 
Ura phenotype is entirely accounted for by the loss of pPH28. Similarly, when 
tryptophan selection is relaxed, the loss of either plasmid, 0.06 generation', is similar 
to the loss ofpME554 from the double transformant under the same growth 
conditions. it is therefore probable that the value of the rate of loss of the Trp 4 , Ura 
phenotype is entirely accounted for by the loss of pME554. When selection for both 
plasmids is relaxed, the loss of the Trp, Ura phenotype appears to increase to 0.10 
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generation', close to the maximum rate for loss ofpME554 alone. The probable 
reason for this, as discussed previously, is the possible underestimate of colonies on 
plates containing neither uracil nor tryptophan because of the slower growth of cells 
containing pPH28 alone. 
5.2.4 	Enzyme activities 
In order to explore the maintenance of enzyme activities during culture and to 
evaluate whether copy number changed during loss of plasmid, the activities of 
anthranilate synthase, encoded on pME554 and SDH, encoded by pPH28 were 
assayed. The results are shown in Figure 5-9 and 5-10 
Anthranilate synthase 
Anthranilate synthase activities are maintained at high levels in cultures in which 
selection for pME554 is enforced by the absence of tryptophan in the growth medium. 
There appears to be a consistent increase in activity after Day 0. This may result from 
an underestimation of anthranilic acid at Day 0 
When selection for pME554 was relaxed, the enzyme activity dropped at a similar rate 
to that of loss of prototrophy. As in the previous experiment, this suggests that copy 
number is maintained during the experiment. 
Shikimate dehydrogenase 
Estimates of SDH activity in these cultures are shown in Figure 5-10. These data 
show that SDH activities were not reduced over time, regardless of the presence or 
absence of uracil in the media. These results therefore show the same pattern as in the 
previous experiment where tyrosine and phenylalanine are omitted from the media. 
The possible explanations for this phenomenon are similar. They include the 
possibility of high enzyme stability or maintained synthesis of protein from stable 
mRNA in cells which no longer carry pPH28. This stability would have to be 
significantly greater than that of the URA3 gene product, orotidine-5'-phosphate 
decarboxylase. However, further experiments are required to substantiate this claim 
and to investigate the factors involved. 
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Figure 5-9 	Anthranilate synthase (specific activity) in single and 
double transformants +1- selection in MV + LVFY 
A. Linear plots. Note that the activities of }{K1/pPH28 was zero in both media at all 
time points, since this strain has quintuple trp mutations and requires tryptophan in the 
medium. B. Semi-logarithmic 'plots (HK1/pPH28 results omitted because activities 
were zero). 
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Figure 5-10 Shikimate dehydrogenase (specific activity) in single 
and double transformants +1- selection in MV + LYFY 
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Single and double transformants bearing pME554 and/or pPH28 were cultured under 
all relevant selective and non-selective conditions in media containing LVFY. 
The results show 
. 	that both plasmids are retained under selective conditions. 
. 	that the multi-copy TRP plasmid, pME554, is lost when selection is 
relaxed: mitotic instability was estimated at about 0.06 - 0.08 
generation- '. 
. 	that the centromeric ARO plasmid, pPH28, was lost when selection 
was relaxed, but at a slower rate than the TRP plasmid: instability 
was estimated at about 0.02 - 0.05 generation'. 
. 	that anthranilate synthase activity matches the loss of pME554 very 
closely, at least over the first two days. This suggests that copy 
number is maintained. Enzyme activity continued to drop at an 
increased rate. 
. 	that there may be an interaction between the two plasmids under 
some conditions, such that the stability ofpME554 is increased 
when selection is maintained upon pPH28. 
5.3 	Discussion 
Before discussing the results in more detail, there are a number of reservations which 
need to be made concerning the underlying assumptions and limitations of these 
experiments. 
Assumptions and limitations 
The data on loss of prototrophy are assumed to give information on the percentage of 
cells carrying at least one copy of the plasmid in question. This data can be used to 
calculate the mitotic instability of the plasmid. However, this assumes that the level of 
selection is constant during the experiment. This is not necessarily so, since a strict 
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selection is only applied once a day. Neither is there control over the concentration of 
the selective nutrient within the medium at other times. The nutrient (e.g. tryptophan) 
may be released by excretion or by lysis of cells. Furthermore the growth rate of 
prototrophic and auxotrophic strains may differ in permissive cultures as well as 
selective ones. If the loss of one plasmid from the double transformant gives a single 
transformant which grows more slowly than the other strains, then this will tend to 
lead to an underestimate for the rate of loss of the first plasmid. This situation applies 
here. HK1/pPH28 has a significantly lower growth rate than both HK1/pME554 and 
HK1/pM1E554/pPH28 under both selective and permissive conditions. Finally, the 
observed rate of loss of plasmid will depend upon how many times the resulting strain 
may divide once the auxotrophic marker/plasniid has been lost. This will depend upon 
factors such as stability of the protein encoded by the auxotrophic marker or its 
corresponding mRNA, and the complex relationship between the activity of the 
selective marker (e.g. URA3 gene product), flux in the particular pathway 
(biosynthesis of pyrimidines) and growth rate. This relationship will not be obvious, a 
priori. Generally, therefore, the cultures are, over time, ill-defined with respect to 
medium composition, strain composition, homogeneity of growth and detailed 
dynamic physiology. Although a more rigorous analysis is possible in a series of 
experiments using chemostats, which at least overcomes the variability of the medium 
over time, the problem of defining an "intrinsic' instability is probably intractable. 
For most purposes however, it is the estimation of stability in batch culture, and in this 
project, the resulting stability of enzyme activity, which is important. 
The level of enzyme activity within the cell samples has been assumed to reflect the 
level of expression and hence, the plasmid copy number. A number of other factors 
may be involved however. For instance, a clear result of both experiments was the 
maintenance of SDH activity whilst the corresponding Ura prototrophy was 
decreasing. This can be interpreted in different ways. The copy number in those cells 
carrying the plasmid may increase at a rate sufficient to offset the loss of plasmid in 
other cells. Secondly, the stability of the enzyme and/or its mRNA may, at least 
partially, offset the loss of SDH activity caused by loss of plasmid. Finally, some 
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other level of regulation of expression may be operating to maintain enzyme activity in 
the culture as a whole. A number of approaches may be used to clarify this question. 
For example, the half-life of SDH and/or its mRNA may be estimated by inhibiting 
protein synthesis and RNA synthesis and compared with that for anthranilate synthase. 
Alternatively, the demonstration that other ARO enzymes, such as chorismate 
synthase, lose activity in line with the loss of plasmid would support the 'stability' 
argument. It should also be emphasised that there is a relatively small increase in 
activity of enzymes of the shikimate pathway relative to a wild-type (chromosomal) 
background (as opposed to the tryptophan pathway). Both of these factors make the 
empirical relationship between loss of plasmid and enzyme activity more vulnerable to 
error and variability. 
5.4 	Conclusions 
Whilst bearing in mind the limitations of the data and the problematic relationships 
between such factors as strain and media composition, enzyme activity, growth rates 
etc., the following conclusions are suggested by the results. 
Both the plasmids, pME554 and pPH28, are stable under selective conditions. Under 
permissive conditions, pME554 was lost from both the single and the double 
transformant with a frequency of between 0.06 and 0.10 generation'. There was 
some evidence that the rate of loss from the double transformant grown with selection 
for pPH28, was reduced to about 0.06 generation' in media which contained 
phenylalanine and tyrosine. This was interpreted either in terms of stability being 
conferred by pPH28, for example, through metabolic fitness, or, more likely, by the 
poor growth rate of HK1/pPH28. Under permissive conditions, the stability of 
pP1128 was higher. However the values for mitotic instability obtained, ranging from 
0.01 to 0.05, were higher than expected for a centromeric plasmid. The loss of 
pPH28 from the double transformant was particularly high, 0.05, when selection for 
pME554 was also relaxed in media containing phenylalanine and tyrosine. The 
reasons for these results are likely to include the poor growth rate of the single 
transformant, HK1/pPH28, compared to the other strains, HK1, HK1/pME554 and 
HK1/pME554/pPH28. 
The loss of anthranilate synthase activity corresponded with the loss of plasmid 
pME554 in all cases, although there was some evidence that the loss of activity was 
progressive, with loss of activity being slower at first and then increasing relative to 
the loss of plasmid. A loss of SDH activity, on the other hand, was not detected 
under permissive conditions. 
There was little evidence that phenylalanine and tyrosine in the media contributed to 
the stability of either plasmid. 
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Chapter 6 
Aromatic amino acid production and flux analysis 
The previous three chapters describe the construction and characterisation of a single-
copy plasmid, pPH28, which bears a copy of each of the genes (ARO1-4) encoding 
the enzymes of the shikimate pathway. Chapter 4 described the effect of this plasmid 
upon the specific activity of these enzymes in transformed strains. The enzyme 
multipliers obtained in various strains generally ranged from 2-5. Similarly, a multi-
copy plasmid, pME554, constructed by Niederberger and colleagues (Niederberger et 
al. 1984) and bearing a copy of each of the genes (TRP1-5) encoding enzymes of the 
tryptophan pathway, gave enzyme multipliers for anthranilate synthase and tryptophan 
synthase of between 20 and 70. A double transformant, HK1/pME554/pPH28, gave 
corresponding levels of overexpression from both plasmids. In Chapter 5 the 
stabilities of both plasmids and the specific activities of the enzymes encoded, were 
characterised in single and double transformants and in various selective and non-
selective media. These data suggested that expression from these plasmids would be 
maintained at high levels over a period of 24 hours when grown in selective media, at 
least during exponential phase.. 
This chapter presents a limited set of data obtained from batch cultures of the 
reference and transformed strains which were sampled for enzyme activity and 
metabolite concentration determinations. Here, a single time point, near to the end of 
exponential phase, is used to allow an estimation of the fluxes in the three branches of 
the shildmate pathway from values of the intracellular, extracellular and total pools of 
the aromatic amino acids. The flux can be calculated in two ways. Firstly, the 
difference between two closely spaced time points may give rates of production. 
Secondly, provided that steady state conditions during exponential growth apply, 
rates of production may be calculated from concentrations at a single time point and 
the growth rate. Since it was not possible here, because of small concentrations, to 
make accurate determinations by differences between closely spaced time points, it 
was necessary to use the second method. Estimations from cultures close to the end 
148 
of exponential phase were adjudged most likely to fulfil assumptions of steady state 
and to yield reasonable metabolite concentrations with least error. 
A more extensive analysis of the full data set is given in Chapter 7. It includes an 
investigation of changes during the 'diauxic shift' and onset of stationary phase, the 
excretion and re-uptake of amino acids, and the effect of 'bypassing' anthranilate 
synthase by feeding cells with anthranilic acid. 
6.1 	The effects of pM1E554 and pPH28 on aromatic 
amino acid production 
RH805 (the reference strain), HK1/pME554 and HK1/pME554/pPH28 were cultured 
in MV+LV(100) (+ U(40) for HK1/pME554). Freshly grown isolated colonies were 
grown in 10 ml of media (MV+LVFY(100) +1- U(40)) containing phenylalanine and 
tyrosine (starter culture) prior to transfer to 'pre-cultures', in shake flasks, consisting 
of 100 ml of the same media but lacking phenylalanine and tyrosine. Cells were 
pelleted and transferred to 400 ml 'main' cultures which used this same media, as 
described fully in Chapter 2. 
The optical densities of starter cultures were between 0.41 and 1.01, depending upon 
the strain, at inoculation of 100 ml pre-cultures. These were grown overnight to an 
0D546 of 0.76 - 1.27. At this point, cells were used to inoculate 400 ml cultures at 
time t0, to an 0D546 of 0.170. 
Optical densities were monitored and samples taken at intervals for the determination 
of enzyme activities, protein concentrations and intracellular, extracellular and total 
tryptophan concentrations. 
6.1.1 	Growth of cultures. 
The optical densities of the main cultures are plotted in Figure 6-1. The semi-
logarithmic plots allow the estimation of growth rates (pt, hr- ') during exponential 
phase. These were 0.31 for RH805, 0.30 for HIK1/pME554 and 0.29 for 
HK1/pIvtE554/pPH28. The data show evidence of a 'diauxic shift' after about 12 
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Figure 6-1 Growth of strains on MV + LV(100) 
A. The growth of strains on linear scale. B. Growth of strains during the first 20 
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hours ('mid-culture'), where cell growth transiently slowed, due to the exhaustion of 
glucose. This was followed by a subsequent adaptation to respiratory metabolism, 
during which the growth rate increased again. A discussion of these changes is 
included in Chapter 7. 
The optical densities of the cultures after 10 hours were 2.41 for RH805, 2.35 for 
HK1/pME554 and 2.33 for HK1/pME554/pPH28. Reference to Figure 6-1 shows 
that these 0D 546 occurred towards the end of the exponential phase prior to the 
'diauxic shill'. The following analysis of enzyme activities and metabolite 
concentrations concerns samples taken at this time point only. The full data set is 
given and analysed in Chapter 7. 
	
6.1.2 	Enzyme activities 
The specific and relative activities of SDH and anthranilate synthase in the three 
strains after 10 hours are given in Table 6-1. The activity of SDH was raised 2.7-fold 
in HK1/pME554/pPH28 and anthranilate synthase was overexpressed by a factor of 
between 38 -46 in both of the strains transformed with pME554, all relative to 
activities in RH805. These factors are similar to those reported in the previous 
chapter and indicate that the copy number of pPH28 and pME554 were within the 
required, and expected range. 
6.1.3 	Tryptophan concentrations 
The concentrations of intracellular, extracellular and total tryptophan (for a reminder 
of the terminology used to identify concentrations, please consult Section 2.8.2) at 10 
hours are given in Table 6-2, along with the data for phenylalanine and tyrosine. The 
estimated intracellular concentrations are calculated from internal pools as described 
in Chapter 2. Also included are the sums of the experimentally determined internal 
pools and extracellular concentrations, for comparison with the experimentally 
determined total concentrations. There was usually good agreement (within 




Shikimate dehydrogenase Anthranilate synthase 
Specific Relative Specific Relative 
Strain activity activity activity activity 
mnol•min'• nmol•mm'• 
mg protein' mg protein' 
RH805 39.5 1.00 0.02 1.0 
HK1/pME554 36.3 0.92 0.94 45.7 
HK1/pME554/pPH28 107.4 2.72 0.78 38.2 
Table 6-1 Enzyme activities 
The specific activity of shikimate dehydrogenase and anthranilate synthase in strains RH805, HK1/pME554 and I{K1/pME554/pPH28 after 
10 hours of culture in MV + LV(100) (+ U(40) for HK1/pME554) are given. Relative activities are calculated with respect to RH805 at 
this time point, and are therefore dimensionless. 
Internal + 	Total pool 
Intracellular pool 	Extracellular extracellular measured 
pool 	pool 	from culture 
internal pool 	intracellular 
concentration 
Metabolite 	Strain 
	 Concentration (tM) 
RH805 0.07 50 0.06 0.13 0.16 
Tryptophan 	HK1/pME554 0.10 70 0.06 0.15 0.16 
HK1/pME554/pPH28 0.15 110 0.11 0.26 0.25 
R}{805 	 0.59 	410 	 0.56 	 1.15 	 1.10 
Phenylalanine 	HK1/pME554 0.49 350 1.06 1.55 1.48 
HK1/pME554/pPH28 	1.30 	930 	 3.85 	5.15 	5.83 
RH805 0.97 670 1.13 2.10 1.90 
Tyrosine 	HIK1/pME554 0.75 530 1.35 2.09 1.95 
HK1/pME554/pPH28 2.97 2130 3.03 6.00 7.16 
Table 6-2 Amino acid concentrations in late exponential phase 
This data was obtained from main cultures when the 0D546 lay between 2.33 and 2.41 (i.e. at the end of exponential phase). The intracellular 
pools are expressed with respect to culture volume (internal pool) and cell volume (intracellular concentration), as described in Section 
2.8.2. The intracellular pool and extracellular pools may be summed to give an estimated total pool, which may be compared with the actual 
total pool given in the final column. 
Intracellular tryptophan 
The internal tryptophan pools (i.e. concentrations with respect to culture volume, as 
described in Chapter 2) were 0.07, 0.10 and 0.15 j.tM for RH805, HK1/pME554 and 
HK1 /pME554IpPH28, respectively. The intracellular tryptophan concentrations (i.e. 
concentrations with respect to cell volume, calculated from the internal pool and 
0D546, as described in Chapter 2) for RH805 (50 tM) was about twice the estimate 
(20 - 30 .tM) previously made (Fantes et al., 1976). p1v1iE554 gave an increased value 
of 70 .tM. Subsequent transformation with pPH28 increased the intracellular 
concentration two-fold to 110 j.tM. 
Extracellular tryptophan 
Estimation of excreted tryptophan gave 0.06, 0.06 and 0.11 LM for RH805, 
HK1/pME554 and HK1/pMIE554/pPH28, respectively. These concentrations are low 
and are therefore subject to large errors in their determination. However, they 
suggest that cells in all strains may excrete tryptophan into the media, even at normal 
intracellular tryptophan concentrations. 
Total tryptophan 
The total culture concentrations of tryptophan were 0. 16, 0.16 and 0.25 p.M for 
RH805, HKI/pME554 and HK1/pME554/pPH28, respectively. These values give 
good agreement with the estimations based on the sum of the independently 
determined internal pools and extracellular concentrations. Thus, pME554 led to 
little, if any, increase in tryptophan concentrations, while the additional presence of 
pPH28 increased the concentration of tryptophan nearly two-fold. 
Summary 
These results show that overexpression of the tryptophan enzymes, by a factor of 
about 50, did not greatly increase tryptophan concentrations, if at all, but that the 
additional overexpression of the shikimate enzymes, by a factor of 2-5, did increase 
tryptophan concentrations. The resulting pool sizes were nearly twice those of the 
untransformed strain. 
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6.1.4 	Phenvlalanine concentrations 
Intracellular phenylalanine 
The internal pools of phenylalanine were 0.59, 0.49 and 1.30 IM for RH805, 
HK1/pME554 and HK1/pME554/pPH28, respectively. The corresponding values for 
the estimated intracellular concentrations are 410, 350 and 930 p.M, compared to the 
value of 600 p.M reported by Messenguy et al. (1980). Therefore, the overexpression 
of the tryptophan enzymes gave little change in the concentration of phenylalanine. 
The additional overexpression of the shikimate enzymes increase concentrations to 
double that of the reference strain. 
Extracellular phenylalanine 
The extracellular concentration of phenylalanine increased from 0.56 to 1.06 p.M 
when the tryptophan enzymes were overexpressed and to 3.85 J.LM when the 
shikimate enzymes were also overexpressed. As with tryptophan, all strains excreted 
phenylalanine. However, excretion appears to have increased, relative to RH805, in 
the single transformant by a small amount, and in the double transformant by a much 
greater factor. 
Total phenylalanine 
The values for total phenylalanine concentrations in RH805, HK1/pME554 and 
HK1/pME554/pPH28 were 1.1, 1.48 and 5.83, respectively. Again, the agreement 
between the sum of intracellular and extracellular determinations and that of the total 
concentration is good. The overexpression of the tryptophan enzymes increased the 
total phenylalanine concentrations within the culture by a small factor. A further small 
overexpression of the shikimate pathway enzymes led to a large increase in 
phenylalanine concentrations (5 times that of the reference strain). 
Summary 
These results indicate that the intracellular concentration of phenylalanine was 
unchanged when tryptophan enzyme activities were increased. When the shikimate 
enzymes were also overexpressed, the intracellular pool increased by a factor of about 
2. Extracellular and total pools of phenylalanine were increased in both the single 
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and, especially, the double transformants. Thus both of these strains showed 
increased excretion of phenylalanine, compared to that of R11805. 
6.1.5 	Tyrosine concentrations 
Intracellular tyrosine 
The internal tyrosine pools were 0.97, 0.75 and 2.97 iM for RH805, HK1/pME554 
and HK1/pME554/pPH28, respectively, and these may be used to calculate estimated 
intracellular concentrations of 670, 530 and 2130 pM. The value of 670 pM for 
RH805 is similar to the value of 500 pM given by Messenguy et al. (1980). The data 
show that intracellular tyrosine concentrations were largely unchanged by the 
overexpression of the tryptophan enzymes, but were increased more significantly 
(factor of 3-4), by the simultaneous overexpression of the shikimate enzymes. These 
factors are quite similar to those obtained with phenylalanine. 
Extracellular tyrosine 
Values for the extracellular tyrosine concentrations were 1. 13, 1.35 and 3.03 pM for 
RH805, HK1/pME554 and HK1/pME554/pPH28, respectively. These results, again, 
show a very similar pattern to that seen with phenylalanine, pPH28 giving a significant 
increase in the extracellular pool. 
Total tyrosine 
The total concentrations of tyrosine within the cultures were 1.90, 1.95 and 7.16 pM 
for RH805, HK1IpME554 and HK1/pME554/pPH28, respectively. As with 
tryptophan and phenylalanine, there is good agreement between the sums of the 
internal and extracellular pools and the value for the total pool. The overexpression 
of enzymes of the tryptophan pathway did not appear to change the total tyrosine 
pool. The overexpression of the shikimate enzymes resulted in a 3 - 4-fold increase in 
tyrosine concentration. 
Summary 
These results indicate that intracellular concentrations of tyrosine were essentially 
unchanged when tryptophan enzyme activities were increased. When the shikimate 
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enzymes were also overexpressed, the intracellular, extracellular and total 
concentrations increased. The results are very similar to those of phenylalanine. 
6.1.6 	Flux estimations 
The estimation of pathway flux may be achieved in two ways. Firstly, appropriate 
concentrations of metabolites and protein concentrations may be measured at two 
closely spaced time points. Secondly, if the culture approaches a steady state, one 
time point will suffice. In this case, the concentrations of the various pools may be 
multiplied by the growth rate and a factor to account for protein concentration. Both 
methods require knowledge of the concentration of amino acids in protein. Because 
the changes in pool size (especially tryptophan) in the present experiment were small, 
the determination of concentrations in the various pools at closely spaced times was 
error-prone and adjudged inadvisable. Therefore, the second option was adopted 
here. The method by which fluxes were calculated is given in Chapter 2. The protein 
concentrations in cultures measured in the course of this study lay between 150 and 
170 mg F' at 0D546 = 1, in contrast to the value of 80 mg mf 1 given by Fantes et al. 
(1976). This discrepancy may be due to differences in spectrophotometric estimation 
of cell density, calibration of protein assay with different grades of BSA, variations in 
procedure of protein determination etc. Since there was no strain variation in the 
protein concentration at 0D 546 = 1, all calculations were carried out using a protein 
concentration of 160 mg 1.1  at 0D546 = 1. 
The fluxes calculated from the amino acid composition of yeast proteins (Cortessa et 
al., 1995) and the concentrations of amino acids in the intra- and extracellular 
compartments, as determined above, are shown in Table 6-3. These may be 
summarised as follows. 
. 	The total flux in the shikimate pathway in all three strains amounted to nearly 
3 nmol min' mg protein'. This figure compares closely with the value of 
Contessa et al. (1995) who calculate the flux through erythrose-4-phosphate 





nmol • mm 1 • mg protein' % of shikimate 
Metabolite Strain flux 
To protein To metabolite pool Total 
(Accumulation rate) 
RH805 0.31 0.002 0.31 10.4 
Tryptophan HK1/pME554 0.30 0.002 0.30 10.4 
IIK1/pME554/pPH28 0.29 0.003 0.29 10.1 
R}{805 1.50 0.015 1.51 50.7 
Phenylalanine HK1/pME554 1.44 0.021 1.46 50.7 
HK1/pME554/pPH28 1.39 0.066 1.45 50.5 
RH805 1.13 0.028 1.16 38.9 
Tyrosine HK1/pME554 1.09 0.028 1.12 38.9 
HK1/pME554/pPH28 1.05 0.077 1.13 39.3 
RH805 2.63 0.044 2.67 89.6 
Prephenate HK1/pME554 2.53 0.048 2.58 89.6 
HK1/pME554/pPH28 2.43 0.144 2.58 89.9 
RH805 2.94 0.045 2.98 100 
Shikimate HK1/pME554 2.83 0.050 2.88 100 
HK1/pME554/pPH28 2.72 0.147 2.87 100 
Table 6-3 Fluxes in tryptophan, phenylalanine and tyrosine pathways during late log phase 
This data was obtained from main cultures when the 0D 546 lay between 2.33 and 2.41 (i.e. at the end of exponential phase). 
. 	0.21 mg dry wt. mt' culture at 1 unit 0D546, this is equivalent to 2.01 nmol 
min 1 mg protein'. 
. 	The total flux to tryptophan in RH805 was 0.31 nmol min' mg protein'. 
. 	The relative proportions of this total flux attributed to the tryptophan, 
phenylalanine and tyrosine branches in all three strains were approximately 
10%, 50% and 40%, respectively, in agreement with the projections made 
and summarised in Table 1-4. 
. 	The total fluxes to tryptophan, phenylalanine and tyrosine all decreased by a 
small factor in the single and double transformant, relative to the reference 
strain. This result occurs largely because of the reduction in the growth rates 
of the single and double transformants. This decrease is therefore ignored in 
the present context and analysis given below, although it is recognised that 
the changes in growth rate may be related to the changes in the tryptophan 
and shikimate pathways. 
Apart from this factor, there was no significant effect of overexpressing 
enzymes of the tryptophan pathway, by a large factor, upon the total fluxes 
to tryptophan, phenylalanine and tyrosine. Subsequent overexpression of the 
enzymes of the shikimate pathway also gave minimal changes in the fluxes. 
. 	The total flux may be broken down into two components. The flux to 
protein accounted for a overwhelming proportion of the total flux. For 
tryptophan, the contribution of flux to protein was about 99% of the total 
flux. For phenylalanine, the contribution was also about 99% in the 
reference strain, while for tyrosine, the contribution was about 97%. This, of 
course, means that even large changes in the flux to free amino acid will 
result in only small increases in total flux. 
Significant changes in flux to free metabolite did occur. These occurred 
because of changes in the intracellular and extracellular pools. 
• 	Flux to free tryptophan in RH805 was 0.002 nmol mid 1 mg protein', which, 
given the detection limits experienced here is similar to the value of 0.001 
obtained with wild-type strain X2180-1A (Miozzari etal., 1977). There was 
no significant increases in either the single or the double transformant. 
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. 	For phenylalariine, there was a small increase in flux to metabolite pool upon 
transformation with pME554. There was little change in flux to intracellular 
phenylalanine and a small increase in flux to the extracellular pool. 
Transformation with pPH28 gave a further increase in flux (both intra- and 
extracellular pools) which represented a four-fold increase over that of 
RH805. 
Similarly, there was little change in flux to free tyrosine upon transformation 
with pME554. An increased flux to the external pool was balanced by a 
decrease in flux to the internal pool. Additional transformation with pPH28, 
however, gave a three fold increase in flux relative to RH805. 
	
. 	The absolute changes in flux to total phenylalanine and tyrosine pools were 
similar. However these changes have disproportionate effects on total flux 
to phenylalanine and tyrosine, because flux to tyrosine pool is a greater 
proportion of total flux to tyrosine than is the case for phenylalanine 
6.2. 	Discussion 
The experimental data presented here, confirm that both pME554 and pPH28 lead to 
the required and expected overexpression of enzymes of the tryptophan and shikimate 
pathways. pME554 leads to anthranilate synthase activities which are approximately 
50 times that of the reference strain, while pPH28 leads to a three-fold increase in 
SDH activities. Enzymes encoded by other genes born on the two plasmids were not 
assayed in this experiment. Chapter 4 described how these other activities were 
increased by similar factors to anthranilate synthase (for the TRP enzymes encoded on 
pME554) and SDH (for the ARO enzymes encoded on pPH28) in various 
transformed strains grown to an 0D 546 of about 1-1.5 (i.e. during mid-exponential 
phase). There is reason to believe that expression of these genes is regular and 
predictable. 
Control of flux 
The effect of overexpressing enzymes of the tryptophan pathway upon the three 
component fluxes in the shikimate pathway were negligible. Transformation with 
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pME554 does not significantly change the flux to tryptophan. This is consistent with 
the results of Niederberger and colleagues who measured flux to free tryptophan 
using an aro7 (chorismate mutase) mutant transformed with pME554 and report that 
tryptophan accumulation was 'very low' during this phase of culture (Prasad et al., 
1987). Careful examination of their data suggests that concentrations were close to 
their limits of detection, as is the case during this study. 
These results are highly suggestive of low flux control coefficients for all enzymes of 
the tryptophan pathway, which is consistent with the results of the tetraploid analysis 
of Miozzari et al. (1978a). Since Metabolic Control Analysis considers the 
consequences of small changes (strictly, infinitesimal) in enzyme activity upon flux, it 
is not strictly possible to interpret the present results in the terms of MCA (e.g. flux 
control coefficients). For instance, a large change in enzyme activity may produce a 
significant change in flux for the initial small changes in enzyme activity, followed by 
no change (or even, conceivably, a negative change) for the greater proportion of the 
change in enzyme activity. This implies that the distribution of control may change as 
the expression of one or more enzymes are modified, and as modulation of the flux 
occurs. However, the number of enzymes overexpressed together with both the 
magnitude of the level of overexpression and the minimal changes in flux produced, 
suggest that most of the control of flux within the tryptophan pathway lies outwith the 
tryptophan pathway itself, at least within the context of the growth conditions (media, 
growth rate etc.) and genotype used here. In particular, it must be emphasised that 
(feedback inhibitable) anthranilate synthase is no more likely to have a significant flux 
control coefficient than the other enzymes of the pathway. 
When enzymes of the shikimate pathway were also increased by a smaller factor of 2 - 
5, there was little observable change in fluxes either. This implies that the flux control 
coefficients for these enzymes are also low. 
Control of intracellular concentrations 
There were small, possibly insignificant, changes to the internal metabolite pools when 
the enzymes of the tryptophan pathway were overexpressed by a large factor. 
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However, there were significant changes to the pools when the enzymes of the 
shikimate pathway were also overexpressed by a smaller factor. Thus internal pools 
of tryptophan increased by a factor of 1.5 relative to RH805 and the single 
transformant. Phenylalanine and tyrosine pools increased by factors of between 3 and 
4. This suggests that the control coefficients for tryptophan, phenylalanine and 
tyrosine concentrations are higher for the shikimate pathway enzymes than for the 
tryptophan pathway enzymes. 
In summary, there appears to be little control of flux to tryptophan (and phenylalanine 
and tyrosine) by the activity of the enzymes of the tryptophan and shikimate 
pathways. Instead, the control of flux to tryptophan may be located (i) downstream, 
in transporter-mediated excretion, degradation of tryptophan, tyrosine and 
phenylalanine, or in steps involved in protein synthesis, (ii) upstream within the 
pathways generating the pathway precursors erythrose-4-phosphate and phospho-
enol-pyruvate, in enzymes involved in the generation of NADPH, ribose-5-phosphate 
and ATP or, (iii) elsewhere in the rest of metabolism. In particular, it is emphasised 
that there is no evidence that the 'regulatory' enzymes, DAHP synthase and 
anthranilate synthase have significant control coefficients. 
Control and regulation of metabolite pools 
The changes in the intracellular concentrations were small, even after large increases 
in the activity of the enzymes of the tryptophan pathway. This result suggests that the 
intracellular pools are highly regulated. The question of control, as defined by MCA, 
was considered in the foregoing paragraphs. However, it will have become obvious, 
that this does not necessarily illuminate the mechanisms involved in the behaviour of 
this pathway. This is a problem of regulation. 
This regulation may simply be a result of the buffering of the metabolic pathway 
mediated by an interaction between the rates of variably-saturated enzymes (whose 
kinetic parameters in vivo are not well characterised) and changes in intermediate 
metabolite pools which may be complex. For instance, the increase of an enzyme 
which is close to saturation by its substrates, is unlikely to increase the concentrations 
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of downstream metabolites. In this case, though, we would expect such an enzyme to 
exhibit a significant control on flux. Alternatively, there may be an important role for 
the regulation of tryptophan concentration through the feedback inhibition of 
anthranilate synthase by tryptophan. This inhibition does not imply a high flux control 
coefficient for tryptophan synthase. On the contrary, as discussed above, the fact that 
the overall activity of the enzyme changes by a factor of 50, far in excess of that of the 
flux change, argues in favour of a rather small control coefficient. Furthermore, a 
theoretical analysis shows that the effect of introducing modulation of activity by 
introduction of a feedback mechanism is to reduce the flux control coefficient control 
of that enzyme. This may be illustrated by reconsidering the effects of a feedback-
resistant anthranilate synthase, first discussed in section 1.3. The changes which may 
be considered are (i) the intracellular concentrations of tryptophan, (ii) the flux to 
tryptophan and (iii) the new control coefficient of the enzyme. Fantes et al. (1976) 
report that two feedback resistant mutants, RH597 and RH598, give 50-fold increases 
in internal tryptophan pools, while Kradolfer etal. (1982) used RH51 1 which gave a 
100-fold increase. On the assumption that excretion is negligible and that the growth 
rates are unaltered, it is possible to predict that the overall flux to free tryptophan will 
be about 0.1 - 0.2 nmol • min' mg proteii7 1 . In fact, this value is in good agreement 
with the data of Miozzari et al. (1978a) and Kradolfer et al. (1982) who estimated 
tryptophan accumulation in RH5 11 at 0.17 and 0.13 nmol • min' 'mg protein 1 , 
respectively. If the flux to tryptophan in protein is included, the total tryptophan flux 
is predicted to be 0.4 - 0.5 nmol• mm 4 mg protein'. This is in close agreement 
with the flux determined (0.43 nmol• min' • mg proteiif') in wild-type strains using 
exogenous anthranilic acid to avoid feedback inhibition of anthranilate synthase 
(Niederberger et al., 1992). This shows that feedback resistance of anthranilate 
synthase results in 50 - 100-fold increases in intracellular tryptophan concentrations 
and a total flux increase of about 40%. These data address the first two questions 
posed above. Thus, feedback inhibition of anthranilate synthase is essential for the 
regulation of tryptophan concentrations observed in wild-type cells. The regulation of 
flux is less decisive. The question regarding the new flux control coefficient must rest 
upon the work of Prasad etal. (1987) who show that the flux in strain R}11207 when 
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transformed with pME559 (bearing all five TRP genes, including TRP2ftr) increases to 
values between 3.1 and 3.8, representing about a 6 - 9-fold increase relative to an 
untransformed feedback-resistant mutant. Clearly, this represents a much greater 
increase compared to the experiments conducted in this study, and suggests that 
significant flux control has shifted to anthranilate synthase. These results are 
consistent with the idea that the change to a feedback-resistant allele has increased the 
control coefficient for this enzyme. it is worth emphasising the point that changing 
the feedback networks of metabolic pathways may not necessarily change fluxes, but 
may change the distribution of control such that changes in flux become easier to 
effect by overexpressing enzymes. A corollary to this principle is that the evolution of 
feedback mechanisms may fuffil two functions. Firstly, they allow regulation of 
metabolite concentrations and secondly, they may distribute flux control more evenly. 
The explanations for the limited decreases in phenylalanine and tyrosine 
concentrations when enzymes of the tryptophan pathway are overexpressed by such 
large factors may involve a number of similar factors to those described for 
tryptophan. The concentration of chorismic acid may be regulated itself by general 
'buffering' of the system, as discussed above, and by the feedback inhibition of 
anthranilate synthase. This may interact with other factors such as the regulation of 
chorismate mutase activity by tryptophan (activation) and tyrosine (inhibition) and the 
regulation of the two isoenzylnes of DA}IP synthase, the first enzyme of the shikimate 
pathway. The effect of these factors and their interactions cannot easily be evaluated 
because the change in chorismic acid concentrations was not quantified and because 
the in vivo regulation of chorismate mutase and DAFT synthase activities and their 
subsequent effect on phenylalanine and tyrosine concentrations cannot be defined 
without more thorough investigation, involving the characterisation of metabolite 
concentrations and the effects of regulatory mutants. In addition, it is necessary, as 
with all regulatory mechanisms, to co-ordinate an investigation of the in vivo kinetics 
of the enzymes with mathematical modelling of the system. 
Both tryptophan and phenylalanine intracellular pools doubled (with respect to 
R11805) while the increase for tyrosine was somewhat larger (three-fold) when the 
164 
enzymes of the shikimate pathway was overexpressed. It is likely that this resulted in 
an increase in chorismic acid concentrations which, as a common substrate, may 
compensate the feedback inhibitions of chorismate mutase by increased intracellular 
concentrations of tyrosine and of anthranilate synthase activity by increased 
tryptophan concentration, all occurring within a context of maintained total flux. 
Also, there may be a role for the two feed-back inhibited isoenzymes of DAHP 
synthase in regulating these concentrations. 
Aromatic amino acid excretion 
All strains appeared to show some excretion even when intracellular concentrations 
were at or below those obtained with RH805. This phenomenon is discussed below. 
However, it begs the question of the possible mechanisms by which this process 
occurs. For instance, how specific is the excretion? Does it occur through passive 
diffusion? Are the aromatic amino acid transporters, encoded by TA Ti and TA T2 
involved, or are these proteins, as often suggested, strictly uni-directional in favour of 
uptake of amino acids into the cell (for example, see Opekarova etal., 1993). Is there 
'leakage' of some metabolites into secretory vesicles, perhaps during the insertion of 
membrane proteins and fusion of vesicles during the secretory process or loss of 
metabolites during cell division. 
Net excretion may arise when the export process is greater than uptake through active 
proton/amino acid symporters. Alternatively transporters may mediate an equilibrium. 
Thus the external concentration of amino acids may depend upon their intracellular 
concentrations and the relative concentrations of intracellular and extracellular 
protons. This could be modulated by an electrogenic potential. Also there may be 
kinetic constraints. For instance, Kotyk and others report that the activity of the 
membrane H 4JATP-ase affects the uptake of amino acids, while the external bulk pH 
does not (Kotyk and Dvorakova, 1992; Kotyk, 1994). This suggests that the local 
proton concentration in the vicinity of the transporter may be critical, and that this is 
kinetically controlled. This increases the possibility that at higher intracellular 
concentrations of amino acids, or when active proton concentrations at the 
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extracellular domain are low, transporters may facilitate the specific excretion of 
amino acids. 
Summary and conclusion 
In summary, the flux through all the three major branches of the shikimate pathway 
are unresponsive to changes in the activities of all of the enzymes of the tryptophan 
and shikimate pathway. Insignificant changes in concentrations of tryptophan,, 
phenylalanine and tyrosine occur following the overexpression of the tryptophan 
pathway, whereas larger changes were observed (with respect to enzyme multiplier) 
when enzymes of the shikimate pathway were increased. The perspective offered here 
is that the buffering of metabolic pathways by non-saturated enzyme kinetics and 
feedback inhibition of anthranilate synthase (also possibly, chorismate mutase and 
DAI{P synthase) activity mediates regulation of metabolite concentration, at least 
within a context where flux is maintained. This should not imply that flux is 
controlled in the same way, since feedback inhibition of enzyme activity (for example, 
anthranilate synthase) acts to reduce the enzyme's flux control coefficient. Thus the 
use of a feedback resistant allele is predicted to increase the intracellular concentration 
of tryptophan, and to increase the enzyme's flux control coefficient such that 
overexpression of this allele may now lead to a significant change in flux. Finally, the 
use of transport processes to reduce the intracellular concentrations of metabolites 
requires a characterisation of the mechanisms and kinetics of excretion and uptake, 
and an investigation of changes following the overexpression or deletion of 




The previous chapter outlined the effects of overexpressing enzymes of the 
tryptophan and shikimate pathways upon the concentrations of tryptophan, 
phenylalanine and tyrosine and upon the fluxes through the pathways, at a single time-
point toward the end of the exponential phase of batch culture. Flux changes in the 
pathways were negligible although there were significant changes in the intracellular 
and extracellular concentrations of the aromatic amino acids. In this respect the 
overexpression of enzymes of the shikimate pathway by a factor of 3 gave larger 
changes than a fifty-fold overexpression of the enzymes of the tryptophan pathway. 
This chapter gives a more detailed account of the measurements made at different 
time points during the growth of the strains. It also describes an experiment 
performed to evaluate the effect of feeding cells on anthranilic acid. 
7.1 	Growth on MV + LV(100) 
The following data are taken from the same culture as that described in Chapter 6. 
Three other time points are considered; at about 2.5, 24 and 48 hours after the 
inoculation of the cultures. The growth curves were given in Figure 6-1. Even 
though determinations of cell density were not made consistently through the course 
of the cultures, Figure 6-1 shows clear evidence of a transient slowing of growth rate 
between 10 and 20 hours followed by a further increase. This behaviour is the diauxic 
shift which occurs as glucose becomes exhausted and as cells change from 
fermentative to respiratory metabolism, provided that cultures are well aerated. 
Important changes in the pattern of gene expression are known to occur during this 
phase. 
Reproducibility of results 
As explained in Chapter 6, the estimations of fluxes are insensitive to errors made in 
the determination of metabolite concentrations, because the contributions of 
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accumulation rates are small compared to the fluxes to protein. On the other hand, a 
discussion of the effects of pME554 and pPH28 upon metabolite pools should take 
account of likely errors, reproducibility and variation. Unfortunately, a rigorous 
assessment of standard errors in determinations was beyond the scope of this study. 
In particular, an evaluation of the variation in results between similar experiments was 
difficult. 
Replicate determinations of amino acid concentrations rarely differed by more than 
20%. If different dilutions of samples were used, this factor was, on occasions, 
larger. It has been emphasised however that the difference between experimental 
determinations of internal and external pools were usually close to the experimental 
values for external pools. 
A number of pilot, aborted and repeat experiments were performed. This allowed 
some discrimination between those phenomena which appeared repeatable and those 
which were less so. Naturally, those phenomena which concerned me in this and the 
previous chapter, are of the former kind. It is appreciated that a rigorous 
confirmation of these would require further extensive experimental work. 
7.1.1 	Enzyme activities 
The specific activities of SDH and anthranilate synthase in the three strains are shown 
in Figure 7-1. 
Shikimate dehydrogenase 
As expected, the specific activity in the double transformant remained significantly 
higher than in both RH805 and HK1/pME554 throughout culture. SDH activities 
(relative to the initial activity for RH805) varied between 1 - 1.9, 0.6 - 2.4 and 2.4 - 
5.1 for RH805, HK1/pME554 and HK1/pME554/pPH28, respectively. The specific 
activity of the strain transformed with pPH28 was greater than the other two strains at 
all time points by a factor of between 2 and 5. The level of overexpression achieved 
from the plasmid was thus in line with the results described in Chapter 5. SDH 
activities of RH805 and IiKl/pME554 were similar. However, the values suggest 
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Figure 7-1 	Relative specific enzyme activities 
The specific activities of shikimate dehydrogenase (A) and anthranilate synthase (B) 
are expressed relative to the initial activities of the reference strain (RH805) which 
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that in RH805 and HK1/pME554 there was a gradual increase in activity for 24 hours 
before a decline to initial levels. HK1/pME554/pPH28, on the other hand showed a 
steady decline throughout the culture, although after 48 hours, its activity was still 
over double that of the other two strains. 
Possible explanations for the transient increases in activity include the possibility of 
increased gene expression of biosynthetic enzymes during the later stages of 
exponential growth, mediated by the transcriptional activator, GCN4, during 
starvation of specific amino acids. However, this is not considered likely; firstly 
because anthranilate synthase activities (also subject to GCN4 control) did not appear 
to show a similar trend (but see below) and secondly because cells were probably not 
starved for a specific amino acid, at this stage during culture. SDH may instead be 
subject to more specific control. In this context, it may be relevant that the double 
transformant HK1/pME554/pPH28 does not show the same behaviour, i.e. there is no 
observed increase in activity at any time during culture. Finally, chromosomal genes 
and plasmid-borne genes may show different patterns of expression. This may result 
from the influence of enhancer binding sequences at distant sites upstream of the 
normal promoter regions, or from the effect of chromatin structure, which includes 
patterns of nucleosomes and histone binding. 
Since all three strains showed a decline in the activities over the final 24 hour period, 
this loss in HK1/pME554/pPH28 is unlikely to result from a significant loss of 
plasmid, pPH28. it is possible that some of the loss is due to a change in the pattern 
of gene expression during the diauxic shift, when up-regulation of some genes, for 
instance those encoding the respiratory enzymes, may be expected. Alternatively, 
there may be specific down-regulation of genes of the shikimate pathway, or increased 
mRNA turnover in response to higher intracellular concentrations of the aromatic 
amino acids. 
Anthranilate synthase 
Figure 7-1B shows that the two strains bearing the plasmid pME554 gave greatly 
increased anthranilate synthase activities over the entire time course. Relative 
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anthranilate synthase activities varied between 1 - 1.9, 16.8 - 57.7 and 11.5 - 43.1 for 
RH805, HK1/pME554 and HK1/pME554/pPH28, respectively. The level of 
overexpression obtained from pME554 was about 6-50 times that of the reference 
strain. These results are in line with previous estimations of activities in transformed 
and untransformed strains 
However, there was a marked loss of activity in the transformants in the later stages. 
For the single transformant, HK1/pME554, this loss occurred between 24 and 48 
hours, while for the double transformant, the loss began earlier, at some point 
between 10 and 24 hours. By 48 hours these strains had specific activities of between 
10 and 20 times that of RH805. Part of this loss may have been due to the loss of 
plasmid when the concentration of tryptophan within the medium was increasing, 
leading to a possible loss of selection. However, this is unlikely to play a major role, 
because the loss occurs over a period of only two to four cell divisions. Also, the 
stability data given in Chapter 5 do not easily sustain an argument for this rate of loss. 
Another possible explanation involves a differential change in the pattern of gene 
expression from the chromosomal and plasmid-borne copies of the gene. 
The anthranilate synthase activity of RH805 appeared to increase during the culture 
(by a factor of nearly 2 by 48 hours). It is possible that this was due to upregulation 
of GCN4 as nutrients became depleted at very high cell densities. This may not be 
observed with HK1/pME554 and HK1/pME554/pPH28 because by 48 hours, the 
optical density of the two transformed strains were approximately half that of RH805. 
Therefore, nutrient depletion may not have been so advanced in the transformed 
strains. 
An investigation of the factors involved in the maintenance and change of enzyme 
activity in these experiments would require a close study of the time course of specific 
activity and plasmid stability and their dependence upon different growth conditions 
such as nutrient concentration, in different strains including, for example, a gcn4 
mutant. An analysis of other enzyme activities both within and outwith the pathway 
would be required to resolve the question. 
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In conclusion, estimation of enzyme activity confirms that the two plasmids gave the 
required and the expected levels of SDH and anthranilate synthase activities within the 
three strains. Since the activities of the other enzymes of the shikimate and 
tryptophan pathways in these strains were previously demonstrated (Chapter 5) to be 
overexpressed by broadly similar factors during exponential phase, it is assumed that 
this is the case, also, in this experiment. The changes in these enzyme activities during 
later phases of the cultures are unknown. 
7.1.2 	Tryptophan concentrations 
The intracellular pools of tryptophan are shown in Figure 7-2 and the extracellular and 
total concentrations in Figure 7-3. 
The internal pools showed a steady rise with time. When these are plotted relative to 
cell volume (Figure 7-2B) the calculated intracellular concentrations show 
approximate constancy, with the exception of the initial time point, for which low 
measured concentrations (low cell density) increased the probability of large errors. 
Despite this reservation, pME554 gave a small increase in intracellular concentration, 
and the double transformant gave a further and more significant increase. 
The extracellular pools (figure 7-3A) showed a different picture. Large differences 
between the three strains are evident after 24 hours only. The extracellular 
concentration of the single transformant is increased by a large factor relative to 
RH805 (almost 10-fold). The double transformant gave an increase over the single 
transformant by a further factor of six (i.e. 60 - fold). Following these increases, the 
extracellular concentrations fell to nearly zero after 48 hours. Thus, it appears that 
the transformed strains, particularly the double transformant, excreted tryptophan, 
toward the end of exponential phase or at onset of the diauxic shift. Furthermore, the 
results suggest that this tryptophan was then taken up from the medium as cells 
progressed toward stationary phase. It should be noted here that the large increases 
in excretion in HK1/pME554 and HK1/pME554/pPH28 occurred despite relatively 
small changes in intracellular concentrations. However, if raised internal 
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Figure 7-2 	Intracellular tryptophan 
A. The internal pools of tryptophan are expressed as concentrations with reference to 
the culture volume. B. The intracellular tryptophan concentrations are expressed 
with respect to cell volume as described in Chapter 2. 
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Figure 7-3 Extracellular and total tryptophan 
A. The concentrations of tryptophan within the supernatant are plotted. B. The 
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concentrations lead to increased excretion, then excreted tryptophan may accumulate 
in the media. 
The data on total tryptophan concentrations (Figure 7-3B) gave similar trends to the 
extracellular data, and reasonable agreement with the values calculated from the 
independent determination of intracellular and extracellular concentrations. Thus 
RH805 gave a steady increase in tryptophan concentrations over the course of the 
culture, while both the transformants give maximum concentrations after 24 hours. 
At this point the concentrations are much higher than for RH805 (5 - 15-fold) which 
is largely a reflection of the contribution of extracellular concentrations. At 24 and 48 
hours, there is some discrepancy between calculated and experimentally determined 
total concentrations. Specifically, the experimental values are higher by a factor of 
about 1.3-1.5 than those calculated. This may be due to a systematic under-
estimation of intracellular concentrations at high 0D 546 or, conversely, an over-
estimation of the experimental total concentrations. The former explanation is 
favoured here. The procedure used for extracting intracellular pools on filters, using 
TCA, at high 0D 546 is considered more likely to lead to poor extraction of amino 
acids, than the possibility that total concentrations are over-estimated using a protocol 
similar to that used for the determination of extracellular pool. 
7.1.3 	Phenylalanine concentrations 
The values for intracellular pools are given in Figure 7-4 and the extracellular and 
total concentrations are given in Figure 7-5. 
The intracellular pool of phenylalanine show trends which are similar to those of 
tryptophan, except that the values are considerably larger. There is a steady increase 
in internal pools (Figure 74A) as biomass increases. Intracellular concentrations 
(Figure 74B) are fairly constant, with the double transformant giving values 2-3 times 
those of RH805. The single transformant gave similar concentrations to R11805, 
except at 24 hours. At this time point HK1/pME554 and HK1/pME554/pPH28 both 
gave rather large increases in intracellular concentrations, which paralleled the results 
obtained for tryptophan. 
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Figure 7-4 Intracellular phenylalanine 
A. The internal pools of phenylalanine are expressed as concentrations with respect 
to the culture volume. B. The intracellular phenylalanine concentrations are 
expressed with respect to cell volume as described in Chapter 2. 
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Figure 7-5 Extracellular and total phenylalanine 
A. The concentrations of phenylalanine within the supernatant are plotted. B. The 
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Extracellular concentrations of phenylalanine (Figure 7-5A) were much greater in the 
double transformant. At 10 hours, the concentration was about 4 times that of 
RH805 and I{Kl/pME554 and at 24 hours the factor was about 8. In all three strains, 
maximum phenylalanine concentrations were obtained after 10 hours. After this, 
extracellular concentrations fell, presumably due to re-uptake by the cells. 
The total pools (Figure 7-5B) generally reflected the component pools. As with 
tryptophan, there was a similar discrepancy between calculated and experimentally 
determined figures at 12 and 24 hours. Again, a systematic under-estimation of 
internal pools would account for the results. 
Total pools rose in the transformants to a maximum at 24 hours. Because the two 
component pools showed maximum values at different times (24 - 48 hours for 
intracellular and 12 hours for extracellular), the time course for total concentration 
shows a less pronounced peak than those observed for tryptophan and tyrosine. As 
with tryptophan, RH805 showed steady accumulation of phenylalanine throughout the 
culture. 
The distinctive feature of phenylalanine production, compared to tryptophan and 
tyrosine production (see below), is the time of excretion of phenylalanine into the 
medium. For phenylalanine, maximum intracellular concentrations appear later than 
that of the extracellular concentration, whereas the reverse is true for tryptophan and 
tyrosine. Indeed, significant excretion had already taken place at 2.5 hours. This 
suggests that excretion may not be solely dependent upon intracellular concentration. 
7.1.4 	Tyrosine concentrations 
The values for intracellular pools are given in Figure 7-6 and the extracellular and 
total concentrations are given in Figure 7-7. 
The intracellular concentrations of tyrosine showed broadly similar trends to those of 
phenylalanine. However, the absolute values were about 3 - 4 times greater and also 
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Figure 7-6 Intracellular tyrosine 
A. The internal pools of tyrosine are expressed as concentrations with reference to 
the culture volume. B. The intracellular tyrosine concentrations are expressed with 
respect to cell volume as described in Chapter 2. 
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Figure 7-7 Extracellular and total tyrosine 
A. The concentrations of tyrosine within the supernatant are plotted. B. The total 
tyrosine concentrations within the culture are plotted. 
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there was a sharper increase in intracellular concentrations (Figure 7-611) at 24 hours 
for the transformants HK1/pME554 and HK1/pME554/pPH28. 
The extracellular concentrations of tyrosine in the transformants also showed a rather 
dramatic increase at 24 hours (Figure 7-7A) and thereafter a decay to zero at 48 
hours, indicating significant excretion and re-uptake. Unlike phenylalanine, this is 
consistent with the dependence of excretion upon intracellular concentrations. 
The total concentrations of tyrosine (Figure 7-713) follow the patterns set out for 
tiyptophan and phenylalanine. They show reasonable agreement with values 
calculated on the basis of the experimentally determined intracellular and extracellular 
pools, but exhibit a similar discrepancy at 24 and 48 hours as that observed for 
tryptophan and phenylalanine. 
7.1.5 	Summa 
The complex set of data presented in the preceding sections illustrates the following 
trends which were also observed in other similar experiments performed in the context 
of this project. The intracellular concentrations of tryptophan were increased by 
overexpression of the enzymes of the tryptophan pathway and, additionally, by 
overexpression of enzymes of the shikimate pathway throughout the time course. The 
appearance of tryptophan in the medium around the onset of the diauxic shift was also 
greatly increased by both manipulations. These trends were even more marked in the 
case of phenylalanine and tyrosine, and particularly marked in the double 
transformant. This constitutes some evidence of excretion of amino acids towards the 
end of exponential phase followed by a thirly rapid re-uptake from the medium. 
It is also worth emphasising another interesting result. In RH805 the internal pools 
and total pools for tryptophan, phenylalanine and tyrosine all increased steadily 
throughout the culture. In contrast there was a decrease (or marked levelling off) of 
internal pools in both the single and double transformants between 24 and 50 hours. 
For the total pools, there was a decrease in all three amino acids in the transformants 
between these time point. Indeed, the total pool for all three amino acids was actually 
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higher in RH805 than in the single transformant at the final time point. This may be a 
function of the higher cell densities achieved in the untransformed strain. 
7.1.6 	Discussion 
Dynamics of aromatic amino acid production 
The results presented in the above sections reinforce some of the conclusions drawn 
in the previous chapter which considered data from a single time-point (10 hours) 
towards the end of exponential phase. Most importantly, the total pools of 
tryptophan, phenylalanine and tyrosine were increased significantly when enzymes of 
both the shildmate and tryptophan pathways are overexpressed. It is important to 
stress that although the changes, particularly after 24 hours, were quite dramatic, the 
effect on flux is still minimal, because of the disproportionate contribution of flux to 
protein, as discussed fully in Chapter 6. 
On the other hand, there were some results which emerged here which contrast with 
those of Chapter 6. Data from samples taken at 10 hours (Chapter 6) showed that 
HK1/pME554 had concentrations of tryptophan, phenylalanine and tyrosine which 
were not significantly different to those obtained with PJ{805. The implications of 
this result was discussed in the previous chapter. After 24 hours however, the 
intracellular concentrations and the extracellular pools of tryptophan, phenylalanine 
and tyrosine were both increased by a significant factor in I{Kl/pME554 and by a 
larger factor in the double transformant. Thus, the more general result presented in 
this chapter, is that overexpression of enzymes of the tryptophan pathway actually 
increases the concentrations of phenylalanine and tyrosine, especially at 24 hours. 
How may we account for these results? 
One possibility concerns the interaction of tryptophan and tyrosine concentrations in 
modulating the activity of chorismate mutase, the first enzyme of the prephenate 
pathway. This enzyme is inhibited by tyrosine and, effectively, activated by 
tryptophan, as explained in section 1.2.6. Regardless of the change in chorismic acid 
concentrations, an activation of chorismate mutase by an increased concentration of 
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tryptophan is capable of increasing concentrations of tyrosine and phenylalanine, 
within a context of no change in fluxes. 
Another possibility concerns the possible role of phosphoribosyl isomerase, encoded 
by TRPJ. pME554 contains a form of this gene, TRPJd, which has a defective 
promoter, such that the specific activity of the gene product, phosphoribosyl-
anthranilate isomerase, does not reach the same levels of overexpression as the other 
enzymes encoded upon the plasmid. The experiments conducted by Niederberger and 
others (Niederberger et al., 1992) show that this does not seem to have a detrimental 
effect on the rate of flux through the pathway when cells are fed on anthranilic acid. 
However, it is possible that reduced overexpression of this enzyme could lead to 
increases in metabolite pools upstream and decreases in metabolite pools downstream. 
This may have the effect of increasing the concentration of chorismic acid and of 
decreasing the concentration of tryptophan, both relative to those levels which would 
be obtained in strains carrying a TRPJ gene with the wild-type promoter. Thus, it is 
still possible that chorismic acid concentrations had increased in HK1/pME554 
relative to RE1805. In this case, tyrosine and phenylalanine concentrations could 
increase, when flux is maintained, independently of any effect of an increase in 
tryptophan concentrations. 
A third possibility is that increased tryptophan concentrations may up-regulate the 
expression of the genes encoding enzymes of the prephenate pathway, though the 
adaptive significance of this is not clear. 
The first two possibilities could be resolved by investigating the effect of replacing 
TRPId by TRPI on pME554, and by determining chorismic acid concentrations.. 
This is a non-trivial change requiring a considerable investment of time and could not 
be attempted in the present study. 
Alternatively, a study of the relationship between tryptophan concentration and 
phenylalanine and tyrosine concentrations, using anthranilic acid as an exogenous 
substrate for the tryptophan pathway might illuminate the problem. Unfortunately, 
the effect of feeding cells on anthranilic acid will not only increase tryptophan 
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concentrations, but will also tend to increase the intracellular chorismic acid 
concentration. Therefore, any increase in phenylalanine and tyrosine concentrations 
may result directly from the increase in chorismic acid concentration or from the 
'activation' of chorismate mutase. Nevertheless, partly because a large increase in 
tryptophan concentration would give some assurance that enzymes other than 
anthranilate synthase were overexpressed, an experiment involving feeding strains on 
exogenous anthranilic acid was undertaken. The results of this experiment are given 
below, in section 7.2 
7.2 	Cultures fed with exogenous anthranific acid 
400 ml cultures of both RH805 and HKl/pME554 were generated from freshly 
isolated colonies, using 10 ml starter cultures in MV + LVFY ( + U (40) for 
HKJ/pME554) and 100 ml pre-cultures in media lacking phenylalanine and tyrosine. 
Cells were pelleted from the pre-cultures and washed before resuspension in medium. 
This inoculum was split equally between two identical main cultures, one to be grown 
with the addition of anthranilic acid ('fed') and one without ('unfed'). Anthranilic 
acid was added at intervals (see below) to a concentration of 20 p.M, using a sterile 20 
mM stock solution. Optical densities at 546 nm were monitored during the growth of 
the cultures, and samples were taken at intervals for the analysis of anthranilate 
synthase and SDH activity, and for the determination of concentrations of 
tryptophan, phenylalanine and tyrosine. 
Aliquots of anthranilic acid were added at hourly intervals from 3.25 hr to 9.25 hr and 
from 23.5 hr to 27.5 hr. inclusive. This schedule therefore involved two periods of 
addition; one during the exponential phase and one closer to the diauxic shift, 
separated by a period of 'recovery'. A final period of recovery was included. These 
were included to detect re-uptake of amino acids from the large extracellular pools 
which were assumed would develop during 'feeding'. 
Samples for amino acid analysis were taken after 2.7, 6.25, 8.5, 23.5, 27.5 and 51.5 
hours. For clarity, these times are given subsequently, to the nearest hour. 
Comparison of the sampling times with feeding times shows that a sample was taken 
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some time after inoculation but prior to the initiation of feeding, and two samples 
taken during the first period of feeding. After the first recovery period (over-night), a 
sample was taken prior to the start of the second period of feeding. and another 
during feeding. A final sample was taken after another overnight recovery period. 
In the previous experiment, there was good agreement between the estimated total 
concentration (calculated by adding the experimentally determined intra- and 
extracellular concentrations) and the experimentally determined concentration. For 
this reason, in this experiment, the extracellular concentrations were estimated by 
subtracting the intracellular values from the corresponding total concentrations. 
	
7.2.1 	Growth of cultures 
The optical densities of the four cultures at 546 nm are illustrated in Figure 7-8. 
RH805 grew slightly quicker (p. = 0.31 hr-) than HK1/pME554 (p. = 0.29 hi') 
during exponential phase which ended at about 9 hours. The addition of anthranilic 
acid made little difference to the growth rate of RH805. For HK1/pME554, it 
appears that the feeding of anthranilic acid slightly decreased the growth rate after 4-5 
hours. This inhibitory effect may have arisen from the rapid and large increase in 
intracellular tryptophan concentration (or intermediates of the tryptophan pathway), 
or because of effects at the cell membrane connected with the rapid excretion of 
tryptophan (see below). 
7.2.2 	Enzyme activi 
The activities of SDH and anthranilate synthase in the four cultures after 15 hours and 
36 hours are given in Table 7-1. These data show that the activity of SDH varied 
between 21.4 and 39.4 which is within the normal range of activities for a 
chromosomal copy of the gene ARO1. These activities, relative to RH805 ('unfed') at 
15 hours, varied between 0.7 and 1.3. There appeared to be no distinct difference 
between the activities of R11805 and HK1/pME554, nor between cells grown in the 
absence and presence of anthranilic acid. There were no large changes between the 
activities at the two time points. 
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Figure 7-8 Growth of cultures 
The growth of RH805 and HK1/pME554, +1- anthranilic acid are represented by 
changes in optical density at 546 mi. A Linear plot, showing times at which 
anthranilic acid was added. B Semi-logarithmic plot over the first ten hours, when 
growth appeared to be exponential. 
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Shikimate dehydrogenase 	Anthranilate synthase 
Specific Specific 
activity 	Relative activity 	Relative 
(nmol • min- ' • activity (nmoi • min 1 • activity 
mg protein) mg protein) 
30.0 1.0 0.03 
22.1 0.7 0.02 
21.4 0.7 1.37 
39.4 1.3 1.23 
21.9 0.7 0.02 
27.7 0.9 0.03 
24.2 0.8 1.17 
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Table 7-1 Enzyme activities 
The specific activity of shikimate dehydrogenase and anthranilate synthase in strains RH805, HK1/pME554 after 14.7 and 35.5 hours of 
culture in MV + LV(100) +1- anthranilic acid are given. Relative activities are calculated with respect to RH805 after 14.7 hours. 
The anthranilate synthase activities clearly shows that HK1/pME554 ('fed' and 'unfed') 
overexpresses this enzyme by factors of between 38 and 54, relative to RH805 
('unfed') at 15 hours. The relative activities in RH805 varied between 0.8 and 1.0. 
These data show that expression of these two enzymes from chromosomal and/or 
plasmid borne genes was within the range obtained in the previous experiments. 
7.2.3 	Tryptophan concentrations 
Intracellular tryptophan 
The internal pools and intracellular concentrations of tryptophan, in the four cultures 
are given in Figure 7-9A,B. 
Because of the scale of the vertical axis in Figure 7-9, the values obtained for RH805 
and I{Kl/pME554 grown in the absence of anthranilic acid ('unfed') are not clearly 
visible but were similar to those obtained from the previous experiment, in section 
7.1.3. The following features (obtained for 'unfed' cultures) are common to both 
experiments. 
The internal pools of tryptophan in R}1805 rose steadily through the course of the 
culture, whereas HK1/pME554 gave higher values (3-fold increase relative to 
RH805) during mid-culture, which then levelled off after 24 hours. This was only 
partly accounted for by the increased 0D 546 in R11805, because by 50 hours, the 
intracellular concentration in RH805 was greater than that of I{Kl/pME554. At other 
time points, the intracellular concentrations ofHKl/pME554 were only slightly 
greater than for RH805 (less than 2-fold) 
When the strains were cultured in the presence of anthranilic acid ('fed'), there were 
very large changes in intracellular concentrations of tryptophan. Increases were 
specific for times when anthranilic acid was being added to the cultures, or soon after. 
Thus, concentrations showed marked rises from 7 - 9 hours and at 28 hours, but not 
at 3, 24 and 52 hours. For RH805, intracellular concentrations reached 1.4 MM at 6 - 
9 hours and 2.3 mM after 28 hours, representing a 20 - 40-fold increase in 
188 
Figure 7-9 Intracellular tryptophan 
A. The internal pools of tryptophan are expressed as concentrations with reference to 
the culture volume. B. The intracellular tryptophan concentrations are expressed as 
concentrations within the cell based upon the equations given in Chapter 2. 
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concentration. For }IKl/pME554, the corresponding concentrations were 22.8 mM 
at 7 hours and 8.8 mM at 28 hours, representing increases in tryptophan 
concentrations by a factor of 40 - 300. 
Direct comparison of 'fed' RH805 and HK1/pME554 shows that overexpression of 
the tryptophan enzymes leads to a 4 - 16-fold increase in intracellular tryptophan 
concentrations, under this particular feeding regimen of anthranilic acid. 
Total tryptophan 
The values of the experimentally determined total concentrations are given in Figure 
7-1A. Again, values for RH805 and HK1/pME554 grown in the absence of 
anthranilic acid are not clearly illustrated because of the scale of the vertical axes. 
However, they gave similar results to those reported for the previous experiment. 
Thus, RH805 showed a steady accumulation of tryptophan over the course of the 
experiment while HK1/pME554 gave an increased accumulation of tryptophan at 
only 24 and 28 hours, when the total concentration was 2-5 times that of RH805. 
From 24-50 hours, HK1/pMiE554 showed a net loss of free tryptophan. The absolute 
values obtained here were in the same range as those reported from the previous 
experiment. 
With the addition of exogenous anthranilic acid, both RH805 and HK1/pME554 
showed very large increases in total tryptophan pools, followed by rapid loss during 
the 'recovery' periods. RH805 gave 3.1 and 4.8 .tM tryptophan at 7 and 9 hours, 
respectively; a 25-fold increase over 'unfed' RH805. At 28 hours there was 7.1 p.M 
tryptophan; which was a 30-fold increase. However, at 24 hours, prior to the 
initiation of the second phase of 'feeding'. the tryptophan concentration was 0.3 p.M, 
which was almost the same as that of'unfed' RH805. HIK1/pME554 gave an even 
higher concentration of free tryptophan; 53, 59 and 50 p.M at 7, 9 and 28 hours 
respectively, representing a 600 - 700-fold increase in concentration, relative to the 
'unled' strain. At 24 hours, after a 12 hour recovery period, the concentration had 
dropped to 20 p.M, still a 20-fold increase over the 'unfed' cells. 
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Figure 7-10 Total and estimated extracellular tryptophan 
A. Total tryptophan. B. The extracellular tryptophan is calculated from the values 
determined for total and internal pools. 
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The calculated values (see section 7.2) are plotted in Figure 7.10 (B). 
In 'unfed' strains, the calculated extracellular concentrations are low, (less than 0.07 
tM), except for HK1/pME554 at 24 hours, when the concentration was calculated to 
be 0.42 M. This result is in good agreement with the previous experiment, where a 
definite peak in excreted tryptophan was obtained in the single (and double) 
transformant during mid-culture. 
The concentrations calculated for the 'fed' strains are as follows. RH805 gave 
elevated values at times when the internal concentrations of tryptophan were highest; 
2.3 and 3.4 .tM at 6 and 9 hours. It is not possible to give a valid factor by which 
these values exceed those of the 'unfed' strains, because of the very low values 
obtained in RH805 ('unfed') which therefore incur unacceptably large errors. At 28 
hours, when the intracellular concentration of this strain was at its maximum value, 
the estimated extracellular concentration was -2.9 tM. In order to investigate this 
value, determinations of concentrations in samples taken at this time-point were 
repeated many times. Negative values for the estimated extracellular concentration 
were always obtained. The corresponding calculations for tyrosine and phenylalanine 
gave large positive values. Hence, it must be concluded that the extracellular 
tryptophan concentration was probably quite low and that the negative concentration 
arose because of an underestimation of tryptophan in the 'total' sample, an over -
estimation of tryptophan in the 'intracellular' sample, or both of these. The calculated 
concentrations at other time-points did not differ from those of'unfed' RH805. 
For HK1IpME554, the calculated extracellular tryptophan concentrations were much 
higher. Values of 44.4, 54.3, 18.7 and 24.7 4M were obtained at 7, 9, 24 and 28 
hours, respectively. The values at 3 hours (before feeding) and 52 hours (after 
feeding) are low and not significantly different from those of the 'unfed' culture. 
These results show that excretion of tryptophan is greatly increased in 'fed' strains by 
a large factor compared to 'unfed' strains. For instance, at 24 hours there was a 40- 
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fold increase. Furthermore, the results show that tryptophan is rapidly taken up from 
the supernatant, during both recovery periods. 
Summary 
• pME554 increases tryptophan production especially during mid-culture. This 
confirms the results of the previous experiment. 
Exogenous anthranilic acid increased the intracellular concentrations, and total 
concentrations in RH805 and HK1/pME554 during both periods of feeding. 
• Increased excretion of tryptophan accompanied these changes (except in the 
case of RH805, during the second feeding period). 
• in 'fed' cultures, pME554 gave a 12 - 17-fold increase in total tryptophan 
concentrations during exponential phase compared to RH805. 
The fact that HK1/pME554 gives such a large amplification of tryptophan 
accumulation when exogenous anthranilic acid is supplied, compared to R11805, 
strongly suggests that some, if not all, of the other enzymes of the tryptophan 
pathway are being overexpressed, in addition to the two enzymes (anthranilate 
synthase and tryptophan synthase) which have been assayed in this study. 
This experiment also suggests that anthranilate synthase's sensitivity to feedback 
inhibition by tryptophan plays a role in the regulation of intracellular concentration. 
Of course, it does not constitute rigorous evidence, because the internal concentration 
of anthranilic acid is likely to be much higher than when exogenous anthranilic acid is 
not supplied. Instead, a proper evaluation of the role of feedback inhibition requires 
the use of a feedback insensitive anthranilate synthase mutant. 
7.2.4 	Phenylalanine concentrations 
Intracellular phenylalanine 
The intracellular concentrations of phenylalanine are illustrated in Figure 7-11. 
For RH805 and HK1/p1v1E554 grown in the absence of anthranilic acid, the observed 
concentrations were very similar to those obtained in the previous experiment. Thus 
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Figure 7-11 Intracellular phenylalanine 
A. The internal pools of phenylalanine are expressed as concentrations with reference 
to the culture volume. B. The intracellular phenylalanine concentrations are 
expressed with respect to cell volume as described in Chapter 2. 
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in RH805, internal phenylalanine pools increased steadily over time in RH805, 
resulting in a constant intracellular concentration of about 250 - 450 jiM. 
In HK1/pME554, the intracellular concentrations were slightly greater than those of 
RH805, except for a large increase to 850 and 630 jiM after 24 and 28 hours, 
respectively, when the 0D 546 were 4.4 - 5.0. 
When fed with anthranilic acid, the cultures showed increased phenylalanine 
concentrations. RH805 showed slight increases in intracellular concentrations at most 
time points. For instance, there were 10%, 37%, 53% and 6% increases at 6, 8, 24 
and 52 hours, respectively. However, at 28 hours, there was a very large increase of 
320%. At this point, the intracellular concentration (1,220 PM) was about double 
that of the strain transformed with pME554 (unfed)( 630 jiM). This point appears 
toward the end of the second phase of feeding with anthranilic acid. For 
HKl/pME554, feeding with anthranilic acid increased intracellular phenylalanine 
concentrations by over 100% after 6, 9 and 28 hours. In contrast, the increases (with 
respect to the unfed transformant) appeared to be less marked after the two periods 
when feeding was relaxed (24 and 52 hours). The observed profile therefore shows 
two definite peaks of intracellular concentration which appear during the 'feeding' 
periods. 
Total phenylalanine 
The total concentrations of phenylalanine are illustrated in Figure 7-12A. These data 
showed similar patterns observed with the intracellular concentrations. Thus, an 
increase in total concentration was observed in HK1/pME554 ('fed') between 3 and 9 
hours, during the first period of feeding, whilst no significant increase was noted in 
RH805 or in HK1/pME554 ('unfed'). In this culture, there was also a subsequent rise 
during the second period of feeding. In contrast the 'unfed' I{Kl/pME554 showed an 
increase from 9 hours to 24 hours which was followed by a subsequent decrease, in 
line with the previous experiment. RH805 ('fed') showed a hugely increased 
concentration during the second period of feeding, before dropping back to former 
levels. 
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Figure 7-12 Total and estimated extracellular phenylalanine 
A. Total phenylalanine. B. The extracellular phenylalanine is calculated from the 
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These data are given in Figure 7-12B. In the 'unfed' strains, there was an increase in 
the calculated extracellular phenylalanine from HK1/pME554 compared to RH805 
and this difference was particularly marked at 24 hours, somewhat later than in the 
previous experiment where the excretion of phenylalanine was observed to occur 
earlier than the excretion of tyrosine. This may result from the sharp increase (and 
subsequent decrease) which appeared at this time point, and leads to a high sensitivity 
of phenylalanine concentration upon rather small changes in time (or 0D 546). In the 
two 'fed' strains there was a clear, and striking result; increased extracellular 
concentrations were expected to occur in two separate waves, corresponding to the 
periods of feeding on anthranilic acid. During the two subsequent 'recovery' phases, 
the extracellular concentrations dropped, suggesting re-uptake of phenylalanine into 
the cells. 
Summary 
. For 'unfed' cells, the results of the previous experiment were confirmed. Of 
particular interest here, is the peak concentration which occurred at 24 hours in 
HK1/pME554. 
. Anthranilic acid increased intracellular concentrations of phenylalanine at all 
stages, in both HK1/pME554 and in R11805, but big rises occurred during both 
feeding periods for HK1/pME554 but only the second period with R11805. 
. Total concentrations of phenylalanine and extracellular concentrations followed 
a similar pattern 
When attempting to account for these results (and those of tyrosine and, to a lesser 
extent, tryptophan) it is important to appreciate that during the period from 9 hours to 
28 hours, two separate factors appear to operate. One is the transient increases in 
intracellular and extracellular concentrations which accompany transformation with 
pME554 and which were also observed in the previous experiment. This occurred 
between 9 and 24 hours (0D 546 = 1.29 - 4.41) in this experiment and between 10 and 
25 hours in the previous experiment (0D5 46 = 2.35 - 5.10). The second factor, in the 
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present experiment, is the increased concentrations which appear to be contingent 
upon anthranilic acid. Thus HK1/pME554 showed two increases in intracellular 
phenylalanine concentration at 7 and 28 hours while both 'fed' strains showed 
increased intracellular phenylalanine concentrations at 28 hours after the second phase 
of 'feeding'. 
The results suggest a number of questions which need to be addressed. Why do 
transformed strains (pME554) show higher intracellular concentrations of 
phenylalanine than RH805 in mid-culture? Why does feeding of anthranilic acid 
increase the intracellular phenylalanine concentrations (in both RH805 and 
HK1/pME554), particularly during the feeding period? Finally, what factors are 
involved in the particularly abrupt increase in RH805 (fed) between 24 and 28 hours. 
These questions are discussed in section 7.2.6 below. 
7.2.5 	Tyrosine concentrations 
Intracellular tyrosine 
The results of the determination of intracellular pools of tyrosine are given in Figure 
7-13. The data for 'unfed' strains are similar to those obtained in the previous 
experiment. Thus, intracellular concentrations of tyrosine in HK1/pME554 are very 
similar to those of RH805 except at 24 (and 27) hours when a large increase was 
observed. In this experiment, the increase was over 10-fold, compared to about six-
fold in the previous experiment. This discrepancy may occur because of the rather 
sharp rise (and subsequent decrease) which probably occurs around this time point, as 
discussed above. 
The effect of feeding anthranilic acid upon the values of intracellular tyrosine 
concentrations was rather small, in comparison to the phenylalanine concentrations. 
Firstly, there was only a small initial increase in IiKl/pME554 during the first period 
of feeding, as was the case with phenylalanine. But there was only a small effect 
during the second period. Thus, RH805 showed an increase by 28 hours, while for 
HK1/pME554 the drop in concentration was lower for the 'fed' cells, compared to 
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Figure 7-13 Intracellular tyrosine 
A. The internal pools of tyrosine , are expressed as concentrations with respect to the 
culture volume. B. The intracellular tyrosine concentrations are expressed with 
respect to cell volume as described in Chapter 2. 
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that of the 'unfed' cells. In all cases, the intracellular concentrations returned to the 
'normal' levels. 
Total tyrosine 
The total concentrations of free tyrosine (Figure 7-14A) generally reflected the values 
obtained for the intracellular concentrations, with the exception of 'fed' RH805. Thus 
the transformed strain, HK1/pME554 ('fed' and 'unfed') showed large increases in 
tyrosine concentrations at the 24 (and maintained at the 27) hour time point, 
confirming the result of the previous experiment. The surprising result was the large 
increase observed in the 'fed' RH805 which occurred between the 24 and 28 hour 
sample. This increase is thus likely to be a response to feeding on anthranilic acid. 
This result paralleled that obtained for phenylalanine. However, another distinctive 
result for phenylalanine, namely the increases which occurred for HK1/pME554 
during both periods of feeding, was not observed for tyrosine. 
Extracellular tyrosine 
The calculated extracellular concentrations of tyrosine show large increases by 24 
hours in HK1/pME554 ('fed' and 'unfed'). RH805 ('fed') showed a massive increase 
during the second period of feeding.. In all cultures, the concentrations of 
extracellular tyrosine were predicted to fall back to low levels by 52 hours. 
Summary 
In the 'unfed' strains, intracellular tyrosine concentrations peaked at 24 hours in 
HK1/pME554, before returning to previous concentrations, whereas RH805 
maintains a more constant concentration. This result confirms those of the 
previous experiment. 
. The addition of anthranilic acid had little effect on intracellular concentrations 
during the first period (exponential phase). During the second feeding period, 
the concentration in RH805 increased slightly and there was a small decrease in 
the (normal) drop in concentration in HK1/pME554. 
. The total concentrations largely reflected the effect of the intracellular 
concentrations. However, the second period of anthranilate acid addition 
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Figure 7-14 Total and estimated extracellular tyrosine 
A. Total tyrosine. B. The extracellular tyrosine is calculated from the values 
determined for total and internal pools. 
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• greatly increased the total concentration in RH805 (at similar levels to those of 
HK1/pME554). 
• The calculated extracellular concentrations followed a similar pattern. Feeding 
only slightly increased extracellular concentrations, relative to 'unfed' culture at 
28 hours. For R11805, however, there is a very large predicted appearance of 
tyrosine into the medium, during the second feeding period. 
7.2.6 	Discussion 
Before discussing the effects of adding exogenous anthranilic acid upon the 
production of tryptophan, phenylalanine and tyrosine, some comments on the results 
from the 'unfed' control cultures are required. The results obtained here confirmed 
the findings of the previous experiment, reported in section 7.1. In particular, there 
was a striking increase in intracellular and extracellular concentrations of tiyptophan, 
phenylalanine and tyrosine which appeared during mid-culture, in strains transformed 
with pME554. This peak occurs somewhere between 9 and 28 hours; i.e. between 
0D546 of 1 - 5. Because of the limited number of data points, and because of the 
possible rapidity with which concentrations may rise (and fall), it is not possible to 
define accurately the growth phase where this increase occurs, nor is it possible to be 
absolutely sure that a corresponding rise in concentrations does not occur in RH805. 
Nevertheless, the fact that no evidence of a rise has been detected in any of the three 
metabolites in three (including 'fed' RH805) different cultures reported here, nor in 
other 'pilot' experiments, strongly argues against this. Clearly, further experiments 
using more closely spaced time-points are required to confirm this presupposition and, 
more interestingly, to characterise the dynamics of the production for all three amino 
acids. For instance, in the light of the possibility that maximum phenylalanine 
excretion might occur before that of tryptophan and tyrosine (see Figure 7-5A), it 
would be helpful to know if the increase in one amino acid was contingent upon the 
change in another. Furthermore, it might be important to know if these phenomena 
are related to a specific growth phase or to cell density. In this case, an experiment 
which shills cells into fresh medium at high cell densities may resolve this question. 
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It is necessary to offer some speculation about the reasons for the phenomenon as it 
stands. It is possible that these mid-culture changes are associated with increased 
internal tryptophan concentrations. This might be mediated by two mechanisms, as 
was discussed in section 7.1.6. Firstly, increased tryptophan concentrations may 
activate the enzyme chorismate mutase. This may increase both phenylalanine and 
tyrosine concentrations, in the context of constant flux. Secondly, increased 
tryptophan concentrations may inhibit anthranilate synthase, leading to an increase in 
chorismic acid concentrations, which may allow phenylalanine and tyrosine 
concentrations to rise. The evidence that one or other of these mechanisms may 
operate is not clear. Thus, feeding anthranilic acid to RH805 and J{Kl/pME554 
between 3 - 10 hours and between 23 - 28 hours is associated with transient increases 
in intracellular and extracellular phenylalanine and, possibly, tyrosine (see Figures 7-
11B, 7-12A, 7-13B and 7-14A). The presence or absence of effects are summarised 
in Table 7-2. The effect upon phenylalanine concentrations is large for both internal 
and external concentrations (Figure 7-11 B, 7-12A) except during the first feeding 
period in R11805. There are similar effects with tyrosine except that extracellular 
concentrations are not increased in the double transformant, probably because the 
concentrations are already so high (Figures 7-13B and 7-14A). These data suggest 
that tryptophan over-production may have the predicted effect but that this is 
modified by differential regulation of phenylalanine and tyrosine. Despite this 
demonstration that tryptophan may regulate the concentrations of phenylalanine and, 
to a lesser degree, tyrosine, it must remain doubtful that this effect is responsible for 
the 'mid-culture' peaks in 'unfed' IiKl/pME554 seen in both experiments. Thus the 
rise in tryptophan concentration under these circumstances is so much smaller (2-fold 
relative to 'unfed' RH805) than those resulting from the exogenous addition of 
anthranilic acid. Also, it is predicted that feeding anthranilic acid to HK1/pME554 
will have a greater effect than for RH805, since tryptophan concentrations are 
increased by a larger factor in the transformant. The data do not fully support this 
hypothesis. Although the data in respect of the production of phenylalanine during 
the first period of feeding are consistent with this view, the situation is reversed 
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	 24-28 hours 	+ 	 + 	 + 	 + 
7-9 hours 	+ 	 + 	 + 
HK1/pME554 
24-28 hours 	+ 	 + 	 +1- 
Table 7-2 The effect of Anthranilic acid on phenylalanine and tyrosine concentrations 
The degree to which anthranilic acid appears to increase intracellular and extracellular concentrations of phenylalanine and tyrosine in RH805 
and HK1/pME554 during two time intervals is shown. '-' indicates no apparent change, '+' indicates a definite increase and '+1-' indicates a 
doubtful or small increase. 
phenylalanine production. In any event, explanations must be sought for the rather 
transient increase in tryptophan concentration itself in transformed cells. 
It as seems likely, the increase in tryptophan concentration resulting from 
transformation by pME554 is not wholly responsible for the rather large increases in 
phenylalanine and tyrosine concentrations during mid-culture in the absence of 
anthranilic acid, then other reasons must be sought. It is tempting to speculate that 
these effects are coincident with changes occurring during the diauxic shift. During 
this period, cells are adapting to low concentrations of glucose and are shifting from a 
fermentative to a respiratory mode of metabolism. This requires a shift in the pattern 
of gene expression. For instance, enzymes specific to glycolysis may be down-
regulated, while those specific to respiratory and gluconeogenic pathways are up-
regulated. Similarly, and possibly significantly, the flux through amino acid 
biosynthetic pathways is likely to be less because of the reduction in the growth rate 
which reduces the requirement for amino acids in protein, and may lead to a transient 
over-supply of amino acids if flux cannot be regulated rapidly without changing 
enzyme expression levels. It seems not unlikely, therefore, that a transient increase in 
amino acids arises during this period of adjustment. A number of predictions follow 
from this analysis. For instance, the appearance of peaks in the intracellular 
concentrations of the aromatic amino acid are expected to arise as the growth rate 
begins to drop. Also, similar increases in the intracellular concentrations of other 
amino acids are expected. In contrast, the timing of the subsequent 're-adjustment' of 
amino acid concentrations may be less significant. It may occur as a response to an 
increase in growth rate after the diauxic shift. Alternatively, it may occur earlier in 
response to an adaptive change in patterns of gene expression. However, this analysis 
does not explain the fact that the untransformed strain, RH805, does not show the 
phenomenon. Because of this fact, the differences in the growth curves obtained for 
RH805 and HK1/p1v1E554 may be crucial. For example, HK1/pME554 grows slower 
than RH805 after the end of exponential phase and, indeed, may not grow to such a 
high density. This suggests that HK1/pME554 may be less able to adapt during the 
diauxic shift. This may be connected with a loss in this strain's ability to regulate the 
concentrations of aromatic amino acids. Clearly, experiments which involve a more 
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thorough investigation of the time-course of aromatic amino acid concentrations and 
its relation to cell density, growth rate and pattern of gene expression during the 




This final discussion briefly summarises the main findings of the present study. It 
attempts to place these results in the context of the original objectives of the project 
and discusses their implications with respect to an understanding of metabolic 
regulation. The biotechnological implications are considered with special reference to 
recent attempts both to provide a theoretical basis for pathway manipulation and 
experimental work on the system of aromatic amino acid biosynthesis. Finally, some 
thoughts about how future work in this area should be taken forward are presented. 
8.1 	Summary of the results 
In order to apply the universal method to the problem of tryptophan over-production, 
a plasmid, pPH28 has been constructed which overexpresses enzymes of the shikimate 
pathway by a small factor. It has been introduced into an appropriate host strain. 
HK!, along with a multi-copy plasmid, pME554, which overexpresses the enzymes of 
the tryptophan pathway by a much larger factor. The effects of these changes were 
remarkably small under the conditions tested. 
Fluxes to all three aromatic amino acids were effectively unchanged. During 
exponential growth when steady state conditions were most likely to prevail, there 
were, however, some changes to amino acid pools, especially those of phenylalanine 
and tyrosine. Nevertheless, these changes were very limited. When pME554 alone 
was present there were fairly insignificant changes to tryptophan, phenylalanine and 
tyrosine, while all three were slightly increased when both plasmids were present. 
These results were interpreted as suggesting that the flux and metabolite control 
coefficients of the enzymes within these pathways are very small. The levels of 
tryptophan, in particular, are highly regulated and this was discussed in terms of the 
role of feedback inhibition of anthranilate synthase by tryptophan. The data of 
Niederberger and others was used to discuss how feedback resistance has the effect of 
reducing the control coefficient of the enzyme. Thus removing feedback resistance 
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not only has the effect of allowing the metabolite pool to increase, but also allows 
greater amplification of flux following overexpression of the enzyme (Prasad et al., 
1987). 
The concentrations of tryptophan, phenylalanine and tyrosine increased quite 
dramatically during the intermediate phase of batch culture of transformants 
containing pME554 and, especially, those containing both plasmids. This 
corresponded to the onset of the diauxic shift. The increases were largely accounted 
for by an increase in the extracellular pool. There was therefore evidence of excretion 
of all three amino acids during this phase which was subsequently followed by re-
uptake of amino acids during respiratory growth phase. 
8.2 	Evaluation of the project's objectives 
The objectives set at the beginning of the project and given in Chapter 1 were 
• 	to apply the universal method to tryptophan biosynthesis in yeast 
• 	to achieve increases in tryptophan production 
• 	to reduce changes in other closely-related pathways 
• 	to test the validity of 'the universal method' 
• 	to understand what factors may limit the effectiveness and 
applicability of the method 
The universal method has been applied, at least in a limited form (see below section 
8.3). As explained above, significant increases in tiyptophan production were not 
observed (except transiently during the diauxic shift). The third objective was 
founded on a false premise; i.e. it was assumed that the overexpression of the 
tryptophan enzymes would lead to a reduction in the flux to phenylalanine and 
tyrosine, or at least to a reduction in their pools. This was found not to be the case. 
Indeed, during the diauxic shift, phenylalanine and tyrosine were found at higher 
concentrations. Also, the changes in phenylalanine and tyrosine concentrations upon 
transformation with pPH28 were actually greater than those obtained for tryptophan. 
The evaluation of the final two objectives is given below in the next section. 
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8.3 	Evaluation of the universal method 
The implementation of the changes outlined in Chapter 1 has resulted in an 
insignificant change to flux to tryptophan.. Therefore, experimental support for the 
universal method has not been obtained. 
However, there are a number of important factors which suggest that the universal 
method has not been properly applied to this system. Most importantly, the full 
pathway has not been considered. Other fluxes from tryptophan were ignored. Also, 
because there remains the need to maintain internal tryptophan pools at unchanged 
concentrations, excess tryptophan should be excreted from the cell into the medium. 
If this is the case, then another branch point metabolite (tryptophan) appears (Figure 
8-1). This creates two new pathway sections. Excretion to extracellular tryptophan 
and incorporation to protein. If the universal method is applied to these sections (in a 
comparable way to its application at the branch-point metabolite, chorismic acid) then 
excretion would have to be increased by a factor of about, say, 2500 for the full 
effects of the present system to be realised. Alternatively, a more realistic increase in 
the excretion step would require a much smaller overexpression of the tryptophan 
pathway enzymes than was achieved here, and a negligible increase in the shikimate 
pathway enzymes. 
The question of increasing tryptophan excretion may, however, be problematic as 
discussed earlier in Chapter 6. If excretion depends upon the specific transporters, 
TAT] and TA T2, the intracellular concentration of tryptophan required to give 
significant net excretion may be significantly higher than the normal tryptophan 
concentration, which defeats the purpose of the exercise and, in any case, is likely to 
limit the flux to small increases. The most practical way to achieve increased 
excretion is to use the feedback resistant allele encoding anthranilate synthase, 
TRP2ft, which allows the pathway to function at very high intracellular 
concentrations of tryptophan and, thereby, leads to increased excretion (Prasad et al., 
1987; Kradolfer etal., 1982). This implies that a serious evaluation of the universal 
method is only possible by comparing the changes in flux in a TRP2Jb host strain, 
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Figure 8-1 The tryptophan pathway, branch pathways and 
branch-point metabolites 
E4P, erythrose-4-phosphate; PEP, phosphoenolpyruvate 
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before and after transformation with pME559 (which bears the same allele as well as a 
copy of the other tryptophan genes) and pPH28. Unfortunately, no stable 
transformant bearing pME559 was obtained. Even if the universal method were 
successfully employed in this modified system, the applicability of the method would 
be restricted. One of the claims of the method negates the need to understand or 
modify the regulatory mechanisms operating within the pathway of interest. In the 
case of pathways which are highly regulated by their end-product, this problem must 
be specifically addressed. This thesis has therefore clarified the constraints which may 
operate to limit the applicability of the method. 
8.4 	Metabolic engineering with specific reference to 
aromatic amino acid biosynthesis. 
The approach adopted in this thesis is not the only one used in attempts to increase 
production through aromatic amino acid biosynthesis. An examination of these others 
is revealing. 
For instance, Flores et al (1996) describe the manipulation of a number of factors 
using E. coli as a model system. Firstly, they identify PEP production as a limiting 
factor. Since the phosphotransferase system (PTS) uses PEP to transport glucose 
into the cell, they generate a PTS derivative of their chosen strain, which can still 
utilise glucose (using a galactose transporter of reduced specificity). In addition, they 
also overexpress a feedback insensitive DAHP synthase from a plasmid and measure 
the DAI{P excreted into the culture supernatant. Their data show that excretion of 
DAI{P is approximately doubled in the PTS strain. They also overexpress a 
transketolase from the same plasmid in order to increase the supply of E4P. This also 
has the effect of doubling DAHP excretion in both the PTS and PTS strains. 
A number of comments may be made. These experiments were performed in strains 
which already overproduced tryptophan (unpublished work). it is difficult to make 
claims about the generality of the data without knowing the genotype of their strains. 
Secondly, the use of a feedback resistant allele of DA}{P synthase may change the 
structure of control within the pathway. Thirdly, and most importantly, the results tell 
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us nothing about the effect of these changes upon flux to chorismate and beyond. 
They only report on possible increases in DAHP excretion. What the results do 
suggest is the idea that many factors may contribute to the control of metabolite 
concentration. This important point was not made explicit. What were the effects 
upon tryptophan production? It would seem certain that significant increases in 
tryptophan would have been reported. Therefore it is tempting to suppose that very 
modest increases were obtained, if at all. 
Katsuniata and Ikeda (1993) studied tryptophan overproduction in Corynebacterium 
glutamicum. Their starting strain bears a mutation in chorismate mutase giving 
auxotrophy for phenylalanine and tyrosine. It was also derepressed for tryptophan. It 
excreted tryptophan into the medium to a concentration of 28 g t 1 . They assumed 
that DAI{P synthase was rate-limiting because they could not detect tryptophan 
pathway intermediates in supernatants. However, when DAHP synthase was 
overexpressed (by a factor of 8), tryptophan production increased by only 10%. 
Since they now detected chorismate in the medium, they assumed that anthranilate 
synthase was now rate-limiting. However when this and the other tryptophan 
enzymes were over-expressed by a factor of about 10 no increase in tryptophan 
production was noted. A modest increase (about 25%) was only obtained when 
anthranilate synthase and anthranilate phosphoribosyltransferase were made 
insensitive to feedback inhibition by tryptophan. 
Despite the fact that the starting strain produced enormous amounts of tryptophan 
even before manipulation, data such as these as well as those presented in this thesis 
may convince us that control of metabolite concentration and control of flux may be 
(and probably usually are) distributed across many metabolic reactions, that simple 
efforts to manipulate fluxes are rarely successful, and that success will most easily be 
gained by (i) identification of those steps which do exert control by experiment rather 
than argument based upon inappropriate theory, (ii) manipulation of many steps or 
(iii) manipulation of the mechanisms which operate to regulate the concentrations of 
useful metabolites. 
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8.5 	Future directions 
Despite the limitations of the Universal Method illustrated here, it would be 
interesting to repeat the same manipulations substituting a feedback-insensitive 
anthranilate synthase allele in the TRP plasmid and in the host strain. The results of 
Prasad et al. (1987) suggest that the flux multipliers obtained would be greater than 
obtained with pME554. Additionally, the role of the aromatic amino acid transporters 
TAT1 and TAT2 in mediating excretion and a further increase in tryptophan 
production could be investigated by overexpressing these genes. 
Our ability to predictively manipulate microbiological growth in order to achieve a 
given output is likely to depend upon a matching of mathematical modelling with 
observed physiology. This in turn may depend upon our theoretical understanding of 
pathway regulation but will also involve validation of models against their real 
behaviour. Thus, there is a need to determine the kinetic parameters operating within 
a pathway and to test these against the actual behaviour of the pathway, possibly 
under 'steady state' conditions within a chemostat. The tryptophan pathway is 
reasonably well characterised in different micro-organisms and has real industrial 
potential. It would provide a good model system for further kinetic characterisation 
and modelling. 
The problems of modelling other modes of culture more relevant to industrial needs 
(e.g batch mode) are, of course, more complex. The rapid increases in excretion of 
tryptophan, phenylalanine and tyrosine toward the end of exponential phase and their 
subsequent re-uptake from the medium are interesting phenomena which are now 
amenable for study. A more precise characterisation of their dynamics and their 
contingencies could be undertaken in order to better understand the transitions in 
physiological state during the diauxic shift. 
It is interesting to speculate that any future exploitation of biotechnology may be 
limited by our lack of understanding of microbiological physiology as much as our 
ability to manipulate gene expression at will. 
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